Affiliations
Division of Biostatistics, Mayo Clinic, Rochester, Minnesota
Given name(s)
Rachel E.
Family name
Gullerud
Degrees
BS

Heart Failure and Hip Fracture Repair

Article Type
Changed
Mon, 05/22/2017 - 21:23
Display Headline
Impact of heart failure on hip fracture outcomes: A population‐based study

As the population ages, hip fractures and heart failure increase in prevalence.1, 2 Heart failure prevalence is also increasing in hospitalized patients.3 Indeed, hospitalizations involving heart failure as an active issue tripled in the last 30 years.4 Heart failure has been associated with an increased risk for hip fracture,5, 6 and previous studies report a 6%20% prevalence of preoperative heart failure in hip fracture patients.710 While exacerbation of heart failure increases the mortality risk in patients admitted for hip fractures,8 the incidence of new heart failure, as well as the preoperative factors that predict postoperative heart failure in this patient population remain unclear.

American College of Cardiology/American Heart Association (ACC/AHA) perioperative guidelines identify orthopedic surgeries, including hip fracture repair, as intermediate risk procedures.11 Compared to other intermediate risk operations, however, postoperative outcomes following hip fracture repair differ significantly.1216 Overall mortality in hip fracture patients has been reported at 29% at one year,8 with the excess mortality from hip fracture alone at nearly 20%.10, 13 However, the exact factors that contribute to this excess mortality, particularly with regard to heart failure, remain unclear.

To examine the preoperative prevalence, subsequent incidence, and predictors of heart failure in patients undergoing hip fracture repair operations, this study used an established, population‐based database to compare the postoperative consequences in hip fracture repair patients with and without preexisting heart failure. We hypothesized that preoperative heart failure worsens postoperative outcomes in hip fracture patients.

METHODS

Case Ascertainment

Following approval by the Institutional Review Boards of Mayo Clinic and the Olmsted Medical Center, we used the Rochester Epidemiology Project (REP) to identify the patients for this study. The REP is a population‐based medical records linkage system that records all diagnoses, surgical procedures, laboratory data, and death information from hospital, emergency room, outpatient, and nursing home care in the community.17

All Olmsted County, Minnesota, residents who sustained a hip fracture and underwent surgical repair from 1988 through 2002 were evaluated. Patients with more than one hip fracture during the study period (96 occurrences) were censored from the data analysis at the time of the subsequent hip fracture and then included as new cases. The complete enumeration of hip fracture episodes managed in the three Olmsted County hospital facilities (Mayo Clinic's Saint Mary's and Rochester Methodist Hospitals, and the Olmsted Medical Center Hospital) occurred in three phases: First, all hospitalizations with the surgical procedure (International Statistical Classification of Diseases, 9th Revision [ICD‐9]) codes 79.15 (reduction, fracture, femur, closed with internal fixation), 79.25 (reduction, fracture, femur, open, without internal fixation), 79.35 (reduction, fracture, femur, open with internal fixation), 79.95 (operation, unspecified bone injury, femur), 80.05 (arthrotomy for removal of hip prosthesis), 80.15 (arthrotomy, other, hip), 80.95 (excision, hip joint), 81.21 (arthrodesis, hip), 81.40 (repair hip, not elsewhere classified), 81.51 (total hip replacement), 81.52 (partial hip replacement), and 81.53 (revision hip replacement) were identified. Second, through review of the original inpatient and outpatient medical records, we confirmed that a fracture was associated with the index hospitalization. Finally, radiology reports of each index hospitalization verified the presence and exact anatomical location of each fracture. Of those with fractures on admission x‐rays, only patients with a proximal femur (femoral neck or intertrochanteric) fracture as the primary indication for the surgery were included in the study. Surgical report or radiographic evidence of hip fracture was available for all patients. Secondary fractures due to a specific pathological lesion (eg, malignancy) or high‐energy trauma (by convention, motor vehicle accidents or falls from significant heights) were excluded. Only patients who had provided an authorization to review their medical records for research were ultimately included in the study cohort.18 Medical records were search manually, if indicated.

Criteria for Heart Failure and Death

Preoperative heart failure was based on clinical documentation of heart failure in a patient's medical record prior to the time of the hip fracture repair. Postoperative heart failure, including acute exacerbations, was defined according to Framingham criteria.19 Framingham criteria included clinical evidence of increased central venous pressure, pulmonary edema, an S3 gallop, radiographic pulmonary edema, and response to diuresis. Heart failure was not graded on clinical severity (ie, New York Heart Association classification). We did not distinguish between systolic and diastolic heart failure. Mortality was defined as death from any cause within the first year following hip fracture repair. Deaths were identified either through REP resources or the National Death Index.

Statistical Methods

Continuous variables are presented as mean standard deviation and categorical variables as number (percent). Two‐sample t tests or Wilcoxon rank sum tests were used to test for significant differences in continuous variables. Chi‐square or Fisher's exact tests were used for categorical variables. Rates of postoperative outcomes were calculated using the KaplanMeier method for the overall group and for those with and without preoperative heart failure. A landmark survival curve was used to evaluate postoperative mortality among patients who experienced heart failure in the first seven postoperative days versus those who did not. Patients who died or underwent another hip operation within the first seven postoperative days were excluded from this analysis. Univariate Cox proportional hazards models were used to evaluate the predictors of postoperative heart failure and mortality. Patients who died or experienced a second hip surgery within one year of their first were censored at that time. Any subsequent hip fracture repair was treated as a new case. To account for the inclusion of multiple hip fracture repairs for a given patient, the Cox proportional hazards model included a robust variance estimator. This provided an accurate calculation of the standard error in the presence of within‐subject correlation.20 Statistical tests were two‐sided, and P values were considered significant if less than 0.05. Statistical analyses were performed using SAS (version 9.1.3, SAS Institute, Cary, NC).

RESULTS

From among 1327 potential hip fracture repairs, we excluded 115 cases involving multiple injuries or operations (19), pathological fractures (20), in‐hospital fractures (3), or an operation >72 hours after the initial fracture (5). Three patients under 65 years of age were also excluded, as were cases with missing information (9) or cases managed nonoperatively (56). The final analysis included 1212 surgical cases in 1116 subjects. No subjects were lost to surveillance for 1 year following their hip fracture repair.

Table 1 summarizes the baseline characteristics of the study population. The overall prevalence of preoperative heart failure was 27.0% (327 of 1212). Those with preoperative heart failure were older, heavier, more likely male and white, and less likely to live independently preoperatively. They were also more likely to suffer from preexisting cardiovascular comorbidities.

Baseline Characteristics and Outcomes Among Olmsted County, Minnesota, Residents Undergoing Hip Fracture Repair, 19882002, by Preoperative Heart Failure Status
 All (N = 1,212)HF (N = 327)No HF (N = 885)P Value*
  • Abbreviations: BMI, body mass index; HF, heart failure; SD, standard deviation.

  • P values for those with, vs without, preoperative heart failure (1Rank sum, 2Chi‐square, 3Fisher's exact).

  • BMI data were missing for 15 cases, preoperative ambulatory status was missing for 2 cases, and discharge disposition was missing for 1 case.

  • All values are N (%) unless otherwise noted.

  • Chronic renal insufficiency was defined as a creatinine >2.0 mg/dL.

Demographics    
Mean age (years) (SD)84.2 (7.44)85.5 (6.54)83.7 (7.70)0.00101
Male gender237 (19.6)76 (23.2)161 (18.2)0.04912
Mean BMI (kg/m2) (SD)23.3 (4.97)24.1 (5.68)23.0 (4.65)0.01231
White1,204 (99.3)322 (98.5)882 (99.7)0.03713
Preoperative living situation    
Nursing facility468 (38.6)144 (44)324 (36.6)0.01842
Home744 (61.4)183 (56)561 (63.4)0.05192
Preoperative ambulatory status    
Dependent149 (12.3)50 (15.3)99 (11.2) 
Independent1,061 (87.7)276 (84.7)785 (88.8) 
Medical history    
Hypertension705 (58.2)226 (69.1)479 (54.1)<0.00012
Diabetes mellitus143 (11.8)63 (19.3)80 (9)<0.00012
Cerebrovascular disease331 (27.3)129 (39.4)202 (22.8)<0.00012
Peripheral vascular disease195 (16.1)80 (24.5)115 (13)<0.00012
Coronary artery disease464 (38.3)237 (72.5)227 (25.6)<0.00012
Atrial fibrillation/flutter254 (21)133 (40.7)121 (13.7)<0.00012
Complete heart block18 (1.5)9 (2.8)9 (1)0.03373
Pacer at time of admission32 (2.6)16 (4.9)16 (1.8)0.00292
Chronic obstructive pulmonary disease196 (16.2)78 (23.9)118 (13.3)<0.00012
Liver disease15 (1.2)7 (2.1)8 (0.9)0.13753
Chronic renal insufficiency131 (10.8)61 (18.7)70 (7.9)<0.00012
Mean length of hospitalization (days) (SD)10.0 (7.57)11.1 (8.82)9.6 (7.01)0.00101
Discharge disposition   0.00192
Home150 (12.4)26 (8.0)124 (14.0) 
Skilled nursing facility1,004 (82.9)278 (85.0)726 (82.1) 
Dead57 (4.7)23 (7.0)34 (3.9) 

Table 1 also summarizes the main outcome characteristics of the study population. Those with preoperative heart failure had longer mean lengths of stay (LOS), were more often discharged to a skilled facility, and demonstrated higher inpatient mortality rates.

Table 2 summarizes the outcomes associated with preoperative heart failure. The overall rate of postoperative heart failure was 6.7% within 7 postoperative days and 21.3% within 1 postoperative year. Postoperative heart failure was significantly more common among those with preoperative heart failure (hazard ratio [HR], 3.0; 95% confidence interval [CI], 2.3 to 3.9; P < 0.001). Among those without preoperative heart failure, rates of postoperative incident heart failure were 4.8% at 7 days and 15.0% at 1 year. Compared to patients without preoperative heart failure, those with preoperative heart failure demonstrated higher one year mortality rates and higher rates of postoperative heart failure at 7 days and 1 year.

Association of Preoperative Heart Failure With Postoperative Outcomes Among Olmsted County, Minnesota, Residents Undergoing Hip Fracture Repair, 19882002
 Preoperative Heart Failure (Subjects)
OutcomeAll (N = 1212)No (N = 885)Yes (N = 327)Risk ratio* (95% CI)P Value
  • Abbreviations: CI, confidence interval.

  • Risk ratio for those with vs without preoperative heart failure. Odds ratios were calculated using logistic regression for the outcome of heart failure exacerbation within seven postoperative days; hazard ratios were calculated using Cox proportional hazards models for each of the one‐year outcomes.

  • Excluded 26 cases in which a patient died in hospital without postoperative heart failure.

  • One‐year rates were estimated using the KaplanMeier method.

Heart failure exacerbation within seven postoperative days6.7% (5.4, 8.3)4.8% (3.5, 6.5)12.1% (8.7, 16.2)2.72 (1.72, 4.31)<0.0001
One‐year postoperative heart failure exacerbation21.3% (18.8, 23.7)15.0% (12.5, 17.4)39.3% (33.3, 44.9)3.00 (2.32, 3.87)<0.0001
One‐year postoperative mortality24.5% (22.0, 26.9)19.8% (17.1, 22.4)37.2% (31.6, 42.3)2.11 (1.67, 2.67)<0.0001
One‐year postoperative mortality or heart failure exacerbation36.5% (33.7, 39.2)29.7% (26.6, 32.6)55.0% (49.3, 60.2)2.28 (1.88, 2.76)<0.0001

Figure 1 displays the outcomes to 1 year of surveillance. Rates of postoperative heart failure and postoperative mortality were consistently higher among those with, versus without, preoperative heart failure. Figure 2 displays similar data stratified by gender. Postoperative heart failure rates did not differ significantly between genders (HR, 1.0; 95% CI, 0.8 to 1.4), but postoperative mortality rates were significantly higher among males than females (HR, 1.9; 95% CI, 1.5 to 2.5; P < 0.001).

Figure 1
Cumulative incidence of postoperative outcomes among Olmsted County, Minnesota, residents undergoing hip fracture repair, 1988–2002, by preoperative heart failure status. Abbreviations: HF, heart failure.
Figure 2
Cumulative incidence of postoperative outcomes among Olmsted County, Minnesota, residents undergoing hip fracture repair, 1988–2002, by gender. Abbreviations: HF, heart failure.

Figure 3 displays survival rates to 1 year based on the occurrence of incident or recurrent heart failure within the first 7 postoperative days. Survival rates were lowest among patients with recurrent heart failure in the first 7 postoperative days and highest among those with no preoperative or postoperative heart failure. Subjects with incident heart failure in the first postoperative week, and those with preoperative heart failure who did not suffer a recurrence, demonstrated intermediate survival rates (P < 0.001 for trend across all four groups).

Figure 3
Landmark survival curve to outcome of survival, by heart failure status; excluded 30 records where the patient died or underwent a second surgery before postoperative day 7. Abbreviations: HF, heart failure.

DISCUSSION

This population‐based study found that heart failure represents a highly prevalent condition in elderly patients undergoing hip fracture repairs. It demonstrates that those with preoperative heart failure typically suffer from more cardiovascular comorbidities and carry a higher risk of postoperative heart failure and postoperative mortality.

While many studies have focused on the epidemiology of hip fractures,21 population‐based data on cardiac complications following hip fracture repair are significantly less common. The ACC/AHA preoperative cardiac evaluation guidelines classify orthopedic procedures, including hip fracture repair, as intermediate risk.11 Consequently, some may assume that all orthopedic patients will have a mortality rate less than 5%. Indeed, the 30‐day postoperative mortality rate published from our institution's Total Joint Registry was 0.6% following elective total hip arthroplasty.22 However, the present study demonstrates that current ACC/AHA preoperative cardiac evaluation guidelines may not apply to the population of frail patients undergoing hip fracture repair. Particularly among those who experience new heart failure within the first seven days following surgery, outcomes are substantially worse than the ACC/AHA perioperative guidelines may suggest.11

Preoperative heart failure has been associated with adverse risk for postoperative mortality after hip fracture.9, 10, 12 However, these studies did not report heart failure as a complication of hip fracture repair. A prospective cohort study of 2448 hip fracture patients at an academic hospital in Great Britain found a 5% rate of inpatient heart failure as a postoperative complication.23 The hazard ratio for one‐year mortality was 11.3 with postoperative heart failure.23 However, the British study did not distinguish heart failure from other cardiovascular diseases as a preoperative comorbidity or stratify the risk for postoperative mortality by preoperative heart failure status.23 Our findings add to previous literature by measuring heart failure as a specific complication of hip fracture repair and examining the association of preoperative heart failure with postoperative heart failure and mortality.

Length of stay after hip fracture repair varies in the literature, but previous work has not clearly associated heart failure with length of hospitalization in the setting of hip fracture repair.24, 25 Our study found a significantly higher mean length of stay among those with preoperative heart failure. This adds to previous work by delineating an association between heart failure and increased length of stay after hip fracture repair.

We found a higher rate of postoperative mortality among men compared to women. Rates of postoperative heart failure, however, were more similar (Figure 2). Previous studies have found a consistently higher mortality rate among men versus women after hip fracture.9, 23, 2529 Possible explanations for these findings include the overall increased burden of cardiovascular disease among men, lower treatment rates of osteoporosis in men,30 and increased susceptibility to other postoperative complications, such as infection.25

The findings of this study carry important clinical implications for the perioperative care of hip fracture patients with, or at risk for, heart failure. They suggest that current risk stratification guidelines classifying orthopedic operations as intermediate risk procedures do not reflect the high risk for morbidity that hip fracture patients face.11 The association of heart failure with adverse outcomes implies the need for heightened surveillance in the perioperative period, particularly with regard to volume status and medication reconciliation. Hip fracture patients and their families must be counseled about the ramifications of perioperative heart failure, including higher rates of postoperative heart failure, longer hospitalizations, and ultimate mortality.

This research carries several limitations and remains subject to biases inherent in retrospective cohort studies. The reported effects of heart failure on outcomes after hip fracture repair may be due to confounding from age, functional status, and other comorbidities. We attempted to minimize sampling bias through complete enumeration of hip fracture surgeries among Olmsted County residents. Completeness of follow‐up (100% at one year) was possible given the availability of documentation of all inpatient and outpatient medical care in the community.17 We used objectively defined outcomes to minimize measurement bias. Applicability to a more diverse population may be limited because >95% of the research population was from a single, predominantly white community. However, prior studies have documented that hip fracture incidence rates31 and socioeconomic factors17 in Olmsted County are similar to those for other white residents of the United States. Heart failure rates were determined clinically according to the Framingham criteria. However, the Framingham criteria may inappropriately diagnose individuals with heart failure32 and falsely elevate the prevalence of heart failure as a preoperative comorbidity or postoperative complication.

The statistical analysis included patients counted multiple times if they underwent subsequent hip fracture repair during the study period. Including these patients may inaccurately inflate event rates or contribute to incorrect estimates of standard error. However, we felt it was appropriate to include recurrent hip fracture repair cases in the analysis because they represent a clinically distinct patient from both a medical and functional perspective. We used a robust variance estimator in the Cox proportional hazards models to provide an accurate calculation of the standard error given the possibility for correlation within subjects.20 Finally, the proportion of these patients was low (94 of 1116 unique patients; 8.4%).

Future work must involve further risk stratification and therapeutic interventions in perioperative hip fracture patients. A more robust analysis of heart failure, with differentiation between systolic and diastolic dysfunction, may facilitate risk stratification. Assessment of compliance with standard preoperative heart failure medications and the impact of heightened clinical vigilance may enlighten means to improve postoperative outcomes. Studies on risk stratification and therapeutic interventions may then inform policy regarding length of stay and reimbursement in hip fracture patients.

CONCLUSION

In summary, our population‐based findings reveal that heart failure represents a prevalent and serious comorbidity in patients undergoing hip fracture repair. Clinicians caring for perioperative hip fracture patients must pay particular attention to risk for, and implications of, new or recurrent heart failure.

Acknowledgements

The authors thank Donna K. Lawson, LPN, Kathy Wolfert, and Cherie Dolliver for their assistance in data collection and management.

Files
References
  1. Melton LJ.Epidemiology of hip fractures: Implications of the exponential increase with age.Bone.1996;18(3 suppl):121S125S.
  2. Bueno H,Ross JS,Wang Y, et al.Trends in length of stay and short‐term outcomes among Medicare patients hospitalized for heart failure, 1993–2006.JAMA.2010;303(21):21412147.
  3. Koelling TM,Chen RS,Lubwama RN,L'Italien GJ,Eagle KA.The expanding national burden of heart failure in the United States: The influence of heart failure in women.Am Heart J.2004;147(1):7478.
  4. Fang J,Mensah GA,Croft JB,Keenan NL.Heart failure‐related hospitalization in the U.S., 1979 to 2004.J Am Coll Cardiol.2008;52(6):428434.
  5. van Diepen S,Majumdar SR,Bakal JA,McAlister FA,Ezekowitz JA.Heart failure is a risk factor for orthopedic fracture: A population‐based analysis of 16,294 patients.Circulation.2008;118(19):19461952.
  6. Sennerby U,Melhus H,Gedeborg R, et al.Cardiovascular diseases and risk of hip fracture.JAMA.2009;302(15):16661673.
  7. Nigwekar SU,Job AV,Kouides RW,Polashenski W.Effectiveness of hospitalist involvement in hip fracture management questioned.South Med J.2007;100(9):912913.
  8. Batsis JA,Phy MP,Melton LJ, et al.Effects of a hospitalist care model on mortality of elderly patients with hip fractures.J Hosp Med.2007;2(4):219225.
  9. Kannegaard PN,van der Mark S,Eiken P,Abrahamsen B.Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival.Age Ageing.2010;39(2):203209.
  10. Vestergaard P,Rejnmark L,Mosekilde L.Increased mortality in patients with a hip fracture—Effect of pre‐morbid conditions and post‐fracture complications.Osteoporos Int.2007;18(12):15831593.
  11. Fleisher LA,Beckman JA,Brown KA, et al.ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.J Am Coll Cardiol.2007;50(17):17071732.
  12. Tosteson ANA,Gottlieb DJ,Radley DC,Fisher ES,Melton LJ.Excess mortality following hip fracture: The role of underlying health status.Osteoporos Int.2007;18(11):14631472.
  13. Giversen IM.Time trends of mortality after first hip fractures.Osteoporos Int.2007;18(6):721732.
  14. Hannan EL,Magaziner J,Wang JJ, et al.Mortality and locomotion 6 months after hospitalization for hip fracture: Risk factors and risk‐adjusted hospital outcomes.JAMA.2001;285(21):27362742.
  15. Meyer HE,Tverdal A,Falch JA,Pedersen JI.Factors associated with mortality after hip fracture.Osteoporos Int.2000;11(3):228232.
  16. Myers AH,Robinson EG,Natta MLV,Michelson JD,Collins K,Baker SP.Hip fractures among the elderly: Factors associated with in‐hospital mortality.Am J Epidemiol.1991;134(10):11281137.
  17. Melton LJ.History of the Rochester Epidemiology Project.Mayo Clin Proc.1996;71(3):266274.
  18. Melton LJ.The threat to medical‐records research.N Engl J Med.1997;337(20):14661470.
  19. McKee PA,Castelli WP,McNamara PM,Kannel WB.The natural history of congestive heart failure: The Framingham Study.N Engl J Med.1971;285(26):14411446.
  20. Lin DY,Wei LJ.The robust inference for the Cox proportional hazards model.J Am Stat Assoc.1989;84(408):10741078.
  21. Marks R.Hip fracture epidemiological trends, outcomes, and risk factors, 1970–2009.Int J Gen Med.2010;3:117.
  22. Wood M,Mantilla CB,Horlocker TT,Schroeder DR,Berry DJ,Brown DL.Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty.Anesthesiology.2002;96(5):11401146.
  23. Roche JJW,Wenn RT,Sahota O,Moran CG.Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: Prospective observational cohort study.BMJ.2005;331(7529):13741376.
  24. Bentler SE,Liu L,Obrizan M, et al.The aftermath of hip fracture: Discharge placement, functional status change, and mortality.Am J Epidemiol.2009;170(10):12901299.
  25. Wehren LE,Hawkes WG,Orwig DL,Hebel JR,Zimmerman SI,Magaziner J.Gender differences in mortality after hip fracture: The role of infection.J Bone Miner Res.2003;18(12):22312237.
  26. Center JR,Nguyen TV,Schneider D,Sambrook PN,Eisman JA.Mortality after all major types of osteoporotic fracture in men and women: An observational study.Lancet.1999;353(9156):878882.
  27. Robbins JA,Biggs ML,Cauley J.Adjusted mortality after hip fracture: From the Cardiovascular Health Study.J Am Geriatr Soc.2006;54(12):18851891.
  28. Haentjens P,Magaziner J,Colon‐Emeric CS, et al.Meta‐analysis: Excess mortality after hip fracture among older women and men.Ann Intern Med.2010;152(6):380390.
  29. Poór G,Atkinson EJ,O'Fallon WM,Melton LJ.Predictors of hip fractures in elderly men.J Bone Miner Res.1995;10(12):19001907.
  30. Curtis J,McClure L,Delzell E, et al.Population‐based fracture risk assessment and osteoporosis treatment disparities by race and gender.J Gen Intern Med.2009;24(8):956962.
  31. Melton LJ,Therneau TM,Larson DR.Long‐term trends in hip fracture prevalence: The influence of hip fracture incidence and survival.Osteoporos Int.1998;8(1):6874.
  32. Maestre A,Gil V,Gallego J,Aznar J,Mora A,Martin‐Hidalgo A.diagnostic accuracy of clinical criteria for identifying systolic and diastolic heart failure: Cross‐sectional study.J Eval Clin Pract.2009;15(1):5561.
Article PDF
Issue
Journal of Hospital Medicine - 6(9)
Publications
Page Number
507-512
Legacy Keywords
heart failure, postoperative evaluation and care, cardiovascular risk assessment
Sections
Files
Files
Article PDF
Article PDF

As the population ages, hip fractures and heart failure increase in prevalence.1, 2 Heart failure prevalence is also increasing in hospitalized patients.3 Indeed, hospitalizations involving heart failure as an active issue tripled in the last 30 years.4 Heart failure has been associated with an increased risk for hip fracture,5, 6 and previous studies report a 6%20% prevalence of preoperative heart failure in hip fracture patients.710 While exacerbation of heart failure increases the mortality risk in patients admitted for hip fractures,8 the incidence of new heart failure, as well as the preoperative factors that predict postoperative heart failure in this patient population remain unclear.

American College of Cardiology/American Heart Association (ACC/AHA) perioperative guidelines identify orthopedic surgeries, including hip fracture repair, as intermediate risk procedures.11 Compared to other intermediate risk operations, however, postoperative outcomes following hip fracture repair differ significantly.1216 Overall mortality in hip fracture patients has been reported at 29% at one year,8 with the excess mortality from hip fracture alone at nearly 20%.10, 13 However, the exact factors that contribute to this excess mortality, particularly with regard to heart failure, remain unclear.

To examine the preoperative prevalence, subsequent incidence, and predictors of heart failure in patients undergoing hip fracture repair operations, this study used an established, population‐based database to compare the postoperative consequences in hip fracture repair patients with and without preexisting heart failure. We hypothesized that preoperative heart failure worsens postoperative outcomes in hip fracture patients.

METHODS

Case Ascertainment

Following approval by the Institutional Review Boards of Mayo Clinic and the Olmsted Medical Center, we used the Rochester Epidemiology Project (REP) to identify the patients for this study. The REP is a population‐based medical records linkage system that records all diagnoses, surgical procedures, laboratory data, and death information from hospital, emergency room, outpatient, and nursing home care in the community.17

All Olmsted County, Minnesota, residents who sustained a hip fracture and underwent surgical repair from 1988 through 2002 were evaluated. Patients with more than one hip fracture during the study period (96 occurrences) were censored from the data analysis at the time of the subsequent hip fracture and then included as new cases. The complete enumeration of hip fracture episodes managed in the three Olmsted County hospital facilities (Mayo Clinic's Saint Mary's and Rochester Methodist Hospitals, and the Olmsted Medical Center Hospital) occurred in three phases: First, all hospitalizations with the surgical procedure (International Statistical Classification of Diseases, 9th Revision [ICD‐9]) codes 79.15 (reduction, fracture, femur, closed with internal fixation), 79.25 (reduction, fracture, femur, open, without internal fixation), 79.35 (reduction, fracture, femur, open with internal fixation), 79.95 (operation, unspecified bone injury, femur), 80.05 (arthrotomy for removal of hip prosthesis), 80.15 (arthrotomy, other, hip), 80.95 (excision, hip joint), 81.21 (arthrodesis, hip), 81.40 (repair hip, not elsewhere classified), 81.51 (total hip replacement), 81.52 (partial hip replacement), and 81.53 (revision hip replacement) were identified. Second, through review of the original inpatient and outpatient medical records, we confirmed that a fracture was associated with the index hospitalization. Finally, radiology reports of each index hospitalization verified the presence and exact anatomical location of each fracture. Of those with fractures on admission x‐rays, only patients with a proximal femur (femoral neck or intertrochanteric) fracture as the primary indication for the surgery were included in the study. Surgical report or radiographic evidence of hip fracture was available for all patients. Secondary fractures due to a specific pathological lesion (eg, malignancy) or high‐energy trauma (by convention, motor vehicle accidents or falls from significant heights) were excluded. Only patients who had provided an authorization to review their medical records for research were ultimately included in the study cohort.18 Medical records were search manually, if indicated.

Criteria for Heart Failure and Death

Preoperative heart failure was based on clinical documentation of heart failure in a patient's medical record prior to the time of the hip fracture repair. Postoperative heart failure, including acute exacerbations, was defined according to Framingham criteria.19 Framingham criteria included clinical evidence of increased central venous pressure, pulmonary edema, an S3 gallop, radiographic pulmonary edema, and response to diuresis. Heart failure was not graded on clinical severity (ie, New York Heart Association classification). We did not distinguish between systolic and diastolic heart failure. Mortality was defined as death from any cause within the first year following hip fracture repair. Deaths were identified either through REP resources or the National Death Index.

Statistical Methods

Continuous variables are presented as mean standard deviation and categorical variables as number (percent). Two‐sample t tests or Wilcoxon rank sum tests were used to test for significant differences in continuous variables. Chi‐square or Fisher's exact tests were used for categorical variables. Rates of postoperative outcomes were calculated using the KaplanMeier method for the overall group and for those with and without preoperative heart failure. A landmark survival curve was used to evaluate postoperative mortality among patients who experienced heart failure in the first seven postoperative days versus those who did not. Patients who died or underwent another hip operation within the first seven postoperative days were excluded from this analysis. Univariate Cox proportional hazards models were used to evaluate the predictors of postoperative heart failure and mortality. Patients who died or experienced a second hip surgery within one year of their first were censored at that time. Any subsequent hip fracture repair was treated as a new case. To account for the inclusion of multiple hip fracture repairs for a given patient, the Cox proportional hazards model included a robust variance estimator. This provided an accurate calculation of the standard error in the presence of within‐subject correlation.20 Statistical tests were two‐sided, and P values were considered significant if less than 0.05. Statistical analyses were performed using SAS (version 9.1.3, SAS Institute, Cary, NC).

RESULTS

From among 1327 potential hip fracture repairs, we excluded 115 cases involving multiple injuries or operations (19), pathological fractures (20), in‐hospital fractures (3), or an operation >72 hours after the initial fracture (5). Three patients under 65 years of age were also excluded, as were cases with missing information (9) or cases managed nonoperatively (56). The final analysis included 1212 surgical cases in 1116 subjects. No subjects were lost to surveillance for 1 year following their hip fracture repair.

Table 1 summarizes the baseline characteristics of the study population. The overall prevalence of preoperative heart failure was 27.0% (327 of 1212). Those with preoperative heart failure were older, heavier, more likely male and white, and less likely to live independently preoperatively. They were also more likely to suffer from preexisting cardiovascular comorbidities.

Baseline Characteristics and Outcomes Among Olmsted County, Minnesota, Residents Undergoing Hip Fracture Repair, 19882002, by Preoperative Heart Failure Status
 All (N = 1,212)HF (N = 327)No HF (N = 885)P Value*
  • Abbreviations: BMI, body mass index; HF, heart failure; SD, standard deviation.

  • P values for those with, vs without, preoperative heart failure (1Rank sum, 2Chi‐square, 3Fisher's exact).

  • BMI data were missing for 15 cases, preoperative ambulatory status was missing for 2 cases, and discharge disposition was missing for 1 case.

  • All values are N (%) unless otherwise noted.

  • Chronic renal insufficiency was defined as a creatinine >2.0 mg/dL.

Demographics    
Mean age (years) (SD)84.2 (7.44)85.5 (6.54)83.7 (7.70)0.00101
Male gender237 (19.6)76 (23.2)161 (18.2)0.04912
Mean BMI (kg/m2) (SD)23.3 (4.97)24.1 (5.68)23.0 (4.65)0.01231
White1,204 (99.3)322 (98.5)882 (99.7)0.03713
Preoperative living situation    
Nursing facility468 (38.6)144 (44)324 (36.6)0.01842
Home744 (61.4)183 (56)561 (63.4)0.05192
Preoperative ambulatory status    
Dependent149 (12.3)50 (15.3)99 (11.2) 
Independent1,061 (87.7)276 (84.7)785 (88.8) 
Medical history    
Hypertension705 (58.2)226 (69.1)479 (54.1)<0.00012
Diabetes mellitus143 (11.8)63 (19.3)80 (9)<0.00012
Cerebrovascular disease331 (27.3)129 (39.4)202 (22.8)<0.00012
Peripheral vascular disease195 (16.1)80 (24.5)115 (13)<0.00012
Coronary artery disease464 (38.3)237 (72.5)227 (25.6)<0.00012
Atrial fibrillation/flutter254 (21)133 (40.7)121 (13.7)<0.00012
Complete heart block18 (1.5)9 (2.8)9 (1)0.03373
Pacer at time of admission32 (2.6)16 (4.9)16 (1.8)0.00292
Chronic obstructive pulmonary disease196 (16.2)78 (23.9)118 (13.3)<0.00012
Liver disease15 (1.2)7 (2.1)8 (0.9)0.13753
Chronic renal insufficiency131 (10.8)61 (18.7)70 (7.9)<0.00012
Mean length of hospitalization (days) (SD)10.0 (7.57)11.1 (8.82)9.6 (7.01)0.00101
Discharge disposition   0.00192
Home150 (12.4)26 (8.0)124 (14.0) 
Skilled nursing facility1,004 (82.9)278 (85.0)726 (82.1) 
Dead57 (4.7)23 (7.0)34 (3.9) 

Table 1 also summarizes the main outcome characteristics of the study population. Those with preoperative heart failure had longer mean lengths of stay (LOS), were more often discharged to a skilled facility, and demonstrated higher inpatient mortality rates.

Table 2 summarizes the outcomes associated with preoperative heart failure. The overall rate of postoperative heart failure was 6.7% within 7 postoperative days and 21.3% within 1 postoperative year. Postoperative heart failure was significantly more common among those with preoperative heart failure (hazard ratio [HR], 3.0; 95% confidence interval [CI], 2.3 to 3.9; P < 0.001). Among those without preoperative heart failure, rates of postoperative incident heart failure were 4.8% at 7 days and 15.0% at 1 year. Compared to patients without preoperative heart failure, those with preoperative heart failure demonstrated higher one year mortality rates and higher rates of postoperative heart failure at 7 days and 1 year.

Association of Preoperative Heart Failure With Postoperative Outcomes Among Olmsted County, Minnesota, Residents Undergoing Hip Fracture Repair, 19882002
 Preoperative Heart Failure (Subjects)
OutcomeAll (N = 1212)No (N = 885)Yes (N = 327)Risk ratio* (95% CI)P Value
  • Abbreviations: CI, confidence interval.

  • Risk ratio for those with vs without preoperative heart failure. Odds ratios were calculated using logistic regression for the outcome of heart failure exacerbation within seven postoperative days; hazard ratios were calculated using Cox proportional hazards models for each of the one‐year outcomes.

  • Excluded 26 cases in which a patient died in hospital without postoperative heart failure.

  • One‐year rates were estimated using the KaplanMeier method.

Heart failure exacerbation within seven postoperative days6.7% (5.4, 8.3)4.8% (3.5, 6.5)12.1% (8.7, 16.2)2.72 (1.72, 4.31)<0.0001
One‐year postoperative heart failure exacerbation21.3% (18.8, 23.7)15.0% (12.5, 17.4)39.3% (33.3, 44.9)3.00 (2.32, 3.87)<0.0001
One‐year postoperative mortality24.5% (22.0, 26.9)19.8% (17.1, 22.4)37.2% (31.6, 42.3)2.11 (1.67, 2.67)<0.0001
One‐year postoperative mortality or heart failure exacerbation36.5% (33.7, 39.2)29.7% (26.6, 32.6)55.0% (49.3, 60.2)2.28 (1.88, 2.76)<0.0001

Figure 1 displays the outcomes to 1 year of surveillance. Rates of postoperative heart failure and postoperative mortality were consistently higher among those with, versus without, preoperative heart failure. Figure 2 displays similar data stratified by gender. Postoperative heart failure rates did not differ significantly between genders (HR, 1.0; 95% CI, 0.8 to 1.4), but postoperative mortality rates were significantly higher among males than females (HR, 1.9; 95% CI, 1.5 to 2.5; P < 0.001).

Figure 1
Cumulative incidence of postoperative outcomes among Olmsted County, Minnesota, residents undergoing hip fracture repair, 1988–2002, by preoperative heart failure status. Abbreviations: HF, heart failure.
Figure 2
Cumulative incidence of postoperative outcomes among Olmsted County, Minnesota, residents undergoing hip fracture repair, 1988–2002, by gender. Abbreviations: HF, heart failure.

Figure 3 displays survival rates to 1 year based on the occurrence of incident or recurrent heart failure within the first 7 postoperative days. Survival rates were lowest among patients with recurrent heart failure in the first 7 postoperative days and highest among those with no preoperative or postoperative heart failure. Subjects with incident heart failure in the first postoperative week, and those with preoperative heart failure who did not suffer a recurrence, demonstrated intermediate survival rates (P < 0.001 for trend across all four groups).

Figure 3
Landmark survival curve to outcome of survival, by heart failure status; excluded 30 records where the patient died or underwent a second surgery before postoperative day 7. Abbreviations: HF, heart failure.

DISCUSSION

This population‐based study found that heart failure represents a highly prevalent condition in elderly patients undergoing hip fracture repairs. It demonstrates that those with preoperative heart failure typically suffer from more cardiovascular comorbidities and carry a higher risk of postoperative heart failure and postoperative mortality.

While many studies have focused on the epidemiology of hip fractures,21 population‐based data on cardiac complications following hip fracture repair are significantly less common. The ACC/AHA preoperative cardiac evaluation guidelines classify orthopedic procedures, including hip fracture repair, as intermediate risk.11 Consequently, some may assume that all orthopedic patients will have a mortality rate less than 5%. Indeed, the 30‐day postoperative mortality rate published from our institution's Total Joint Registry was 0.6% following elective total hip arthroplasty.22 However, the present study demonstrates that current ACC/AHA preoperative cardiac evaluation guidelines may not apply to the population of frail patients undergoing hip fracture repair. Particularly among those who experience new heart failure within the first seven days following surgery, outcomes are substantially worse than the ACC/AHA perioperative guidelines may suggest.11

Preoperative heart failure has been associated with adverse risk for postoperative mortality after hip fracture.9, 10, 12 However, these studies did not report heart failure as a complication of hip fracture repair. A prospective cohort study of 2448 hip fracture patients at an academic hospital in Great Britain found a 5% rate of inpatient heart failure as a postoperative complication.23 The hazard ratio for one‐year mortality was 11.3 with postoperative heart failure.23 However, the British study did not distinguish heart failure from other cardiovascular diseases as a preoperative comorbidity or stratify the risk for postoperative mortality by preoperative heart failure status.23 Our findings add to previous literature by measuring heart failure as a specific complication of hip fracture repair and examining the association of preoperative heart failure with postoperative heart failure and mortality.

Length of stay after hip fracture repair varies in the literature, but previous work has not clearly associated heart failure with length of hospitalization in the setting of hip fracture repair.24, 25 Our study found a significantly higher mean length of stay among those with preoperative heart failure. This adds to previous work by delineating an association between heart failure and increased length of stay after hip fracture repair.

We found a higher rate of postoperative mortality among men compared to women. Rates of postoperative heart failure, however, were more similar (Figure 2). Previous studies have found a consistently higher mortality rate among men versus women after hip fracture.9, 23, 2529 Possible explanations for these findings include the overall increased burden of cardiovascular disease among men, lower treatment rates of osteoporosis in men,30 and increased susceptibility to other postoperative complications, such as infection.25

The findings of this study carry important clinical implications for the perioperative care of hip fracture patients with, or at risk for, heart failure. They suggest that current risk stratification guidelines classifying orthopedic operations as intermediate risk procedures do not reflect the high risk for morbidity that hip fracture patients face.11 The association of heart failure with adverse outcomes implies the need for heightened surveillance in the perioperative period, particularly with regard to volume status and medication reconciliation. Hip fracture patients and their families must be counseled about the ramifications of perioperative heart failure, including higher rates of postoperative heart failure, longer hospitalizations, and ultimate mortality.

This research carries several limitations and remains subject to biases inherent in retrospective cohort studies. The reported effects of heart failure on outcomes after hip fracture repair may be due to confounding from age, functional status, and other comorbidities. We attempted to minimize sampling bias through complete enumeration of hip fracture surgeries among Olmsted County residents. Completeness of follow‐up (100% at one year) was possible given the availability of documentation of all inpatient and outpatient medical care in the community.17 We used objectively defined outcomes to minimize measurement bias. Applicability to a more diverse population may be limited because >95% of the research population was from a single, predominantly white community. However, prior studies have documented that hip fracture incidence rates31 and socioeconomic factors17 in Olmsted County are similar to those for other white residents of the United States. Heart failure rates were determined clinically according to the Framingham criteria. However, the Framingham criteria may inappropriately diagnose individuals with heart failure32 and falsely elevate the prevalence of heart failure as a preoperative comorbidity or postoperative complication.

The statistical analysis included patients counted multiple times if they underwent subsequent hip fracture repair during the study period. Including these patients may inaccurately inflate event rates or contribute to incorrect estimates of standard error. However, we felt it was appropriate to include recurrent hip fracture repair cases in the analysis because they represent a clinically distinct patient from both a medical and functional perspective. We used a robust variance estimator in the Cox proportional hazards models to provide an accurate calculation of the standard error given the possibility for correlation within subjects.20 Finally, the proportion of these patients was low (94 of 1116 unique patients; 8.4%).

Future work must involve further risk stratification and therapeutic interventions in perioperative hip fracture patients. A more robust analysis of heart failure, with differentiation between systolic and diastolic dysfunction, may facilitate risk stratification. Assessment of compliance with standard preoperative heart failure medications and the impact of heightened clinical vigilance may enlighten means to improve postoperative outcomes. Studies on risk stratification and therapeutic interventions may then inform policy regarding length of stay and reimbursement in hip fracture patients.

CONCLUSION

In summary, our population‐based findings reveal that heart failure represents a prevalent and serious comorbidity in patients undergoing hip fracture repair. Clinicians caring for perioperative hip fracture patients must pay particular attention to risk for, and implications of, new or recurrent heart failure.

Acknowledgements

The authors thank Donna K. Lawson, LPN, Kathy Wolfert, and Cherie Dolliver for their assistance in data collection and management.

As the population ages, hip fractures and heart failure increase in prevalence.1, 2 Heart failure prevalence is also increasing in hospitalized patients.3 Indeed, hospitalizations involving heart failure as an active issue tripled in the last 30 years.4 Heart failure has been associated with an increased risk for hip fracture,5, 6 and previous studies report a 6%20% prevalence of preoperative heart failure in hip fracture patients.710 While exacerbation of heart failure increases the mortality risk in patients admitted for hip fractures,8 the incidence of new heart failure, as well as the preoperative factors that predict postoperative heart failure in this patient population remain unclear.

American College of Cardiology/American Heart Association (ACC/AHA) perioperative guidelines identify orthopedic surgeries, including hip fracture repair, as intermediate risk procedures.11 Compared to other intermediate risk operations, however, postoperative outcomes following hip fracture repair differ significantly.1216 Overall mortality in hip fracture patients has been reported at 29% at one year,8 with the excess mortality from hip fracture alone at nearly 20%.10, 13 However, the exact factors that contribute to this excess mortality, particularly with regard to heart failure, remain unclear.

To examine the preoperative prevalence, subsequent incidence, and predictors of heart failure in patients undergoing hip fracture repair operations, this study used an established, population‐based database to compare the postoperative consequences in hip fracture repair patients with and without preexisting heart failure. We hypothesized that preoperative heart failure worsens postoperative outcomes in hip fracture patients.

METHODS

Case Ascertainment

Following approval by the Institutional Review Boards of Mayo Clinic and the Olmsted Medical Center, we used the Rochester Epidemiology Project (REP) to identify the patients for this study. The REP is a population‐based medical records linkage system that records all diagnoses, surgical procedures, laboratory data, and death information from hospital, emergency room, outpatient, and nursing home care in the community.17

All Olmsted County, Minnesota, residents who sustained a hip fracture and underwent surgical repair from 1988 through 2002 were evaluated. Patients with more than one hip fracture during the study period (96 occurrences) were censored from the data analysis at the time of the subsequent hip fracture and then included as new cases. The complete enumeration of hip fracture episodes managed in the three Olmsted County hospital facilities (Mayo Clinic's Saint Mary's and Rochester Methodist Hospitals, and the Olmsted Medical Center Hospital) occurred in three phases: First, all hospitalizations with the surgical procedure (International Statistical Classification of Diseases, 9th Revision [ICD‐9]) codes 79.15 (reduction, fracture, femur, closed with internal fixation), 79.25 (reduction, fracture, femur, open, without internal fixation), 79.35 (reduction, fracture, femur, open with internal fixation), 79.95 (operation, unspecified bone injury, femur), 80.05 (arthrotomy for removal of hip prosthesis), 80.15 (arthrotomy, other, hip), 80.95 (excision, hip joint), 81.21 (arthrodesis, hip), 81.40 (repair hip, not elsewhere classified), 81.51 (total hip replacement), 81.52 (partial hip replacement), and 81.53 (revision hip replacement) were identified. Second, through review of the original inpatient and outpatient medical records, we confirmed that a fracture was associated with the index hospitalization. Finally, radiology reports of each index hospitalization verified the presence and exact anatomical location of each fracture. Of those with fractures on admission x‐rays, only patients with a proximal femur (femoral neck or intertrochanteric) fracture as the primary indication for the surgery were included in the study. Surgical report or radiographic evidence of hip fracture was available for all patients. Secondary fractures due to a specific pathological lesion (eg, malignancy) or high‐energy trauma (by convention, motor vehicle accidents or falls from significant heights) were excluded. Only patients who had provided an authorization to review their medical records for research were ultimately included in the study cohort.18 Medical records were search manually, if indicated.

Criteria for Heart Failure and Death

Preoperative heart failure was based on clinical documentation of heart failure in a patient's medical record prior to the time of the hip fracture repair. Postoperative heart failure, including acute exacerbations, was defined according to Framingham criteria.19 Framingham criteria included clinical evidence of increased central venous pressure, pulmonary edema, an S3 gallop, radiographic pulmonary edema, and response to diuresis. Heart failure was not graded on clinical severity (ie, New York Heart Association classification). We did not distinguish between systolic and diastolic heart failure. Mortality was defined as death from any cause within the first year following hip fracture repair. Deaths were identified either through REP resources or the National Death Index.

Statistical Methods

Continuous variables are presented as mean standard deviation and categorical variables as number (percent). Two‐sample t tests or Wilcoxon rank sum tests were used to test for significant differences in continuous variables. Chi‐square or Fisher's exact tests were used for categorical variables. Rates of postoperative outcomes were calculated using the KaplanMeier method for the overall group and for those with and without preoperative heart failure. A landmark survival curve was used to evaluate postoperative mortality among patients who experienced heart failure in the first seven postoperative days versus those who did not. Patients who died or underwent another hip operation within the first seven postoperative days were excluded from this analysis. Univariate Cox proportional hazards models were used to evaluate the predictors of postoperative heart failure and mortality. Patients who died or experienced a second hip surgery within one year of their first were censored at that time. Any subsequent hip fracture repair was treated as a new case. To account for the inclusion of multiple hip fracture repairs for a given patient, the Cox proportional hazards model included a robust variance estimator. This provided an accurate calculation of the standard error in the presence of within‐subject correlation.20 Statistical tests were two‐sided, and P values were considered significant if less than 0.05. Statistical analyses were performed using SAS (version 9.1.3, SAS Institute, Cary, NC).

RESULTS

From among 1327 potential hip fracture repairs, we excluded 115 cases involving multiple injuries or operations (19), pathological fractures (20), in‐hospital fractures (3), or an operation >72 hours after the initial fracture (5). Three patients under 65 years of age were also excluded, as were cases with missing information (9) or cases managed nonoperatively (56). The final analysis included 1212 surgical cases in 1116 subjects. No subjects were lost to surveillance for 1 year following their hip fracture repair.

Table 1 summarizes the baseline characteristics of the study population. The overall prevalence of preoperative heart failure was 27.0% (327 of 1212). Those with preoperative heart failure were older, heavier, more likely male and white, and less likely to live independently preoperatively. They were also more likely to suffer from preexisting cardiovascular comorbidities.

Baseline Characteristics and Outcomes Among Olmsted County, Minnesota, Residents Undergoing Hip Fracture Repair, 19882002, by Preoperative Heart Failure Status
 All (N = 1,212)HF (N = 327)No HF (N = 885)P Value*
  • Abbreviations: BMI, body mass index; HF, heart failure; SD, standard deviation.

  • P values for those with, vs without, preoperative heart failure (1Rank sum, 2Chi‐square, 3Fisher's exact).

  • BMI data were missing for 15 cases, preoperative ambulatory status was missing for 2 cases, and discharge disposition was missing for 1 case.

  • All values are N (%) unless otherwise noted.

  • Chronic renal insufficiency was defined as a creatinine >2.0 mg/dL.

Demographics    
Mean age (years) (SD)84.2 (7.44)85.5 (6.54)83.7 (7.70)0.00101
Male gender237 (19.6)76 (23.2)161 (18.2)0.04912
Mean BMI (kg/m2) (SD)23.3 (4.97)24.1 (5.68)23.0 (4.65)0.01231
White1,204 (99.3)322 (98.5)882 (99.7)0.03713
Preoperative living situation    
Nursing facility468 (38.6)144 (44)324 (36.6)0.01842
Home744 (61.4)183 (56)561 (63.4)0.05192
Preoperative ambulatory status    
Dependent149 (12.3)50 (15.3)99 (11.2) 
Independent1,061 (87.7)276 (84.7)785 (88.8) 
Medical history    
Hypertension705 (58.2)226 (69.1)479 (54.1)<0.00012
Diabetes mellitus143 (11.8)63 (19.3)80 (9)<0.00012
Cerebrovascular disease331 (27.3)129 (39.4)202 (22.8)<0.00012
Peripheral vascular disease195 (16.1)80 (24.5)115 (13)<0.00012
Coronary artery disease464 (38.3)237 (72.5)227 (25.6)<0.00012
Atrial fibrillation/flutter254 (21)133 (40.7)121 (13.7)<0.00012
Complete heart block18 (1.5)9 (2.8)9 (1)0.03373
Pacer at time of admission32 (2.6)16 (4.9)16 (1.8)0.00292
Chronic obstructive pulmonary disease196 (16.2)78 (23.9)118 (13.3)<0.00012
Liver disease15 (1.2)7 (2.1)8 (0.9)0.13753
Chronic renal insufficiency131 (10.8)61 (18.7)70 (7.9)<0.00012
Mean length of hospitalization (days) (SD)10.0 (7.57)11.1 (8.82)9.6 (7.01)0.00101
Discharge disposition   0.00192
Home150 (12.4)26 (8.0)124 (14.0) 
Skilled nursing facility1,004 (82.9)278 (85.0)726 (82.1) 
Dead57 (4.7)23 (7.0)34 (3.9) 

Table 1 also summarizes the main outcome characteristics of the study population. Those with preoperative heart failure had longer mean lengths of stay (LOS), were more often discharged to a skilled facility, and demonstrated higher inpatient mortality rates.

Table 2 summarizes the outcomes associated with preoperative heart failure. The overall rate of postoperative heart failure was 6.7% within 7 postoperative days and 21.3% within 1 postoperative year. Postoperative heart failure was significantly more common among those with preoperative heart failure (hazard ratio [HR], 3.0; 95% confidence interval [CI], 2.3 to 3.9; P < 0.001). Among those without preoperative heart failure, rates of postoperative incident heart failure were 4.8% at 7 days and 15.0% at 1 year. Compared to patients without preoperative heart failure, those with preoperative heart failure demonstrated higher one year mortality rates and higher rates of postoperative heart failure at 7 days and 1 year.

Association of Preoperative Heart Failure With Postoperative Outcomes Among Olmsted County, Minnesota, Residents Undergoing Hip Fracture Repair, 19882002
 Preoperative Heart Failure (Subjects)
OutcomeAll (N = 1212)No (N = 885)Yes (N = 327)Risk ratio* (95% CI)P Value
  • Abbreviations: CI, confidence interval.

  • Risk ratio for those with vs without preoperative heart failure. Odds ratios were calculated using logistic regression for the outcome of heart failure exacerbation within seven postoperative days; hazard ratios were calculated using Cox proportional hazards models for each of the one‐year outcomes.

  • Excluded 26 cases in which a patient died in hospital without postoperative heart failure.

  • One‐year rates were estimated using the KaplanMeier method.

Heart failure exacerbation within seven postoperative days6.7% (5.4, 8.3)4.8% (3.5, 6.5)12.1% (8.7, 16.2)2.72 (1.72, 4.31)<0.0001
One‐year postoperative heart failure exacerbation21.3% (18.8, 23.7)15.0% (12.5, 17.4)39.3% (33.3, 44.9)3.00 (2.32, 3.87)<0.0001
One‐year postoperative mortality24.5% (22.0, 26.9)19.8% (17.1, 22.4)37.2% (31.6, 42.3)2.11 (1.67, 2.67)<0.0001
One‐year postoperative mortality or heart failure exacerbation36.5% (33.7, 39.2)29.7% (26.6, 32.6)55.0% (49.3, 60.2)2.28 (1.88, 2.76)<0.0001

Figure 1 displays the outcomes to 1 year of surveillance. Rates of postoperative heart failure and postoperative mortality were consistently higher among those with, versus without, preoperative heart failure. Figure 2 displays similar data stratified by gender. Postoperative heart failure rates did not differ significantly between genders (HR, 1.0; 95% CI, 0.8 to 1.4), but postoperative mortality rates were significantly higher among males than females (HR, 1.9; 95% CI, 1.5 to 2.5; P < 0.001).

Figure 1
Cumulative incidence of postoperative outcomes among Olmsted County, Minnesota, residents undergoing hip fracture repair, 1988–2002, by preoperative heart failure status. Abbreviations: HF, heart failure.
Figure 2
Cumulative incidence of postoperative outcomes among Olmsted County, Minnesota, residents undergoing hip fracture repair, 1988–2002, by gender. Abbreviations: HF, heart failure.

Figure 3 displays survival rates to 1 year based on the occurrence of incident or recurrent heart failure within the first 7 postoperative days. Survival rates were lowest among patients with recurrent heart failure in the first 7 postoperative days and highest among those with no preoperative or postoperative heart failure. Subjects with incident heart failure in the first postoperative week, and those with preoperative heart failure who did not suffer a recurrence, demonstrated intermediate survival rates (P < 0.001 for trend across all four groups).

Figure 3
Landmark survival curve to outcome of survival, by heart failure status; excluded 30 records where the patient died or underwent a second surgery before postoperative day 7. Abbreviations: HF, heart failure.

DISCUSSION

This population‐based study found that heart failure represents a highly prevalent condition in elderly patients undergoing hip fracture repairs. It demonstrates that those with preoperative heart failure typically suffer from more cardiovascular comorbidities and carry a higher risk of postoperative heart failure and postoperative mortality.

While many studies have focused on the epidemiology of hip fractures,21 population‐based data on cardiac complications following hip fracture repair are significantly less common. The ACC/AHA preoperative cardiac evaluation guidelines classify orthopedic procedures, including hip fracture repair, as intermediate risk.11 Consequently, some may assume that all orthopedic patients will have a mortality rate less than 5%. Indeed, the 30‐day postoperative mortality rate published from our institution's Total Joint Registry was 0.6% following elective total hip arthroplasty.22 However, the present study demonstrates that current ACC/AHA preoperative cardiac evaluation guidelines may not apply to the population of frail patients undergoing hip fracture repair. Particularly among those who experience new heart failure within the first seven days following surgery, outcomes are substantially worse than the ACC/AHA perioperative guidelines may suggest.11

Preoperative heart failure has been associated with adverse risk for postoperative mortality after hip fracture.9, 10, 12 However, these studies did not report heart failure as a complication of hip fracture repair. A prospective cohort study of 2448 hip fracture patients at an academic hospital in Great Britain found a 5% rate of inpatient heart failure as a postoperative complication.23 The hazard ratio for one‐year mortality was 11.3 with postoperative heart failure.23 However, the British study did not distinguish heart failure from other cardiovascular diseases as a preoperative comorbidity or stratify the risk for postoperative mortality by preoperative heart failure status.23 Our findings add to previous literature by measuring heart failure as a specific complication of hip fracture repair and examining the association of preoperative heart failure with postoperative heart failure and mortality.

Length of stay after hip fracture repair varies in the literature, but previous work has not clearly associated heart failure with length of hospitalization in the setting of hip fracture repair.24, 25 Our study found a significantly higher mean length of stay among those with preoperative heart failure. This adds to previous work by delineating an association between heart failure and increased length of stay after hip fracture repair.

We found a higher rate of postoperative mortality among men compared to women. Rates of postoperative heart failure, however, were more similar (Figure 2). Previous studies have found a consistently higher mortality rate among men versus women after hip fracture.9, 23, 2529 Possible explanations for these findings include the overall increased burden of cardiovascular disease among men, lower treatment rates of osteoporosis in men,30 and increased susceptibility to other postoperative complications, such as infection.25

The findings of this study carry important clinical implications for the perioperative care of hip fracture patients with, or at risk for, heart failure. They suggest that current risk stratification guidelines classifying orthopedic operations as intermediate risk procedures do not reflect the high risk for morbidity that hip fracture patients face.11 The association of heart failure with adverse outcomes implies the need for heightened surveillance in the perioperative period, particularly with regard to volume status and medication reconciliation. Hip fracture patients and their families must be counseled about the ramifications of perioperative heart failure, including higher rates of postoperative heart failure, longer hospitalizations, and ultimate mortality.

This research carries several limitations and remains subject to biases inherent in retrospective cohort studies. The reported effects of heart failure on outcomes after hip fracture repair may be due to confounding from age, functional status, and other comorbidities. We attempted to minimize sampling bias through complete enumeration of hip fracture surgeries among Olmsted County residents. Completeness of follow‐up (100% at one year) was possible given the availability of documentation of all inpatient and outpatient medical care in the community.17 We used objectively defined outcomes to minimize measurement bias. Applicability to a more diverse population may be limited because >95% of the research population was from a single, predominantly white community. However, prior studies have documented that hip fracture incidence rates31 and socioeconomic factors17 in Olmsted County are similar to those for other white residents of the United States. Heart failure rates were determined clinically according to the Framingham criteria. However, the Framingham criteria may inappropriately diagnose individuals with heart failure32 and falsely elevate the prevalence of heart failure as a preoperative comorbidity or postoperative complication.

The statistical analysis included patients counted multiple times if they underwent subsequent hip fracture repair during the study period. Including these patients may inaccurately inflate event rates or contribute to incorrect estimates of standard error. However, we felt it was appropriate to include recurrent hip fracture repair cases in the analysis because they represent a clinically distinct patient from both a medical and functional perspective. We used a robust variance estimator in the Cox proportional hazards models to provide an accurate calculation of the standard error given the possibility for correlation within subjects.20 Finally, the proportion of these patients was low (94 of 1116 unique patients; 8.4%).

Future work must involve further risk stratification and therapeutic interventions in perioperative hip fracture patients. A more robust analysis of heart failure, with differentiation between systolic and diastolic dysfunction, may facilitate risk stratification. Assessment of compliance with standard preoperative heart failure medications and the impact of heightened clinical vigilance may enlighten means to improve postoperative outcomes. Studies on risk stratification and therapeutic interventions may then inform policy regarding length of stay and reimbursement in hip fracture patients.

CONCLUSION

In summary, our population‐based findings reveal that heart failure represents a prevalent and serious comorbidity in patients undergoing hip fracture repair. Clinicians caring for perioperative hip fracture patients must pay particular attention to risk for, and implications of, new or recurrent heart failure.

Acknowledgements

The authors thank Donna K. Lawson, LPN, Kathy Wolfert, and Cherie Dolliver for their assistance in data collection and management.

References
  1. Melton LJ.Epidemiology of hip fractures: Implications of the exponential increase with age.Bone.1996;18(3 suppl):121S125S.
  2. Bueno H,Ross JS,Wang Y, et al.Trends in length of stay and short‐term outcomes among Medicare patients hospitalized for heart failure, 1993–2006.JAMA.2010;303(21):21412147.
  3. Koelling TM,Chen RS,Lubwama RN,L'Italien GJ,Eagle KA.The expanding national burden of heart failure in the United States: The influence of heart failure in women.Am Heart J.2004;147(1):7478.
  4. Fang J,Mensah GA,Croft JB,Keenan NL.Heart failure‐related hospitalization in the U.S., 1979 to 2004.J Am Coll Cardiol.2008;52(6):428434.
  5. van Diepen S,Majumdar SR,Bakal JA,McAlister FA,Ezekowitz JA.Heart failure is a risk factor for orthopedic fracture: A population‐based analysis of 16,294 patients.Circulation.2008;118(19):19461952.
  6. Sennerby U,Melhus H,Gedeborg R, et al.Cardiovascular diseases and risk of hip fracture.JAMA.2009;302(15):16661673.
  7. Nigwekar SU,Job AV,Kouides RW,Polashenski W.Effectiveness of hospitalist involvement in hip fracture management questioned.South Med J.2007;100(9):912913.
  8. Batsis JA,Phy MP,Melton LJ, et al.Effects of a hospitalist care model on mortality of elderly patients with hip fractures.J Hosp Med.2007;2(4):219225.
  9. Kannegaard PN,van der Mark S,Eiken P,Abrahamsen B.Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival.Age Ageing.2010;39(2):203209.
  10. Vestergaard P,Rejnmark L,Mosekilde L.Increased mortality in patients with a hip fracture—Effect of pre‐morbid conditions and post‐fracture complications.Osteoporos Int.2007;18(12):15831593.
  11. Fleisher LA,Beckman JA,Brown KA, et al.ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.J Am Coll Cardiol.2007;50(17):17071732.
  12. Tosteson ANA,Gottlieb DJ,Radley DC,Fisher ES,Melton LJ.Excess mortality following hip fracture: The role of underlying health status.Osteoporos Int.2007;18(11):14631472.
  13. Giversen IM.Time trends of mortality after first hip fractures.Osteoporos Int.2007;18(6):721732.
  14. Hannan EL,Magaziner J,Wang JJ, et al.Mortality and locomotion 6 months after hospitalization for hip fracture: Risk factors and risk‐adjusted hospital outcomes.JAMA.2001;285(21):27362742.
  15. Meyer HE,Tverdal A,Falch JA,Pedersen JI.Factors associated with mortality after hip fracture.Osteoporos Int.2000;11(3):228232.
  16. Myers AH,Robinson EG,Natta MLV,Michelson JD,Collins K,Baker SP.Hip fractures among the elderly: Factors associated with in‐hospital mortality.Am J Epidemiol.1991;134(10):11281137.
  17. Melton LJ.History of the Rochester Epidemiology Project.Mayo Clin Proc.1996;71(3):266274.
  18. Melton LJ.The threat to medical‐records research.N Engl J Med.1997;337(20):14661470.
  19. McKee PA,Castelli WP,McNamara PM,Kannel WB.The natural history of congestive heart failure: The Framingham Study.N Engl J Med.1971;285(26):14411446.
  20. Lin DY,Wei LJ.The robust inference for the Cox proportional hazards model.J Am Stat Assoc.1989;84(408):10741078.
  21. Marks R.Hip fracture epidemiological trends, outcomes, and risk factors, 1970–2009.Int J Gen Med.2010;3:117.
  22. Wood M,Mantilla CB,Horlocker TT,Schroeder DR,Berry DJ,Brown DL.Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty.Anesthesiology.2002;96(5):11401146.
  23. Roche JJW,Wenn RT,Sahota O,Moran CG.Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: Prospective observational cohort study.BMJ.2005;331(7529):13741376.
  24. Bentler SE,Liu L,Obrizan M, et al.The aftermath of hip fracture: Discharge placement, functional status change, and mortality.Am J Epidemiol.2009;170(10):12901299.
  25. Wehren LE,Hawkes WG,Orwig DL,Hebel JR,Zimmerman SI,Magaziner J.Gender differences in mortality after hip fracture: The role of infection.J Bone Miner Res.2003;18(12):22312237.
  26. Center JR,Nguyen TV,Schneider D,Sambrook PN,Eisman JA.Mortality after all major types of osteoporotic fracture in men and women: An observational study.Lancet.1999;353(9156):878882.
  27. Robbins JA,Biggs ML,Cauley J.Adjusted mortality after hip fracture: From the Cardiovascular Health Study.J Am Geriatr Soc.2006;54(12):18851891.
  28. Haentjens P,Magaziner J,Colon‐Emeric CS, et al.Meta‐analysis: Excess mortality after hip fracture among older women and men.Ann Intern Med.2010;152(6):380390.
  29. Poór G,Atkinson EJ,O'Fallon WM,Melton LJ.Predictors of hip fractures in elderly men.J Bone Miner Res.1995;10(12):19001907.
  30. Curtis J,McClure L,Delzell E, et al.Population‐based fracture risk assessment and osteoporosis treatment disparities by race and gender.J Gen Intern Med.2009;24(8):956962.
  31. Melton LJ,Therneau TM,Larson DR.Long‐term trends in hip fracture prevalence: The influence of hip fracture incidence and survival.Osteoporos Int.1998;8(1):6874.
  32. Maestre A,Gil V,Gallego J,Aznar J,Mora A,Martin‐Hidalgo A.diagnostic accuracy of clinical criteria for identifying systolic and diastolic heart failure: Cross‐sectional study.J Eval Clin Pract.2009;15(1):5561.
References
  1. Melton LJ.Epidemiology of hip fractures: Implications of the exponential increase with age.Bone.1996;18(3 suppl):121S125S.
  2. Bueno H,Ross JS,Wang Y, et al.Trends in length of stay and short‐term outcomes among Medicare patients hospitalized for heart failure, 1993–2006.JAMA.2010;303(21):21412147.
  3. Koelling TM,Chen RS,Lubwama RN,L'Italien GJ,Eagle KA.The expanding national burden of heart failure in the United States: The influence of heart failure in women.Am Heart J.2004;147(1):7478.
  4. Fang J,Mensah GA,Croft JB,Keenan NL.Heart failure‐related hospitalization in the U.S., 1979 to 2004.J Am Coll Cardiol.2008;52(6):428434.
  5. van Diepen S,Majumdar SR,Bakal JA,McAlister FA,Ezekowitz JA.Heart failure is a risk factor for orthopedic fracture: A population‐based analysis of 16,294 patients.Circulation.2008;118(19):19461952.
  6. Sennerby U,Melhus H,Gedeborg R, et al.Cardiovascular diseases and risk of hip fracture.JAMA.2009;302(15):16661673.
  7. Nigwekar SU,Job AV,Kouides RW,Polashenski W.Effectiveness of hospitalist involvement in hip fracture management questioned.South Med J.2007;100(9):912913.
  8. Batsis JA,Phy MP,Melton LJ, et al.Effects of a hospitalist care model on mortality of elderly patients with hip fractures.J Hosp Med.2007;2(4):219225.
  9. Kannegaard PN,van der Mark S,Eiken P,Abrahamsen B.Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival.Age Ageing.2010;39(2):203209.
  10. Vestergaard P,Rejnmark L,Mosekilde L.Increased mortality in patients with a hip fracture—Effect of pre‐morbid conditions and post‐fracture complications.Osteoporos Int.2007;18(12):15831593.
  11. Fleisher LA,Beckman JA,Brown KA, et al.ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.J Am Coll Cardiol.2007;50(17):17071732.
  12. Tosteson ANA,Gottlieb DJ,Radley DC,Fisher ES,Melton LJ.Excess mortality following hip fracture: The role of underlying health status.Osteoporos Int.2007;18(11):14631472.
  13. Giversen IM.Time trends of mortality after first hip fractures.Osteoporos Int.2007;18(6):721732.
  14. Hannan EL,Magaziner J,Wang JJ, et al.Mortality and locomotion 6 months after hospitalization for hip fracture: Risk factors and risk‐adjusted hospital outcomes.JAMA.2001;285(21):27362742.
  15. Meyer HE,Tverdal A,Falch JA,Pedersen JI.Factors associated with mortality after hip fracture.Osteoporos Int.2000;11(3):228232.
  16. Myers AH,Robinson EG,Natta MLV,Michelson JD,Collins K,Baker SP.Hip fractures among the elderly: Factors associated with in‐hospital mortality.Am J Epidemiol.1991;134(10):11281137.
  17. Melton LJ.History of the Rochester Epidemiology Project.Mayo Clin Proc.1996;71(3):266274.
  18. Melton LJ.The threat to medical‐records research.N Engl J Med.1997;337(20):14661470.
  19. McKee PA,Castelli WP,McNamara PM,Kannel WB.The natural history of congestive heart failure: The Framingham Study.N Engl J Med.1971;285(26):14411446.
  20. Lin DY,Wei LJ.The robust inference for the Cox proportional hazards model.J Am Stat Assoc.1989;84(408):10741078.
  21. Marks R.Hip fracture epidemiological trends, outcomes, and risk factors, 1970–2009.Int J Gen Med.2010;3:117.
  22. Wood M,Mantilla CB,Horlocker TT,Schroeder DR,Berry DJ,Brown DL.Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty.Anesthesiology.2002;96(5):11401146.
  23. Roche JJW,Wenn RT,Sahota O,Moran CG.Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: Prospective observational cohort study.BMJ.2005;331(7529):13741376.
  24. Bentler SE,Liu L,Obrizan M, et al.The aftermath of hip fracture: Discharge placement, functional status change, and mortality.Am J Epidemiol.2009;170(10):12901299.
  25. Wehren LE,Hawkes WG,Orwig DL,Hebel JR,Zimmerman SI,Magaziner J.Gender differences in mortality after hip fracture: The role of infection.J Bone Miner Res.2003;18(12):22312237.
  26. Center JR,Nguyen TV,Schneider D,Sambrook PN,Eisman JA.Mortality after all major types of osteoporotic fracture in men and women: An observational study.Lancet.1999;353(9156):878882.
  27. Robbins JA,Biggs ML,Cauley J.Adjusted mortality after hip fracture: From the Cardiovascular Health Study.J Am Geriatr Soc.2006;54(12):18851891.
  28. Haentjens P,Magaziner J,Colon‐Emeric CS, et al.Meta‐analysis: Excess mortality after hip fracture among older women and men.Ann Intern Med.2010;152(6):380390.
  29. Poór G,Atkinson EJ,O'Fallon WM,Melton LJ.Predictors of hip fractures in elderly men.J Bone Miner Res.1995;10(12):19001907.
  30. Curtis J,McClure L,Delzell E, et al.Population‐based fracture risk assessment and osteoporosis treatment disparities by race and gender.J Gen Intern Med.2009;24(8):956962.
  31. Melton LJ,Therneau TM,Larson DR.Long‐term trends in hip fracture prevalence: The influence of hip fracture incidence and survival.Osteoporos Int.1998;8(1):6874.
  32. Maestre A,Gil V,Gallego J,Aznar J,Mora A,Martin‐Hidalgo A.diagnostic accuracy of clinical criteria for identifying systolic and diastolic heart failure: Cross‐sectional study.J Eval Clin Pract.2009;15(1):5561.
Issue
Journal of Hospital Medicine - 6(9)
Issue
Journal of Hospital Medicine - 6(9)
Page Number
507-512
Page Number
507-512
Publications
Publications
Article Type
Display Headline
Impact of heart failure on hip fracture outcomes: A population‐based study
Display Headline
Impact of heart failure on hip fracture outcomes: A population‐based study
Legacy Keywords
heart failure, postoperative evaluation and care, cardiovascular risk assessment
Legacy Keywords
heart failure, postoperative evaluation and care, cardiovascular risk assessment
Sections
Article Source

Copyright © 2011 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Article PDF Media
Media Files

BMI and Postoperative Complications

Article Type
Changed
Sun, 05/28/2017 - 21:20
Display Headline
Body mass index (BMI) and risk of noncardiac postoperative medical complications in elderly hip fracture patients: A population‐based study

Public health concerns such as the aging population1 and the increasing prevalence of obesity2 are also important issues to hospitals. However, little attention has been given to the interface of obesity and the elderly, largely due to the dearth of studies that include elderly patients. An aging population leads to an increase in geriatric syndromes, such as osteoporosis3 and its most devastating complication, hip fracture.4 These frail, hip‐fracture patients pose management challenges to practicing geriatricians and hospitalists.5,6 Furthermore, although fracture risk is inversely correlated to body mass index (BMI),7 this relationship has yet to be fully examined in the postoperative hip‐fracture population. In other surgical settings, there is disagreement as to whether underweight or obese patients are at higher risk of developing medical complications,8‐11 but for orthopedic patients, data have been limited to elective orthopedic populations.12‐14 We previously demonstrated that underweight hip‐fracture patients are at higher risk of postoperative cardiac complications at 1 year,15 consistent with studies of cardiac risk indices determining long‐term events. Because of different pathophysiologic mechanisms, the purpose of this study was to ascertain the influence of BMI on inpatient postoperative noncardiac medical complications and to assess predictors of such complications following urgent hip fracture repair.

Patients and Methods

All Olmsted County, Minnesota, residents undergoing urgent hip repair due to fracture were identified using the Rochester Epidemiology Project, a medical‐record linkage system funded by the Federal government since 1966 to support disease‐related epidemiology studies.16 All patient medical care is indexed, and both inpatient and outpatient visits are captured and available for review, allowing for complete case ascertainment. Medical care in Olmsted County is primarily provided by Mayo Clinic with its affiliated hospitals (St. Mary's and Rochester Methodist) and the Olmsted Medical Center, in addition to a few individual providers. Over 95% of all Olmsted County hip fracture surgeries are ultimately managed at St. Mary's Hospital.

Following approval by the Institutional Review Board we used this unique data resource to identify all residents with an International Classification of Diseases, 9th edition (ICD‐9) diagnosis code of 820 to 829 for hip fracture (n = 1310). Both sexes were included, and all patients included in the study provided research authorization for use of their medical records for research purposes.17 We excluded patients who were managed conservatively (n = 56), had a pathological fracture (n = 20), had multiple injuries (n = 19), were operated on >72 hours after fracture (n = 5), were aged <65 years (n = 2), or were admitted for reasons other than a fracture and experienced an in‐hospital fracture (n = 3). We subsequently excluded patients with missing information (n = 10). World Health Organization (WHO) criteria were used for classifying BMI: underweight (BMI < 18.5); normal (BMI = 18.5‐24.9); overweight (BMI = 25.0‐29.9); and obese (BMI 30.0).18

All data were abstracted using standardized collection forms by trained nurse abstractors blinded to the study hypothesis. Patients' admission height and weight were documented; if unavailable, the nearest data within 2 months prior to surgery were recorded. Patients' preadmission residence, functional status, baseline comorbidities, admission medications, discharge destination, as well as whether patients had an intensive care unit stay or any major surgeries in the past 90 days were abstracted. In addition, American Society of Anesthesia (ASA) class, type of anesthesia, and length of stay were also obtained. Inpatient complications that had been identified by the treating physicians and documented in the medical record or identified on imaging studies were assessed from the time of hip fracture repair to the time of discharge using standardized clinical criteria (Table 1). For criteria that were based on either objective findings or clinical documentation/suspicion, the patient was considered to meet the criteria of having a complication if they fulfilled either one. We did not include any cardiac outcomes, including congestive heart failure, angina, myocardial infarction, or arrhythmias that had been previously reported.15 Noncardiac complications were classified broadly: respiratory (respiratory failure, respiratory depression, or pulmonary hypoxemia); neurologic (any cerebral event including hemorrhagic or ischemic stroke, transient ischemic attack, or delirium); gastrointestinal (ileus or gastrointestinal bleeding); vascular (pulmonary embolus, or deep vein thrombosis); infectious (pneumonia, sepsis, urinary tract, wound, or cellulitis); renal/metabolic (acute renal failure, dehydration, or electrolyte abnormalities); or other (fractures or falls).

Definitions of Postoperative Noncardiac Complications
DefinitionSymptom
  • Abbreviations: PaCO2, pressure of carbon dioxide; SaO2, oxygen saturation.

Gastrointestinal 
IleusDilated loops of bowel on X‐ray; documented ileus with nausea, vomiting, no stool or inability to take oral intake
Gastrointestinal bleedingSudden appearance of frank blood on nasogastric lavage or by rectum AND a decrease in hemoglobin of 2 g/dL or greater with no other suspected source of ongoing blood loss
Infectious 
PneumoniaNew infiltrate on chest x‐ray plus 2 of the following 3 findings: temperature >38C, elevated white cell count, sputum pathogen that requires antibiotic treatment
Bacteremia/sepsisLocalized infection with positive blood culture for the same pathogen AND chills, rigors, fever, elevated white cell count AND intravenous antibiotic treatment
Urinary tract infectionPyuria symptoms
 Positive gram stain symptoms
Wound 
CellulitisAs documented in physician's note of a superficial skin infection
Neurologic 
Cerebral eventhypoxia, thrombosis or hemorrhageNew neurologic dysfunction (hemiplegia, hemianesthesia, hemianopia, aphasia, or unconsciousness) postoperatively
Transient ischemic attackAny neurologic dysfunction resolving within a 24‐hour period
DeliriumPositive Confusion Assessment Method38
Renal/metabolic 
Renal failureA doubling of baseline value of creatinine; serum creatinine >3.0 mg/dL; acute need for dialysis
DehydrationAs documented in the physician's note
Electrolyte abnormalitiesAny laboratory evidence of abnormal electrolytes compared to normal
Respiratory 
  
Respiratory failureNeed for intubation and ventilation >24 hours postoperatively; need for reintubation and ventilation after 1 hour postoperatively
Respiratory depressionRespiratory arrest; PaCO2 >60 mmHg that provider believed was associated with narcotics
Pulmonary hypoxemiaSaO2 <90% with or without supplemental oxygen; supplemental oxygen >24 hours
Vascular 
Deep vein thrombosisPositive lower extremity venous Doppler
Pulmonary embolismAcute onset dyspnea and tachycardia, increased central venous pressure AND (positive ventilation/perfusion scan OR positive computed tomography OR positive pulmonary angiogram)
Other 
FracturesAny in‐hospital documented fracture of any bone
FallsPatients descending to the ground from any position unintentionally

Continuous data are presented as means standard deviation and categorical data as counts and percentages. In testing for differences in patient demographics, past medical history, and baseline clinical data among BMI groups, Kruskal‐Wallis tests were performed for continuous variables and Fisher's Exact or Cochran‐Mantel‐Haenszel tests were used for discrete variables. Bonferroni adjustments were performed where appropriate. The primary outcome was the risk of any noncardiac medical complication during the postoperative hospitalization, based on patients with complications. Incidence rates were calculated for the overall group as well as for each BMI category. BMI was evaluated categorically according to the WHO criteria, as a continuous variable dichotomized as a BMI 18.5 kg/m2 to 24.9 kg/m2 (normal) vs. all others, and above/below 25.0 kg/m2. The effect of BMI and other potential risk factors on the complication rate was evaluated using logistic regression. The effect of BMI category on the overall complication rate was adjusted for the a priori risk factors of age, sex, surgical year, and ASA class both univariately (Model 1) and multivariately (Model 2). In addition to these variables, we also evaluated other potential risk factors, including baseline demographic and baseline clinical variables that were significant (P < 0.05) univariately using a stepwise selection; first forcing in BMI as a categorical variable (Model 3), then repeating the stepwise selection process without forcing in BMI (Model 4). Using data from Lawrence et al.,19 we estimated that we would have 80% power to detect differences in rates of inpatient noncardiac complications equal to an odds ratio (OR) = 2.2 (normal vs. underweight), OR = 2.0 (normal vs. overweight), and OR = 2.4 (normal vs. obese). Finally, because of power considerations, as an exploratory analysis, we additionally identified predictors of inpatient complications within each BMI category using stepwise selection. All statistical tests were 2‐sided, and P values <0.05 were considered significant. All analyses were performed using SAS for UNIX (version 9.1.3; SAS Institute, Inc., Cary, NC).

Results

Between 1988 and 2002, 1195 urgent repairs for hip fracture met our inclusion/exclusion criteria. We subsequently excluded 15 repairs with missing BMI data, and, of the 7 patients with >1 repair, we included only their first fracture episode in our analysis. Two were subsequently excluded due to an administrative error. Ultimately, 1180 hip fracture repairs were included in the analysis cohort. There were 184 (15.6%) patients in the underweight group, 640 (54.2%) with normal BMI, 251 (21.3%) with a BMI 25.0 to 29.9 kg/m2, and 105 (8.9%) with a BMI 30 kg/m2. Baseline characteristics are otherwise shown in Table 2. Normal BMI patients were significantly older than the other groups, and underweight patients were less likely to be admitted from home. Past history of having a cardiovascular risk factor or a cardiovascular diagnosis appeared to increase with increasing BMI. Underweight patients were more likely to have chronic obstructive pulmonary disease (COPD) than patients with normal BMI (P = 0.03) or overweight patients (P = 0.009), but not more than obese patients (P = 0.21). There were no differences across BMI groups in ASA class, type of anesthesia, intensive care unit stay, or length of stay.

Baseline Characteristics of 1180 Olmsted County, Minnestoa, Residents Undergoing Urgent Hip Fracture Repair, 1988‐2002, by Body Mass Index Classification
VariableUnderweight (<18.5 kg/m2) n = 184 n (%)Normal (18.5‐24.9 kg/m2) n = 640 n (%)Overweight (25‐29.9 kg/m2) n = 251 n (%)Obese (30 kg/m2) n = 105 n (%)P Value*
  • NOTE: Continuous variables are represented as mean standard deviations. Discrete variables are represented as number (%). Table adapted with permission from Batsis et al.15

  • Abbreviations: ACE, angiotensin converting enzyme inhibitor; ALC, assisted living center; ARB, angiotensin receptor blocker; ASA, American Society of Anesthesia; COPD, chronic obstructive pulmonary disease; SNF, skilled nursing facility.

  • P values are Kruskal‐Wallis tests for continuous variables and either Fisher Exact or Cochran‐Mantel‐Haenszel values for discrete variables.

  • There were 2 patients with missing data.

  • There was 1 patient with missing data.

  • There were 5 patients with missing data.

Age (years)84.8 8.085.0 7.283.1 7.380.7 7.4<0.001
Female sex171 (92.9)525 (82)177 (70.5)76 (72.4)<0.001
Preadmission residence     
ALC/SNF79 (42.9)250 (39.1)83 (33.1)36 (34.3)0.024
Home105 (57.1)390 (60.9)168 (66.9)69 (65.7) 
Functional status     
Dependent25 (13.6)80 (12.5)24 (9.6)7 (6.7)0.044
Walking independently159 (86.4)560 (87.5)226 (90.4)97 (93.3) 
History of     
Hypertension84 (45.7)374 (58.4)159 (63.3)70 (66.7)<0.001
Diabetes9 (4.9)71 (11.1)30 (12)30 (28.6)<0.001
Cerebrovascular disease40 (21.7)175 (27.3)77 (30.7)33 (31.4)0.028
Myocardial infarction44 (23.9)140 (21.9)61 (24.3)36 (34.3)0.106
Congestive heart failure48 (26.1)150 (23.4)76 (30.3)44 (41.9)0.003
Atrial fibrillation/flutter49 (26.6)118 (18.4)57 (22.7)26 (24.8)0.985
Chronic renal insufficiency11 (6)64 (10)34 (13.5)20 (19)<0.001
Dementia63 (34.2)233 (36.4)74 (29.5)26 (24.8)0.031
Obstructive sleep apnea2 (1.1)5 (0.8)5 (2.0)6 (5.7)0.005
COPD41 (22.3)100 (15.6)32 (12.7)17 (16.2)0.032
Asthma13 (7.1)47 (7.3)18 (7.2)12 (11.4)0.395
COPD or asthma49 (26.6)133 (20.8)45 (17.9)23 (21.9)0.093
Pulmonary embolism or deep vein thrombosis9 (4.9)21 (3.3)21 (8.4)17 (16.2)<0.001
Osteoporosis77 (41.8)253 (39.5)73 (29.1)31 (29.5)<0.001
Collagen vascular diseases10 (5.4)29 (4.5)9 (3.6)12 (11.4)0.34
Cancer61 (33.2)169 (26.4)75 (29.9)32 (30.5)0.88
Lymphoma2 (1.1)3 (0.5)2 (0.8)2 (1.9)0.25
Leukemia2 (1.1)3 (0.5)1 (0.4)1 (1) 
Major surgery within 90 days3 (1.6)10 (1.6)8 (3.2)3 (2.9)0.366
ASA class     
I or II19 (10.4)93 (14.5)46 (18.3)12 (11.4)0.144
III, IV, or V164 (89.6)547 (85.5)205 (81.7)93 (88.6) 
Type of anesthesia     
General134 (72.8)477 (74.5)192 (76.5)84 (80) 
Other (spinal, epidural, local, combination)50 (27.2)163 (25.5)59 (23.5)21 (20)0.16
Admission medications     
Insulin2 (1.1)18 (2.8)11 (4.4)17 (16.2)<0.001
Aspirin50 (27.2)197 (30.8)82 (32.7)37 (35.2)0.126
Beta‐blockers18 (9.8)90 (14.1)50 (19.9)25 (23.8)<0.001
ACE/ARB32 (17.4)95 (14.8)55 (21.9)28 (26.7)0.009
Calcium‐channel blocker26 (14.1)104 (16.3)39 (15.5)21 (20)0.38
Intensive care unit stay63 (34.2)154 (24.1)61 (24.3)30 (28.6)0.16
Length of stay, days10.3 (9.7)9.7 (6.8)10.2 (7.6)11.1 (8.6)0.10
Discharge destination     
Home20 (10.9)65 (10.2)43 (17.1)19 (18.1) 
ALC/nursing home146 (79.8)547 (85.5)199 (79.3)83 (79)<0.001
In‐hospital death17 (9.3)28 (4.4)9 (3.6)3 (2.9) 

There were 77 (41.8%) postoperative inpatient noncardiac complications in the underweight group, 234 (36.6%) in the normal BMI group, 90 (35.9%) in the overweight group, and 42 (40.0%) in the obese group (P = 0.49). Figure 1 demonstrates the main subcategory complication rates by BMI group, and Table 3 outlines the univariate unadjusted complication rates. Other than gastrointestinal complications being more prevalent as BMI increases (P = 0.005), there were no significant differences in crude complication rates across BMI categories (all P > 0.05) for the other complication subcategories. A multiple comparisons analysis did not demonstrate any differences between normal and any of the other BMI categories for ileus. Normal BMI patients were more likely to be discharged to a nursing facility than overweight or obese patients (85.5% vs. 79.3%, P = 0.03; and 85.5% vs. 79.0%, P = 0.03, respectively). The proportion of in‐hospital deaths among underweight patients was significantly higher than in any of the other groups (9.3% vs. 4.4%; P = 0.01), but mean length of stay was not significantly different.

Figure 1
Rate of inpatient noncardiac complications. Rate of noncardiac complications by BMI category. Unadjusted proportions of the number of patients in each category having a given complication are represented in the data table below the figure (as defined in Patients and Methods).
Univariate Unadjusted Inpatient Noncardiac Complication Rates Among 1,180 Olmsted County, Minnesota, Residents Undergoing Urgent Hip Fracture Repair, 1988‐2002
 Overall Cohort n (%)Underweight (<18.5 kg/m2) n = 184 n (%)Normal (18.5‐24.9 kg/m2) n = 640 n (%)Overweight (25‐29.9 kg/m2) n = 251 n (%)Obese (30 kg/m2) n = 105 n (%)P Value
  • NOTE: All values are represented as count (proportion) for categorical variables; counts are the number of cases that fulfilled the criteria for a given inpatient complication. P values represent a Fisher Exact or Cochran‐Mantel‐Haenszel; P < 0.05 is significant.

Gastrointestinal      
Ileus38 (3.2)1 (0.5)21 (3.3)12 (4.8)4 (3.8)0.03
Gastrointestinal bleeding21 (1.8)1 (0.5)11 (1.7)6 (2.4)3 (2.9)0.35
Infectious      
Pneumonia69 (5.8)12 (6.5)39 (6.1)14 (5.6)4 (3.8)0.51
Bacteremia/sepsis8 (0.7)1 (0.5)2 (0.3)5 (2.0)0 (0)0.06
Urinary tract infection84 (7.1)12 (6.5)47 (7.3)15 (6)10 (9.5)0.78
Wound      
Cellulitis      
Neurological      
Cerebral event‐hypoxia, thrombosis or hemorrhage15 (1.3)1 (0.5)6 (0.9)6 (2.4)2 (1.9)0.21
Transient ischemic attack      
Delirium199 (16.9)40 (21.7)106 (16.6)36 (14.3)17 (16.2)0.08
Renal/metabolic      
Renal failure19 (1.6)3 (1.6)9 (1.4)5 (2.0)2 (1.9)0.82
Dehydration      
Electrolyte abnormalities      
Respiratory      
Respiratory failure53 (4.5)10 (5.4)23 (3.6)15 (6.0)5 (4.8)0.61
Respiratory depression23 (1.9)3 (1.6)11 (1.7)8 (3.2)1 (1.0)0.50
Pulmonary hypoxemia157 (13.3)33 (17.9)78 (12.2)34 (13.5)12 (11.4)0.22
Vascular      
Deep vein thrombosis5 (0.4)0 (0)2 (0.3)3 (1.2)0 (0)0.24
Pulmonary embolism16 (1.4)3 (1.6)7 (1.1)5 (2.0)1 (1.0)0.65
Other      
Fractures6 (0.5)1 (0.5)5 (0.8)0 (0)0 (0)0.57
Falls      

Significant univariate predictors of the composite outcome of any noncardiac complication included: age (OR, 1.04 95% confidence interval [CI>], 1.02‐1.06; P < 0.001), age 75 years (OR, 2.25; 95% CI, 1.52‐3.33; P < 0.001), age 85 years (OR, 1.49; 95% CI, 1.17‐1.89; P < 0.001), male sex (OR, 1.41; 95% CI, 1.05‐1.90; P = 0.02), admission from home (OR, 0.77; 95% CI, 0.61‐0.98; P = 0.03), a history of cerebrovascular disease (OR, 1.41; 95% CI, 1.08‐1.83; P = 0.01), myocardial infarction (OR, 1.41; 95% CI, 1.07‐1.86; P = 0.02), angina (OR, 1.32; 95% CI, 1.03‐1.69; P = 0.03), congestive heart failure (OR, 1.45; 95% CI, 1.11‐1.89; P = 0.006), dementia (OR, 1.39; 95% CI, 1.08‐1.78; P = 0.01), peripheral vascular disease (OR, 1.47; 95% CI, 1.06‐2.03; P = 0.02), COPD/asthma (OR, 1.56; 95% CI, 1.18‐2.08; P = 0.002), osteoarthritis (OR, 1.29; 95% CI, 1.01‐1.65; P = 0.04), code status as Do Not Resuscitate (OR, 0.74; 95% CI, 0.58‐0.94; P = 0.015), or ASA class III‐V (OR, 2.24; 95% CI, 1.53‐3.29; P < 0.001). Results were no different after using the Charlson comorbidity index in place of ASA class (data not shown). No significant differences in overall noncardiac complications were observed when examining BMI as a continuous variable, as a categorical variable, as 25 kg/m2 vs. <25 kg/m2, or as 18.5 kg/m2 to 24.9 kg/m2 vs. all others. Examining renal, respiratory, peripheral vascular, or neurologic complications univariately within these aforementioned strata also did not demonstrate any significant differences among BMI categories (data not shown).

Multivariable analyses (Models 1‐4) are shown for any overall noncardiac inpatient medical complication in Table 4. BMI was not a significant predictor in any of our models, specifically in our main model that examined the effect of BMI adjusting for a priori variables (Model 2). However, older age, male sex, and ASA class were highly significant predictors of complications in all four models; however, surgical year was nonsignificant. Notably, after stepwise selection for other demographic and premorbid variables, a history of COPD or asthma was found to be an additional significant factor both in Model 3 (forcing BMI in the model) and Model 4 (without BMI in the model). Exploratory analysis of individual predictors of inpatient noncardiac complications within each BMI category demonstrated that, in underweight patients, admission use of ‐blockers was a significant predictor of having any medical complication (OR, 3.1; 95% CI, 1.1‐8.60; P = 0.03). In normal BMI patients, age 75 years (OR, 2.6; 95% CI, 1.4‐4.9; P = 0.003), ASA class III‐V (OR, 2.3; 95% CI, 1.3‐3.9; P = 0.003), and a history of cerebrovascular disease (OR, 1.5; 95%CI, 1.04‐2.1; P = 0.03) were predictors; and, in obese patients, only age (OR, 1.1; 95% CI, 1.00‐1.12; P = 0.05) was significant. There were no significant predictors of having a medical complication in the overweight group.

Multivariable Analysis for Inpatient Medical Complications Among 1,180 Olmsted County, Minnesota, Residents Undergoing Urgent Hip Fracture Repair, 1988‐2002
 Underweight <18.5 kg/m2 n = 184* n (%)Normal 18.5‐24.9 kg/m2 n = 640* n (%)Overweight 25‐29.9 kg/m2 n = 251* n (%)Obese 30 kg/m2 n = 105* n (%)AgeMale SexSurgical YearASA Score, III‐V vs. I/IICOPD/ Asthma
  • NOTE: Each row represents a separate multivariable logistic regression analysis. All values are listed as hazard ratios (95% confidence intervals).

  • Abbreviations: ASA, American Society of Anesthesia; BMI, body mass index; COPD, chronic obstructive pulmonary disease.

  • The number of observed number of fractures in this category.

  • Model 1: Effect of BMI category (underweight, normal, overweight, and obese) on overall noncardiac inpatient complication rate adjusted, a priori individually, for age, sex, surgical year, and ASA score univariately.

  • P < 0.05.

  • Model 2: Effect of BMI category (underweight, normal, overweight, and obese) on overall noncardiac inpatient complication rate, after adjusting for age, sex, surgical year, and ASA class.

  • Model 3: Model evaluating other potential risk factors, including baseline demographic and baseline clinical variables that were significant (P < 0.05) univariately using stepwise selection. Model includes BMI as a categorical variable (underweight, normal, overweight, and obese), adjusted for age, sex, surgical year, and ASA class.

  • Model 4: Model evaluating other potential risk factors, including baseline demographic and baseline clinical variables that were significant (P < 0.05) univariately using stepwise selection. Model 3 is similar to this, but does not force BMI in.

Model 1a1.25 (0.89‐1.74)Referent0.97 (0.72‐1.31)1.16 (0.76‐1.76)     
Model 1b1.26 (0.90‐1.77)Referent1.05 (0.77‐1.43)1.38 (0.90‐2.13)1.04 (1.02‐1.06)    
Model 1c1.30 (0.93‐1.83)Referent0.93 (0.68‐1.26)1.12 (0.73‐1.71) 1.47 (1.09‐1.98)   
Model 1d1.28 (0.91‐1.79)Referent0.97 (0.71‐1.31)1.13 (0.74‐1.73)  1.03 (1.00‐1.06)  
Model 1e1.23 (0.88‐1.72)Referent1.00 (0.73‐1.36)1.13 (0.74‐1.73)   2.22 (1.52‐3.24) 
Model 21.33 (0.95‐1.88)Referent1.01 (0.74‐1.38)1.28 (0.82‐1.98)1.04 (1.02‐1.06)1.59 (1.17‐2.17)1.02 (0.99‐1.05)1.89 (1.28‐2.79) 
Model 31.30 (0.92‐1.84)Referent1.04 (0.76‐1.42)1.30 (0.84‐2.02)1.05 (1.03‐1.06)1.52 (1.11‐2.07)1.02 (0.99‐1.05)1.77 (1.20‐2.62)1.58 (1.17‐2.12)
Model 4    1.05 (1.03‐1.06)1.49 (1.10‐2.02) 1.84 (1.25‐2.71)1.58 (1.18‐2.12)

Discussion

Most research describing the association of BMI with postoperative outcomes has concentrated on cardiac surgery, general surgical procedures, and intensive care unit utilization.8‐11,20 In the orthopedic literature, an elevated BMI has been associated with a higher number of short‐term complications, but this was limited to elective knee arthroplasty and spine surgery populations.12,13,21 Conversely, no differences were observed in obese patients undergoing hip arthroplasties.14,22 To the best of our knowledge, this study may be the first to examine the impact of BMI on inpatient hospital outcomes following urgent hip fracture repair. Our results suggest the risk of developing a noncardiac medical complication is the same regardless of BMI.

Our overall complication rate was higher (38%) than previous reports by others.19,23‐26 Thus, Lawrence et al.,19 in their retrospective study of 20 facilities, demonstrated an overall complication rate of 17%, even though they also included postoperative cardiac complications. Although their study period overlapped our own (1982‐1993), they additionally included patients aged 60 to 65 years, a population known to have fewer comorbidities and fewer postoperative complications than the elderly hip‐fracture patients studied here. In addition, their population may have been healthier at baseline, in that a higher proportion lived at home (73%) and a lower percentage were ASA class III‐V (71%) than our cohort. These differences in baseline characteristics may explain the higher complication rates observed in our study.

Our findings did not suggest any relationship of BMI with noncardiac postoperative medical complications in any of the 4 methods we used to stratify BMI (continuous, categorical, normal vs. abnormal, and 25 kg/m2). Evidence is contradictory as to what the effect of BMI has on postoperative complications. An elevated BMI (30 kg/m2) has been shown to lead to increased sternal wound infection and saphenous vein harvest infection in a cardiac surgery population,27 but other studies10,28,29 have demonstrated the opposite effect. Among 6336 patients undergoing elective general surgery procedures, the incidence of complications were similar by body mass.30 A matched study design that included urgent and emergent surgeries also did not find any appreciable increased perioperative risk in noncardiac surgery.28 Whether this may be due to the elective nature of the surgeries in these studies, hence leading to selection bias, is unknown.

In geriatric patients, multiple baseline comorbid conditions often are reflected in a higher ASA class, which increases the risk of significant perioperative complications. Our multivariate modeling showed that a high ASA class strongly predicts morbidity and mortality following hip fracture repair, in line with other studies.19,31,32 Although the Charlson comorbidity index could alternatively been used, we elected to adjust for ASA class as it is more commonly used and is simple to use. Interestingly, surgical year did not significantly predict any complication, which can suggest that practice changes play a minimal impact on patient outcomes. However, we caution that because the individual event rates, particularly vascular, were low, we were unable to fully determine whether changes in practice management, such as improved thromboprophylaxis, would impact event rates over time. Finally, other predictors such as older age33 and a concomitant history of either COPD or asthma,34 are well‐accepted predictors of inpatient complications. Our attempt to examine specific predictors of complications in each BMI category revealed differing results, making interpretations difficult. Because of power considerations, this was meant solely as an exploratory analysis, and larger cohorts are needed to further ascertain whether predictors are different in these groups. Such a study may in fact identify perioperative issues that allow practitioners caring for this population to modify these factors.

One of the major limitations in our study was our inability to adjust for individual complications using multivariable models, such as deep vein thrombosis or delirium, within each BMI stratum, because of statistical power issues. Such a study would require large numbers of individual complications or events to allow for appropriate adjustments. The authors acknowledge that such individual complication rates may vary dramatically. We were aware of this potential problem, and therefore a priori ascertained a composite outcome of any noncardiac medical complication. However, our results do provide preliminary information regarding the impact of BMI on noncardiac medical complications. Further studies would be needed, though, to fully determine the effect of BMI on the number of cases with each complication.

Obesity (or BMI) is a known cardiovascular risk factor, and our previous study's aim was to determine cardiovascular events in a comparable manner to the way risk indices, such as the Goldman, Lee, or the AHA preoperative algorithm function. The surgical literature often presents noncardiac complications separately, allowing us to directly compare our own data to other published studies. We used 2 separate approaches, focusing on the inpatient stay (ascertaining noncardiac complications) and 1‐year cardiac outcomes (cardiac complications), as these are mediated by different mechanisms and factors. Furthermore, the intent of both studies was to dispel any concerns that an elevated BMI would in fact lead to an increased number of complications. Whether cardiac complications, though, would impact noncardiac complications, or vice‐versa, is unknown, and would require further investigation.

Although we relied on well‐established definitions for body mass, they have often been challenged, as they may underestimate adiposity in the elderly population due to age‐related reductions in lean mass.35,36 Studies have demonstrated a poor correlation between percent body fat and BMI in the >65 year age group,37 which could impact our results and outcomes by misclassifying patients. Yet, as an anthropometric measurement, BMI is easily obtainable and its variables are routinely documented in patients' medical records, as compared to other anthropometric measurements. Other means of estimating adiposity, such as densitometry or computed tomography (CT) scanning, are impractical, expensive, and not used clinically but routinely in research settings. The lack of standardization in obtaining height and weight, despite nurse‐initiated protocols for bed calibration, may have introduced a degree of measurement bias. Furthermore, the extent of lean mass lost and volume status changes lead to further challenges of using BMI in hospital settings. Whether other anthropometric measurements, including hip circumference, waist circumference, or waist‐hip ratio, should be used in this group of patients requires further examination. However, despite its shortcomings in elderly patients, BMI is still deemed an appropriate surrogate for obesity.

Our main strength was the use of the Rochester Epidemiology Project medical record linkage system to ascertain all patient data. This focuses on patients from a single geographically‐defined community minimizing referral biases often observed in studies originating from a tertiary care referral center. Previous disease‐related epidemiology studies using the Olmsted County population have demonstrated excellent external validity to the U.S. white population.16 We relied on the medical documentation of the treating clinician for many diagnoses in our data abstraction. Although we attempted to use standardized definitions, clinicians may have inadvertently forgotten to document subjective signs or symptoms that would assist in the categorization of these complications. Hence, added inpatient complications may have been overlooked, suggesting that our results may slightly underestimate the true incidence in this population. Additionally, certain complications may overlap categories, such as pneumonia and infections. We agree with Lawrence et al.19 that long periods of time are necessary to accumulate data of this kind in an effort to describe complication rates epidemiologically.

Despite no difference in outcomes among BMI categories, our results have striking implications for the hospitalized patient. Thus, underweight elderly patients, often considered frail with minimal functional reserve, are at no higher risk for developing inpatient medical complications than patients with higher BMIs. This is contrary to our study focusing on cardiac complications, where underweight patients were at higher risk.15 Conversely, obese patients, who have been demonstrated to be at higher risk of medical complications (particularly pulmonary), had no greater risk than patients with normal BMI. To the practicing geriatrician and hospitalist, this information provides important prognostication regarding additional perioperative measures that need to be implemented in these different groups. Based on our results, BMI does not play a particular role in noncardiac medical complications, dispelling any myths of the added burden of excess weight on surgical outcomes in this population. From a hospital perspective, this may be important since additional testing or preventative management in these patients may lead to additional resource use. However, in‐hospital deaths were higher in underweight patients than in patients with a normal BMI. Although we were underpowered to detect any differences in mortality between groups and could therefore not adjust for additional variables, it is unknown whether cardiac or noncardiac complications may be a stronger predictor of death in the underweight patient population. Further studies would be needed to better ascertain this relationship.

Conclusions

In elderly patients undergoing urgent hip fracture repair, BMI does not appear to lead to an excess rate of inpatient noncardiac complications. Our results are the first to demonstrate that BMI has no impact on morbidity in this patient population. Further research on the influence of body composition on inpatient complications in this population is needed to accurately allow for appropriate perioperative prophylaxis. Whether BMI impacts specific complications or in‐patient mortality in this population still requires investigation.

Acknowledgements

The authors thank Donna K. Lawson, LPN, Kathy Wolfert, and Cherie Dolliver, for their assistance in data collection and management.

References
  1. Spillman BC, Lubitz J.The effect of longevity on spending for acute and long‐term care.N Engl J Med.2000;342(19):14091415.
  2. Flegal KM, Graubard BI, Williamson DF, Gail MH.Excess deaths associated with underweight, overweight, and obesity.JAMA.2005;293(15):18611867.
  3. Melton LJ.Adverse outcomes of osteoporotic fractures in the general population.J Bone Miner Res.2003;18(6):11391141.
  4. Burge R, Dawson‐Hughes B, Solomon DH, Wong JB, King A, Tosteson A.Incidence and economic burden of osteoporosis‐related fractures in the United States, 2005–2025.J Bone Miner Res.2007;22(3):465475.
  5. Huddleston JM, Whitford KJ.Medical care of elderly patients with hip fractures.Mayo Clin Proc.2001;76(3):295298.
  6. Phy MP, Vanness DJ, Melton LJ, et al.Effects of a hospitalist model on elderly patients with hip fracture.Arch Intern Med.2005;165(7):796801.
  7. De Laet C, Kanis JA, Oden A, et al.Body mass index as a predictor of fracture risk: a meta‐analysis.Osteoporos Int.2005;16(11):13301338.
  8. Chang SS, Jacobs B, Wells N, Smith JA, Cookson MS.Increased body mass index predicts increased blood loss during radical cystectomy.J Urol.2004;171(3):10771079.
  9. Schwandner O, Farke S, Schiedeck TH, Bruch HP.Laparoscopic colorectal surgery in obese and nonobese patients: do differences in body mass indices lead to different outcomes?Surg Endosc.2004;18(10):14521456.
  10. Shubair MM, Prabhakaran P, Pavlova V, Velianou JL, Sharma AM, Natarajan MK.The relationship of body mass index to outcomes after percutaneous coronary intervention.J Interv Cardiol.2006;19(5):388395.
  11. Wigfield CH, Lindsey JD, Munoz A, Chopra PS, Edwards NM, Love RB.Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI ≥40.Eur J Cardiothorac Surg.2006;29(4):434440.
  12. Miric A, Lim M, Kahn B, Rozenthal T, Bombick D, Sculco TP.Perioperative morbidity following total knee arthroplasty among obese patients.J Knee Surg.2002;15(2):7783.
  13. Patel N, Bagan B, Vadera S, et al.Obesity and spine surgery: relation to perioperative complications.J Neurosurg Spine.2007;6(4):291297.
  14. Perka C, Labs K, Muschik M, Buttgereit F.The influence of obesity on perioperative morbidity and mortality in revision total hip arthroplasty.Arch Orthop Trauma Surg.2000;120(5–6):267271.
  15. Batsis JA, Huddleston JM, Melton LJ, et al.Body mass index and risk of adverse cardiac events in elderly hip fracture patients: a population‐based study.J Am Geriatr Soc.2009;57(3):419426.
  16. Melton L.History of the Rochester Epidemiology Project.Mayo Clin Proc.1996;71(3):266274.
  17. Melton LJ.The threat to medical‐records research.N Engl J Med.1997;337(20):1466170.
  18. Quetelet L.A Treatise on Man and the Development of His Faculties.Brussels:Musquardt;1871.
  19. Lawrence VA, Hilsenbeck SG, Noveck H, Poses RM, Carson JL.Medical complications and outcomes after hip fracture repair.Arch Intern Med.2002;162(18):20532057.
  20. Akinnusi ME, Pineda LA, El Solh AA.Effect of obesity on intensive care morbidity and mortality: a meta‐analysis.Crit Care Med.2008;36(1):151158.
  21. Patel AD, Albrizio M.Relationship of body mass index to early complications in knee replacement surgery.Arch Orthop Trauma Surg.2008;128(1):59.
  22. Andrew JG, Palan J, Kurup HV, Gibson P, Murray DW, Beard DJ.Obesity in total hip replacement.J Bone Joint Surg Br.2008;90(4):424429.
  23. Hardy DC, Descamps PY, Krallis P, et al.Use of an intramedullary hip‐screw compared with a compression hip‐screw with a plate for intertrochanteric femoral fractures. A prospective, randomized study of one hundred patients.J Bone Joint Surg Am.1998;80(5):618630.
  24. Levi N.Blood transfusion requirements in intracapsular femoral neck fractures.Injury.1996;27(10):709711.
  25. Miller K, Atzenhofer K, Gerber G, Reichel M.Risk prediction in operatively treated fractures of the hip.Clin Orthop Relat Res.1993(293):148152.
  26. Parker MJ.Internal fixation or arthroplasty for displaced subcapital fractures in the elderly?Injury.1992;23(8):521524.
  27. Engelman DT, Adams DH, Byrne JG, et al.Impact of body mass index and albumin on morbidity and mortality after cardiac surgery.J Thorac Cardiovasc Surg.1999;118(5):866873.
  28. Klasen J, Junger A, Hartmann B, et al.Increased body mass index and peri‐operative risk in patients undergoing non‐cardiac surgery.Obes Surg.2004;14(2):275281.
  29. Schwann TA, Habib RH, Zacharias A, et al.Effects of body size on operative, intermediate, and long‐term outcomes after coronary artery bypass operation.Ann Thorac Surg.2001;71(2):521530; discussion 530–531.
  30. Dindo D, Muller MK, Weber M, Clavien PA.Obesity in general elective surgery.Lancet.2003;361(9374):20322035.
  31. Batsis JA, Phy MP, Joseph Melton L, et al.Effects of a hospitalist care model on mortality of elderly patients with hip fractures.J Hosp Med.2007;2(4):219225.
  32. Gdalevich M, Cohen D, Yosef D, Tauber C.Morbidity and mortality after hip fracture: the impact of operative delay.Arch Orthop Trauma Surg.2004;124(5):334340.
  33. Shah MR, Aharonoff GB, Wolinsky P, Zuckerman JD, Koval KJ.Outcome after hip fracture in individuals ninety years of age and older.J Orthop Trauma.2001;15(1):3439.
  34. Jiang HX, Majumdar SR, Dick DA, et al.Development and initial validation of a risk score for predicting in‐hospital and 1‐year mortality in patients with hip fractures.J Bone Miner Res.2005;20(3):494500.
  35. Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB.How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?Am J Epidemiol.1996;143(3):228239.
  36. Smalley KJ, Knerr AN, Kendrick ZV, Colliver JA, Owen OE.Reassessment of body mass indices.Am J Clin Nutr.1990;52(3):405408.
  37. Romero‐Corral A, Somers VK, Sierra‐Johnson J, et al.Accuracy of body mass index in diagnosing obesity in the adult general population.Int J Obes (Lond).2008;32(6):959966.
  38. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI.Clarifying confusion: the confusion assessment method. A new method for detection of delirium.Ann Intern Med.1990;113(12):941948.
Article PDF
Issue
Journal of Hospital Medicine - 4(8)
Publications
Page Number
E1-E9
Legacy Keywords
elderly, hip fractures, inpatient, medical complications, obesity, postoperative
Sections
Article PDF
Article PDF

Public health concerns such as the aging population1 and the increasing prevalence of obesity2 are also important issues to hospitals. However, little attention has been given to the interface of obesity and the elderly, largely due to the dearth of studies that include elderly patients. An aging population leads to an increase in geriatric syndromes, such as osteoporosis3 and its most devastating complication, hip fracture.4 These frail, hip‐fracture patients pose management challenges to practicing geriatricians and hospitalists.5,6 Furthermore, although fracture risk is inversely correlated to body mass index (BMI),7 this relationship has yet to be fully examined in the postoperative hip‐fracture population. In other surgical settings, there is disagreement as to whether underweight or obese patients are at higher risk of developing medical complications,8‐11 but for orthopedic patients, data have been limited to elective orthopedic populations.12‐14 We previously demonstrated that underweight hip‐fracture patients are at higher risk of postoperative cardiac complications at 1 year,15 consistent with studies of cardiac risk indices determining long‐term events. Because of different pathophysiologic mechanisms, the purpose of this study was to ascertain the influence of BMI on inpatient postoperative noncardiac medical complications and to assess predictors of such complications following urgent hip fracture repair.

Patients and Methods

All Olmsted County, Minnesota, residents undergoing urgent hip repair due to fracture were identified using the Rochester Epidemiology Project, a medical‐record linkage system funded by the Federal government since 1966 to support disease‐related epidemiology studies.16 All patient medical care is indexed, and both inpatient and outpatient visits are captured and available for review, allowing for complete case ascertainment. Medical care in Olmsted County is primarily provided by Mayo Clinic with its affiliated hospitals (St. Mary's and Rochester Methodist) and the Olmsted Medical Center, in addition to a few individual providers. Over 95% of all Olmsted County hip fracture surgeries are ultimately managed at St. Mary's Hospital.

Following approval by the Institutional Review Board we used this unique data resource to identify all residents with an International Classification of Diseases, 9th edition (ICD‐9) diagnosis code of 820 to 829 for hip fracture (n = 1310). Both sexes were included, and all patients included in the study provided research authorization for use of their medical records for research purposes.17 We excluded patients who were managed conservatively (n = 56), had a pathological fracture (n = 20), had multiple injuries (n = 19), were operated on >72 hours after fracture (n = 5), were aged <65 years (n = 2), or were admitted for reasons other than a fracture and experienced an in‐hospital fracture (n = 3). We subsequently excluded patients with missing information (n = 10). World Health Organization (WHO) criteria were used for classifying BMI: underweight (BMI < 18.5); normal (BMI = 18.5‐24.9); overweight (BMI = 25.0‐29.9); and obese (BMI 30.0).18

All data were abstracted using standardized collection forms by trained nurse abstractors blinded to the study hypothesis. Patients' admission height and weight were documented; if unavailable, the nearest data within 2 months prior to surgery were recorded. Patients' preadmission residence, functional status, baseline comorbidities, admission medications, discharge destination, as well as whether patients had an intensive care unit stay or any major surgeries in the past 90 days were abstracted. In addition, American Society of Anesthesia (ASA) class, type of anesthesia, and length of stay were also obtained. Inpatient complications that had been identified by the treating physicians and documented in the medical record or identified on imaging studies were assessed from the time of hip fracture repair to the time of discharge using standardized clinical criteria (Table 1). For criteria that were based on either objective findings or clinical documentation/suspicion, the patient was considered to meet the criteria of having a complication if they fulfilled either one. We did not include any cardiac outcomes, including congestive heart failure, angina, myocardial infarction, or arrhythmias that had been previously reported.15 Noncardiac complications were classified broadly: respiratory (respiratory failure, respiratory depression, or pulmonary hypoxemia); neurologic (any cerebral event including hemorrhagic or ischemic stroke, transient ischemic attack, or delirium); gastrointestinal (ileus or gastrointestinal bleeding); vascular (pulmonary embolus, or deep vein thrombosis); infectious (pneumonia, sepsis, urinary tract, wound, or cellulitis); renal/metabolic (acute renal failure, dehydration, or electrolyte abnormalities); or other (fractures or falls).

Definitions of Postoperative Noncardiac Complications
DefinitionSymptom
  • Abbreviations: PaCO2, pressure of carbon dioxide; SaO2, oxygen saturation.

Gastrointestinal 
IleusDilated loops of bowel on X‐ray; documented ileus with nausea, vomiting, no stool or inability to take oral intake
Gastrointestinal bleedingSudden appearance of frank blood on nasogastric lavage or by rectum AND a decrease in hemoglobin of 2 g/dL or greater with no other suspected source of ongoing blood loss
Infectious 
PneumoniaNew infiltrate on chest x‐ray plus 2 of the following 3 findings: temperature >38C, elevated white cell count, sputum pathogen that requires antibiotic treatment
Bacteremia/sepsisLocalized infection with positive blood culture for the same pathogen AND chills, rigors, fever, elevated white cell count AND intravenous antibiotic treatment
Urinary tract infectionPyuria symptoms
 Positive gram stain symptoms
Wound 
CellulitisAs documented in physician's note of a superficial skin infection
Neurologic 
Cerebral eventhypoxia, thrombosis or hemorrhageNew neurologic dysfunction (hemiplegia, hemianesthesia, hemianopia, aphasia, or unconsciousness) postoperatively
Transient ischemic attackAny neurologic dysfunction resolving within a 24‐hour period
DeliriumPositive Confusion Assessment Method38
Renal/metabolic 
Renal failureA doubling of baseline value of creatinine; serum creatinine >3.0 mg/dL; acute need for dialysis
DehydrationAs documented in the physician's note
Electrolyte abnormalitiesAny laboratory evidence of abnormal electrolytes compared to normal
Respiratory 
  
Respiratory failureNeed for intubation and ventilation >24 hours postoperatively; need for reintubation and ventilation after 1 hour postoperatively
Respiratory depressionRespiratory arrest; PaCO2 >60 mmHg that provider believed was associated with narcotics
Pulmonary hypoxemiaSaO2 <90% with or without supplemental oxygen; supplemental oxygen >24 hours
Vascular 
Deep vein thrombosisPositive lower extremity venous Doppler
Pulmonary embolismAcute onset dyspnea and tachycardia, increased central venous pressure AND (positive ventilation/perfusion scan OR positive computed tomography OR positive pulmonary angiogram)
Other 
FracturesAny in‐hospital documented fracture of any bone
FallsPatients descending to the ground from any position unintentionally

Continuous data are presented as means standard deviation and categorical data as counts and percentages. In testing for differences in patient demographics, past medical history, and baseline clinical data among BMI groups, Kruskal‐Wallis tests were performed for continuous variables and Fisher's Exact or Cochran‐Mantel‐Haenszel tests were used for discrete variables. Bonferroni adjustments were performed where appropriate. The primary outcome was the risk of any noncardiac medical complication during the postoperative hospitalization, based on patients with complications. Incidence rates were calculated for the overall group as well as for each BMI category. BMI was evaluated categorically according to the WHO criteria, as a continuous variable dichotomized as a BMI 18.5 kg/m2 to 24.9 kg/m2 (normal) vs. all others, and above/below 25.0 kg/m2. The effect of BMI and other potential risk factors on the complication rate was evaluated using logistic regression. The effect of BMI category on the overall complication rate was adjusted for the a priori risk factors of age, sex, surgical year, and ASA class both univariately (Model 1) and multivariately (Model 2). In addition to these variables, we also evaluated other potential risk factors, including baseline demographic and baseline clinical variables that were significant (P < 0.05) univariately using a stepwise selection; first forcing in BMI as a categorical variable (Model 3), then repeating the stepwise selection process without forcing in BMI (Model 4). Using data from Lawrence et al.,19 we estimated that we would have 80% power to detect differences in rates of inpatient noncardiac complications equal to an odds ratio (OR) = 2.2 (normal vs. underweight), OR = 2.0 (normal vs. overweight), and OR = 2.4 (normal vs. obese). Finally, because of power considerations, as an exploratory analysis, we additionally identified predictors of inpatient complications within each BMI category using stepwise selection. All statistical tests were 2‐sided, and P values <0.05 were considered significant. All analyses were performed using SAS for UNIX (version 9.1.3; SAS Institute, Inc., Cary, NC).

Results

Between 1988 and 2002, 1195 urgent repairs for hip fracture met our inclusion/exclusion criteria. We subsequently excluded 15 repairs with missing BMI data, and, of the 7 patients with >1 repair, we included only their first fracture episode in our analysis. Two were subsequently excluded due to an administrative error. Ultimately, 1180 hip fracture repairs were included in the analysis cohort. There were 184 (15.6%) patients in the underweight group, 640 (54.2%) with normal BMI, 251 (21.3%) with a BMI 25.0 to 29.9 kg/m2, and 105 (8.9%) with a BMI 30 kg/m2. Baseline characteristics are otherwise shown in Table 2. Normal BMI patients were significantly older than the other groups, and underweight patients were less likely to be admitted from home. Past history of having a cardiovascular risk factor or a cardiovascular diagnosis appeared to increase with increasing BMI. Underweight patients were more likely to have chronic obstructive pulmonary disease (COPD) than patients with normal BMI (P = 0.03) or overweight patients (P = 0.009), but not more than obese patients (P = 0.21). There were no differences across BMI groups in ASA class, type of anesthesia, intensive care unit stay, or length of stay.

Baseline Characteristics of 1180 Olmsted County, Minnestoa, Residents Undergoing Urgent Hip Fracture Repair, 1988‐2002, by Body Mass Index Classification
VariableUnderweight (<18.5 kg/m2) n = 184 n (%)Normal (18.5‐24.9 kg/m2) n = 640 n (%)Overweight (25‐29.9 kg/m2) n = 251 n (%)Obese (30 kg/m2) n = 105 n (%)P Value*
  • NOTE: Continuous variables are represented as mean standard deviations. Discrete variables are represented as number (%). Table adapted with permission from Batsis et al.15

  • Abbreviations: ACE, angiotensin converting enzyme inhibitor; ALC, assisted living center; ARB, angiotensin receptor blocker; ASA, American Society of Anesthesia; COPD, chronic obstructive pulmonary disease; SNF, skilled nursing facility.

  • P values are Kruskal‐Wallis tests for continuous variables and either Fisher Exact or Cochran‐Mantel‐Haenszel values for discrete variables.

  • There were 2 patients with missing data.

  • There was 1 patient with missing data.

  • There were 5 patients with missing data.

Age (years)84.8 8.085.0 7.283.1 7.380.7 7.4<0.001
Female sex171 (92.9)525 (82)177 (70.5)76 (72.4)<0.001
Preadmission residence     
ALC/SNF79 (42.9)250 (39.1)83 (33.1)36 (34.3)0.024
Home105 (57.1)390 (60.9)168 (66.9)69 (65.7) 
Functional status     
Dependent25 (13.6)80 (12.5)24 (9.6)7 (6.7)0.044
Walking independently159 (86.4)560 (87.5)226 (90.4)97 (93.3) 
History of     
Hypertension84 (45.7)374 (58.4)159 (63.3)70 (66.7)<0.001
Diabetes9 (4.9)71 (11.1)30 (12)30 (28.6)<0.001
Cerebrovascular disease40 (21.7)175 (27.3)77 (30.7)33 (31.4)0.028
Myocardial infarction44 (23.9)140 (21.9)61 (24.3)36 (34.3)0.106
Congestive heart failure48 (26.1)150 (23.4)76 (30.3)44 (41.9)0.003
Atrial fibrillation/flutter49 (26.6)118 (18.4)57 (22.7)26 (24.8)0.985
Chronic renal insufficiency11 (6)64 (10)34 (13.5)20 (19)<0.001
Dementia63 (34.2)233 (36.4)74 (29.5)26 (24.8)0.031
Obstructive sleep apnea2 (1.1)5 (0.8)5 (2.0)6 (5.7)0.005
COPD41 (22.3)100 (15.6)32 (12.7)17 (16.2)0.032
Asthma13 (7.1)47 (7.3)18 (7.2)12 (11.4)0.395
COPD or asthma49 (26.6)133 (20.8)45 (17.9)23 (21.9)0.093
Pulmonary embolism or deep vein thrombosis9 (4.9)21 (3.3)21 (8.4)17 (16.2)<0.001
Osteoporosis77 (41.8)253 (39.5)73 (29.1)31 (29.5)<0.001
Collagen vascular diseases10 (5.4)29 (4.5)9 (3.6)12 (11.4)0.34
Cancer61 (33.2)169 (26.4)75 (29.9)32 (30.5)0.88
Lymphoma2 (1.1)3 (0.5)2 (0.8)2 (1.9)0.25
Leukemia2 (1.1)3 (0.5)1 (0.4)1 (1) 
Major surgery within 90 days3 (1.6)10 (1.6)8 (3.2)3 (2.9)0.366
ASA class     
I or II19 (10.4)93 (14.5)46 (18.3)12 (11.4)0.144
III, IV, or V164 (89.6)547 (85.5)205 (81.7)93 (88.6) 
Type of anesthesia     
General134 (72.8)477 (74.5)192 (76.5)84 (80) 
Other (spinal, epidural, local, combination)50 (27.2)163 (25.5)59 (23.5)21 (20)0.16
Admission medications     
Insulin2 (1.1)18 (2.8)11 (4.4)17 (16.2)<0.001
Aspirin50 (27.2)197 (30.8)82 (32.7)37 (35.2)0.126
Beta‐blockers18 (9.8)90 (14.1)50 (19.9)25 (23.8)<0.001
ACE/ARB32 (17.4)95 (14.8)55 (21.9)28 (26.7)0.009
Calcium‐channel blocker26 (14.1)104 (16.3)39 (15.5)21 (20)0.38
Intensive care unit stay63 (34.2)154 (24.1)61 (24.3)30 (28.6)0.16
Length of stay, days10.3 (9.7)9.7 (6.8)10.2 (7.6)11.1 (8.6)0.10
Discharge destination     
Home20 (10.9)65 (10.2)43 (17.1)19 (18.1) 
ALC/nursing home146 (79.8)547 (85.5)199 (79.3)83 (79)<0.001
In‐hospital death17 (9.3)28 (4.4)9 (3.6)3 (2.9) 

There were 77 (41.8%) postoperative inpatient noncardiac complications in the underweight group, 234 (36.6%) in the normal BMI group, 90 (35.9%) in the overweight group, and 42 (40.0%) in the obese group (P = 0.49). Figure 1 demonstrates the main subcategory complication rates by BMI group, and Table 3 outlines the univariate unadjusted complication rates. Other than gastrointestinal complications being more prevalent as BMI increases (P = 0.005), there were no significant differences in crude complication rates across BMI categories (all P > 0.05) for the other complication subcategories. A multiple comparisons analysis did not demonstrate any differences between normal and any of the other BMI categories for ileus. Normal BMI patients were more likely to be discharged to a nursing facility than overweight or obese patients (85.5% vs. 79.3%, P = 0.03; and 85.5% vs. 79.0%, P = 0.03, respectively). The proportion of in‐hospital deaths among underweight patients was significantly higher than in any of the other groups (9.3% vs. 4.4%; P = 0.01), but mean length of stay was not significantly different.

Figure 1
Rate of inpatient noncardiac complications. Rate of noncardiac complications by BMI category. Unadjusted proportions of the number of patients in each category having a given complication are represented in the data table below the figure (as defined in Patients and Methods).
Univariate Unadjusted Inpatient Noncardiac Complication Rates Among 1,180 Olmsted County, Minnesota, Residents Undergoing Urgent Hip Fracture Repair, 1988‐2002
 Overall Cohort n (%)Underweight (<18.5 kg/m2) n = 184 n (%)Normal (18.5‐24.9 kg/m2) n = 640 n (%)Overweight (25‐29.9 kg/m2) n = 251 n (%)Obese (30 kg/m2) n = 105 n (%)P Value
  • NOTE: All values are represented as count (proportion) for categorical variables; counts are the number of cases that fulfilled the criteria for a given inpatient complication. P values represent a Fisher Exact or Cochran‐Mantel‐Haenszel; P < 0.05 is significant.

Gastrointestinal      
Ileus38 (3.2)1 (0.5)21 (3.3)12 (4.8)4 (3.8)0.03
Gastrointestinal bleeding21 (1.8)1 (0.5)11 (1.7)6 (2.4)3 (2.9)0.35
Infectious      
Pneumonia69 (5.8)12 (6.5)39 (6.1)14 (5.6)4 (3.8)0.51
Bacteremia/sepsis8 (0.7)1 (0.5)2 (0.3)5 (2.0)0 (0)0.06
Urinary tract infection84 (7.1)12 (6.5)47 (7.3)15 (6)10 (9.5)0.78
Wound      
Cellulitis      
Neurological      
Cerebral event‐hypoxia, thrombosis or hemorrhage15 (1.3)1 (0.5)6 (0.9)6 (2.4)2 (1.9)0.21
Transient ischemic attack      
Delirium199 (16.9)40 (21.7)106 (16.6)36 (14.3)17 (16.2)0.08
Renal/metabolic      
Renal failure19 (1.6)3 (1.6)9 (1.4)5 (2.0)2 (1.9)0.82
Dehydration      
Electrolyte abnormalities      
Respiratory      
Respiratory failure53 (4.5)10 (5.4)23 (3.6)15 (6.0)5 (4.8)0.61
Respiratory depression23 (1.9)3 (1.6)11 (1.7)8 (3.2)1 (1.0)0.50
Pulmonary hypoxemia157 (13.3)33 (17.9)78 (12.2)34 (13.5)12 (11.4)0.22
Vascular      
Deep vein thrombosis5 (0.4)0 (0)2 (0.3)3 (1.2)0 (0)0.24
Pulmonary embolism16 (1.4)3 (1.6)7 (1.1)5 (2.0)1 (1.0)0.65
Other      
Fractures6 (0.5)1 (0.5)5 (0.8)0 (0)0 (0)0.57
Falls      

Significant univariate predictors of the composite outcome of any noncardiac complication included: age (OR, 1.04 95% confidence interval [CI>], 1.02‐1.06; P < 0.001), age 75 years (OR, 2.25; 95% CI, 1.52‐3.33; P < 0.001), age 85 years (OR, 1.49; 95% CI, 1.17‐1.89; P < 0.001), male sex (OR, 1.41; 95% CI, 1.05‐1.90; P = 0.02), admission from home (OR, 0.77; 95% CI, 0.61‐0.98; P = 0.03), a history of cerebrovascular disease (OR, 1.41; 95% CI, 1.08‐1.83; P = 0.01), myocardial infarction (OR, 1.41; 95% CI, 1.07‐1.86; P = 0.02), angina (OR, 1.32; 95% CI, 1.03‐1.69; P = 0.03), congestive heart failure (OR, 1.45; 95% CI, 1.11‐1.89; P = 0.006), dementia (OR, 1.39; 95% CI, 1.08‐1.78; P = 0.01), peripheral vascular disease (OR, 1.47; 95% CI, 1.06‐2.03; P = 0.02), COPD/asthma (OR, 1.56; 95% CI, 1.18‐2.08; P = 0.002), osteoarthritis (OR, 1.29; 95% CI, 1.01‐1.65; P = 0.04), code status as Do Not Resuscitate (OR, 0.74; 95% CI, 0.58‐0.94; P = 0.015), or ASA class III‐V (OR, 2.24; 95% CI, 1.53‐3.29; P < 0.001). Results were no different after using the Charlson comorbidity index in place of ASA class (data not shown). No significant differences in overall noncardiac complications were observed when examining BMI as a continuous variable, as a categorical variable, as 25 kg/m2 vs. <25 kg/m2, or as 18.5 kg/m2 to 24.9 kg/m2 vs. all others. Examining renal, respiratory, peripheral vascular, or neurologic complications univariately within these aforementioned strata also did not demonstrate any significant differences among BMI categories (data not shown).

Multivariable analyses (Models 1‐4) are shown for any overall noncardiac inpatient medical complication in Table 4. BMI was not a significant predictor in any of our models, specifically in our main model that examined the effect of BMI adjusting for a priori variables (Model 2). However, older age, male sex, and ASA class were highly significant predictors of complications in all four models; however, surgical year was nonsignificant. Notably, after stepwise selection for other demographic and premorbid variables, a history of COPD or asthma was found to be an additional significant factor both in Model 3 (forcing BMI in the model) and Model 4 (without BMI in the model). Exploratory analysis of individual predictors of inpatient noncardiac complications within each BMI category demonstrated that, in underweight patients, admission use of ‐blockers was a significant predictor of having any medical complication (OR, 3.1; 95% CI, 1.1‐8.60; P = 0.03). In normal BMI patients, age 75 years (OR, 2.6; 95% CI, 1.4‐4.9; P = 0.003), ASA class III‐V (OR, 2.3; 95% CI, 1.3‐3.9; P = 0.003), and a history of cerebrovascular disease (OR, 1.5; 95%CI, 1.04‐2.1; P = 0.03) were predictors; and, in obese patients, only age (OR, 1.1; 95% CI, 1.00‐1.12; P = 0.05) was significant. There were no significant predictors of having a medical complication in the overweight group.

Multivariable Analysis for Inpatient Medical Complications Among 1,180 Olmsted County, Minnesota, Residents Undergoing Urgent Hip Fracture Repair, 1988‐2002
 Underweight <18.5 kg/m2 n = 184* n (%)Normal 18.5‐24.9 kg/m2 n = 640* n (%)Overweight 25‐29.9 kg/m2 n = 251* n (%)Obese 30 kg/m2 n = 105* n (%)AgeMale SexSurgical YearASA Score, III‐V vs. I/IICOPD/ Asthma
  • NOTE: Each row represents a separate multivariable logistic regression analysis. All values are listed as hazard ratios (95% confidence intervals).

  • Abbreviations: ASA, American Society of Anesthesia; BMI, body mass index; COPD, chronic obstructive pulmonary disease.

  • The number of observed number of fractures in this category.

  • Model 1: Effect of BMI category (underweight, normal, overweight, and obese) on overall noncardiac inpatient complication rate adjusted, a priori individually, for age, sex, surgical year, and ASA score univariately.

  • P < 0.05.

  • Model 2: Effect of BMI category (underweight, normal, overweight, and obese) on overall noncardiac inpatient complication rate, after adjusting for age, sex, surgical year, and ASA class.

  • Model 3: Model evaluating other potential risk factors, including baseline demographic and baseline clinical variables that were significant (P < 0.05) univariately using stepwise selection. Model includes BMI as a categorical variable (underweight, normal, overweight, and obese), adjusted for age, sex, surgical year, and ASA class.

  • Model 4: Model evaluating other potential risk factors, including baseline demographic and baseline clinical variables that were significant (P < 0.05) univariately using stepwise selection. Model 3 is similar to this, but does not force BMI in.

Model 1a1.25 (0.89‐1.74)Referent0.97 (0.72‐1.31)1.16 (0.76‐1.76)     
Model 1b1.26 (0.90‐1.77)Referent1.05 (0.77‐1.43)1.38 (0.90‐2.13)1.04 (1.02‐1.06)    
Model 1c1.30 (0.93‐1.83)Referent0.93 (0.68‐1.26)1.12 (0.73‐1.71) 1.47 (1.09‐1.98)   
Model 1d1.28 (0.91‐1.79)Referent0.97 (0.71‐1.31)1.13 (0.74‐1.73)  1.03 (1.00‐1.06)  
Model 1e1.23 (0.88‐1.72)Referent1.00 (0.73‐1.36)1.13 (0.74‐1.73)   2.22 (1.52‐3.24) 
Model 21.33 (0.95‐1.88)Referent1.01 (0.74‐1.38)1.28 (0.82‐1.98)1.04 (1.02‐1.06)1.59 (1.17‐2.17)1.02 (0.99‐1.05)1.89 (1.28‐2.79) 
Model 31.30 (0.92‐1.84)Referent1.04 (0.76‐1.42)1.30 (0.84‐2.02)1.05 (1.03‐1.06)1.52 (1.11‐2.07)1.02 (0.99‐1.05)1.77 (1.20‐2.62)1.58 (1.17‐2.12)
Model 4    1.05 (1.03‐1.06)1.49 (1.10‐2.02) 1.84 (1.25‐2.71)1.58 (1.18‐2.12)

Discussion

Most research describing the association of BMI with postoperative outcomes has concentrated on cardiac surgery, general surgical procedures, and intensive care unit utilization.8‐11,20 In the orthopedic literature, an elevated BMI has been associated with a higher number of short‐term complications, but this was limited to elective knee arthroplasty and spine surgery populations.12,13,21 Conversely, no differences were observed in obese patients undergoing hip arthroplasties.14,22 To the best of our knowledge, this study may be the first to examine the impact of BMI on inpatient hospital outcomes following urgent hip fracture repair. Our results suggest the risk of developing a noncardiac medical complication is the same regardless of BMI.

Our overall complication rate was higher (38%) than previous reports by others.19,23‐26 Thus, Lawrence et al.,19 in their retrospective study of 20 facilities, demonstrated an overall complication rate of 17%, even though they also included postoperative cardiac complications. Although their study period overlapped our own (1982‐1993), they additionally included patients aged 60 to 65 years, a population known to have fewer comorbidities and fewer postoperative complications than the elderly hip‐fracture patients studied here. In addition, their population may have been healthier at baseline, in that a higher proportion lived at home (73%) and a lower percentage were ASA class III‐V (71%) than our cohort. These differences in baseline characteristics may explain the higher complication rates observed in our study.

Our findings did not suggest any relationship of BMI with noncardiac postoperative medical complications in any of the 4 methods we used to stratify BMI (continuous, categorical, normal vs. abnormal, and 25 kg/m2). Evidence is contradictory as to what the effect of BMI has on postoperative complications. An elevated BMI (30 kg/m2) has been shown to lead to increased sternal wound infection and saphenous vein harvest infection in a cardiac surgery population,27 but other studies10,28,29 have demonstrated the opposite effect. Among 6336 patients undergoing elective general surgery procedures, the incidence of complications were similar by body mass.30 A matched study design that included urgent and emergent surgeries also did not find any appreciable increased perioperative risk in noncardiac surgery.28 Whether this may be due to the elective nature of the surgeries in these studies, hence leading to selection bias, is unknown.

In geriatric patients, multiple baseline comorbid conditions often are reflected in a higher ASA class, which increases the risk of significant perioperative complications. Our multivariate modeling showed that a high ASA class strongly predicts morbidity and mortality following hip fracture repair, in line with other studies.19,31,32 Although the Charlson comorbidity index could alternatively been used, we elected to adjust for ASA class as it is more commonly used and is simple to use. Interestingly, surgical year did not significantly predict any complication, which can suggest that practice changes play a minimal impact on patient outcomes. However, we caution that because the individual event rates, particularly vascular, were low, we were unable to fully determine whether changes in practice management, such as improved thromboprophylaxis, would impact event rates over time. Finally, other predictors such as older age33 and a concomitant history of either COPD or asthma,34 are well‐accepted predictors of inpatient complications. Our attempt to examine specific predictors of complications in each BMI category revealed differing results, making interpretations difficult. Because of power considerations, this was meant solely as an exploratory analysis, and larger cohorts are needed to further ascertain whether predictors are different in these groups. Such a study may in fact identify perioperative issues that allow practitioners caring for this population to modify these factors.

One of the major limitations in our study was our inability to adjust for individual complications using multivariable models, such as deep vein thrombosis or delirium, within each BMI stratum, because of statistical power issues. Such a study would require large numbers of individual complications or events to allow for appropriate adjustments. The authors acknowledge that such individual complication rates may vary dramatically. We were aware of this potential problem, and therefore a priori ascertained a composite outcome of any noncardiac medical complication. However, our results do provide preliminary information regarding the impact of BMI on noncardiac medical complications. Further studies would be needed, though, to fully determine the effect of BMI on the number of cases with each complication.

Obesity (or BMI) is a known cardiovascular risk factor, and our previous study's aim was to determine cardiovascular events in a comparable manner to the way risk indices, such as the Goldman, Lee, or the AHA preoperative algorithm function. The surgical literature often presents noncardiac complications separately, allowing us to directly compare our own data to other published studies. We used 2 separate approaches, focusing on the inpatient stay (ascertaining noncardiac complications) and 1‐year cardiac outcomes (cardiac complications), as these are mediated by different mechanisms and factors. Furthermore, the intent of both studies was to dispel any concerns that an elevated BMI would in fact lead to an increased number of complications. Whether cardiac complications, though, would impact noncardiac complications, or vice‐versa, is unknown, and would require further investigation.

Although we relied on well‐established definitions for body mass, they have often been challenged, as they may underestimate adiposity in the elderly population due to age‐related reductions in lean mass.35,36 Studies have demonstrated a poor correlation between percent body fat and BMI in the >65 year age group,37 which could impact our results and outcomes by misclassifying patients. Yet, as an anthropometric measurement, BMI is easily obtainable and its variables are routinely documented in patients' medical records, as compared to other anthropometric measurements. Other means of estimating adiposity, such as densitometry or computed tomography (CT) scanning, are impractical, expensive, and not used clinically but routinely in research settings. The lack of standardization in obtaining height and weight, despite nurse‐initiated protocols for bed calibration, may have introduced a degree of measurement bias. Furthermore, the extent of lean mass lost and volume status changes lead to further challenges of using BMI in hospital settings. Whether other anthropometric measurements, including hip circumference, waist circumference, or waist‐hip ratio, should be used in this group of patients requires further examination. However, despite its shortcomings in elderly patients, BMI is still deemed an appropriate surrogate for obesity.

Our main strength was the use of the Rochester Epidemiology Project medical record linkage system to ascertain all patient data. This focuses on patients from a single geographically‐defined community minimizing referral biases often observed in studies originating from a tertiary care referral center. Previous disease‐related epidemiology studies using the Olmsted County population have demonstrated excellent external validity to the U.S. white population.16 We relied on the medical documentation of the treating clinician for many diagnoses in our data abstraction. Although we attempted to use standardized definitions, clinicians may have inadvertently forgotten to document subjective signs or symptoms that would assist in the categorization of these complications. Hence, added inpatient complications may have been overlooked, suggesting that our results may slightly underestimate the true incidence in this population. Additionally, certain complications may overlap categories, such as pneumonia and infections. We agree with Lawrence et al.19 that long periods of time are necessary to accumulate data of this kind in an effort to describe complication rates epidemiologically.

Despite no difference in outcomes among BMI categories, our results have striking implications for the hospitalized patient. Thus, underweight elderly patients, often considered frail with minimal functional reserve, are at no higher risk for developing inpatient medical complications than patients with higher BMIs. This is contrary to our study focusing on cardiac complications, where underweight patients were at higher risk.15 Conversely, obese patients, who have been demonstrated to be at higher risk of medical complications (particularly pulmonary), had no greater risk than patients with normal BMI. To the practicing geriatrician and hospitalist, this information provides important prognostication regarding additional perioperative measures that need to be implemented in these different groups. Based on our results, BMI does not play a particular role in noncardiac medical complications, dispelling any myths of the added burden of excess weight on surgical outcomes in this population. From a hospital perspective, this may be important since additional testing or preventative management in these patients may lead to additional resource use. However, in‐hospital deaths were higher in underweight patients than in patients with a normal BMI. Although we were underpowered to detect any differences in mortality between groups and could therefore not adjust for additional variables, it is unknown whether cardiac or noncardiac complications may be a stronger predictor of death in the underweight patient population. Further studies would be needed to better ascertain this relationship.

Conclusions

In elderly patients undergoing urgent hip fracture repair, BMI does not appear to lead to an excess rate of inpatient noncardiac complications. Our results are the first to demonstrate that BMI has no impact on morbidity in this patient population. Further research on the influence of body composition on inpatient complications in this population is needed to accurately allow for appropriate perioperative prophylaxis. Whether BMI impacts specific complications or in‐patient mortality in this population still requires investigation.

Acknowledgements

The authors thank Donna K. Lawson, LPN, Kathy Wolfert, and Cherie Dolliver, for their assistance in data collection and management.

Public health concerns such as the aging population1 and the increasing prevalence of obesity2 are also important issues to hospitals. However, little attention has been given to the interface of obesity and the elderly, largely due to the dearth of studies that include elderly patients. An aging population leads to an increase in geriatric syndromes, such as osteoporosis3 and its most devastating complication, hip fracture.4 These frail, hip‐fracture patients pose management challenges to practicing geriatricians and hospitalists.5,6 Furthermore, although fracture risk is inversely correlated to body mass index (BMI),7 this relationship has yet to be fully examined in the postoperative hip‐fracture population. In other surgical settings, there is disagreement as to whether underweight or obese patients are at higher risk of developing medical complications,8‐11 but for orthopedic patients, data have been limited to elective orthopedic populations.12‐14 We previously demonstrated that underweight hip‐fracture patients are at higher risk of postoperative cardiac complications at 1 year,15 consistent with studies of cardiac risk indices determining long‐term events. Because of different pathophysiologic mechanisms, the purpose of this study was to ascertain the influence of BMI on inpatient postoperative noncardiac medical complications and to assess predictors of such complications following urgent hip fracture repair.

Patients and Methods

All Olmsted County, Minnesota, residents undergoing urgent hip repair due to fracture were identified using the Rochester Epidemiology Project, a medical‐record linkage system funded by the Federal government since 1966 to support disease‐related epidemiology studies.16 All patient medical care is indexed, and both inpatient and outpatient visits are captured and available for review, allowing for complete case ascertainment. Medical care in Olmsted County is primarily provided by Mayo Clinic with its affiliated hospitals (St. Mary's and Rochester Methodist) and the Olmsted Medical Center, in addition to a few individual providers. Over 95% of all Olmsted County hip fracture surgeries are ultimately managed at St. Mary's Hospital.

Following approval by the Institutional Review Board we used this unique data resource to identify all residents with an International Classification of Diseases, 9th edition (ICD‐9) diagnosis code of 820 to 829 for hip fracture (n = 1310). Both sexes were included, and all patients included in the study provided research authorization for use of their medical records for research purposes.17 We excluded patients who were managed conservatively (n = 56), had a pathological fracture (n = 20), had multiple injuries (n = 19), were operated on >72 hours after fracture (n = 5), were aged <65 years (n = 2), or were admitted for reasons other than a fracture and experienced an in‐hospital fracture (n = 3). We subsequently excluded patients with missing information (n = 10). World Health Organization (WHO) criteria were used for classifying BMI: underweight (BMI < 18.5); normal (BMI = 18.5‐24.9); overweight (BMI = 25.0‐29.9); and obese (BMI 30.0).18

All data were abstracted using standardized collection forms by trained nurse abstractors blinded to the study hypothesis. Patients' admission height and weight were documented; if unavailable, the nearest data within 2 months prior to surgery were recorded. Patients' preadmission residence, functional status, baseline comorbidities, admission medications, discharge destination, as well as whether patients had an intensive care unit stay or any major surgeries in the past 90 days were abstracted. In addition, American Society of Anesthesia (ASA) class, type of anesthesia, and length of stay were also obtained. Inpatient complications that had been identified by the treating physicians and documented in the medical record or identified on imaging studies were assessed from the time of hip fracture repair to the time of discharge using standardized clinical criteria (Table 1). For criteria that were based on either objective findings or clinical documentation/suspicion, the patient was considered to meet the criteria of having a complication if they fulfilled either one. We did not include any cardiac outcomes, including congestive heart failure, angina, myocardial infarction, or arrhythmias that had been previously reported.15 Noncardiac complications were classified broadly: respiratory (respiratory failure, respiratory depression, or pulmonary hypoxemia); neurologic (any cerebral event including hemorrhagic or ischemic stroke, transient ischemic attack, or delirium); gastrointestinal (ileus or gastrointestinal bleeding); vascular (pulmonary embolus, or deep vein thrombosis); infectious (pneumonia, sepsis, urinary tract, wound, or cellulitis); renal/metabolic (acute renal failure, dehydration, or electrolyte abnormalities); or other (fractures or falls).

Definitions of Postoperative Noncardiac Complications
DefinitionSymptom
  • Abbreviations: PaCO2, pressure of carbon dioxide; SaO2, oxygen saturation.

Gastrointestinal 
IleusDilated loops of bowel on X‐ray; documented ileus with nausea, vomiting, no stool or inability to take oral intake
Gastrointestinal bleedingSudden appearance of frank blood on nasogastric lavage or by rectum AND a decrease in hemoglobin of 2 g/dL or greater with no other suspected source of ongoing blood loss
Infectious 
PneumoniaNew infiltrate on chest x‐ray plus 2 of the following 3 findings: temperature >38C, elevated white cell count, sputum pathogen that requires antibiotic treatment
Bacteremia/sepsisLocalized infection with positive blood culture for the same pathogen AND chills, rigors, fever, elevated white cell count AND intravenous antibiotic treatment
Urinary tract infectionPyuria symptoms
 Positive gram stain symptoms
Wound 
CellulitisAs documented in physician's note of a superficial skin infection
Neurologic 
Cerebral eventhypoxia, thrombosis or hemorrhageNew neurologic dysfunction (hemiplegia, hemianesthesia, hemianopia, aphasia, or unconsciousness) postoperatively
Transient ischemic attackAny neurologic dysfunction resolving within a 24‐hour period
DeliriumPositive Confusion Assessment Method38
Renal/metabolic 
Renal failureA doubling of baseline value of creatinine; serum creatinine >3.0 mg/dL; acute need for dialysis
DehydrationAs documented in the physician's note
Electrolyte abnormalitiesAny laboratory evidence of abnormal electrolytes compared to normal
Respiratory 
  
Respiratory failureNeed for intubation and ventilation >24 hours postoperatively; need for reintubation and ventilation after 1 hour postoperatively
Respiratory depressionRespiratory arrest; PaCO2 >60 mmHg that provider believed was associated with narcotics
Pulmonary hypoxemiaSaO2 <90% with or without supplemental oxygen; supplemental oxygen >24 hours
Vascular 
Deep vein thrombosisPositive lower extremity venous Doppler
Pulmonary embolismAcute onset dyspnea and tachycardia, increased central venous pressure AND (positive ventilation/perfusion scan OR positive computed tomography OR positive pulmonary angiogram)
Other 
FracturesAny in‐hospital documented fracture of any bone
FallsPatients descending to the ground from any position unintentionally

Continuous data are presented as means standard deviation and categorical data as counts and percentages. In testing for differences in patient demographics, past medical history, and baseline clinical data among BMI groups, Kruskal‐Wallis tests were performed for continuous variables and Fisher's Exact or Cochran‐Mantel‐Haenszel tests were used for discrete variables. Bonferroni adjustments were performed where appropriate. The primary outcome was the risk of any noncardiac medical complication during the postoperative hospitalization, based on patients with complications. Incidence rates were calculated for the overall group as well as for each BMI category. BMI was evaluated categorically according to the WHO criteria, as a continuous variable dichotomized as a BMI 18.5 kg/m2 to 24.9 kg/m2 (normal) vs. all others, and above/below 25.0 kg/m2. The effect of BMI and other potential risk factors on the complication rate was evaluated using logistic regression. The effect of BMI category on the overall complication rate was adjusted for the a priori risk factors of age, sex, surgical year, and ASA class both univariately (Model 1) and multivariately (Model 2). In addition to these variables, we also evaluated other potential risk factors, including baseline demographic and baseline clinical variables that were significant (P < 0.05) univariately using a stepwise selection; first forcing in BMI as a categorical variable (Model 3), then repeating the stepwise selection process without forcing in BMI (Model 4). Using data from Lawrence et al.,19 we estimated that we would have 80% power to detect differences in rates of inpatient noncardiac complications equal to an odds ratio (OR) = 2.2 (normal vs. underweight), OR = 2.0 (normal vs. overweight), and OR = 2.4 (normal vs. obese). Finally, because of power considerations, as an exploratory analysis, we additionally identified predictors of inpatient complications within each BMI category using stepwise selection. All statistical tests were 2‐sided, and P values <0.05 were considered significant. All analyses were performed using SAS for UNIX (version 9.1.3; SAS Institute, Inc., Cary, NC).

Results

Between 1988 and 2002, 1195 urgent repairs for hip fracture met our inclusion/exclusion criteria. We subsequently excluded 15 repairs with missing BMI data, and, of the 7 patients with >1 repair, we included only their first fracture episode in our analysis. Two were subsequently excluded due to an administrative error. Ultimately, 1180 hip fracture repairs were included in the analysis cohort. There were 184 (15.6%) patients in the underweight group, 640 (54.2%) with normal BMI, 251 (21.3%) with a BMI 25.0 to 29.9 kg/m2, and 105 (8.9%) with a BMI 30 kg/m2. Baseline characteristics are otherwise shown in Table 2. Normal BMI patients were significantly older than the other groups, and underweight patients were less likely to be admitted from home. Past history of having a cardiovascular risk factor or a cardiovascular diagnosis appeared to increase with increasing BMI. Underweight patients were more likely to have chronic obstructive pulmonary disease (COPD) than patients with normal BMI (P = 0.03) or overweight patients (P = 0.009), but not more than obese patients (P = 0.21). There were no differences across BMI groups in ASA class, type of anesthesia, intensive care unit stay, or length of stay.

Baseline Characteristics of 1180 Olmsted County, Minnestoa, Residents Undergoing Urgent Hip Fracture Repair, 1988‐2002, by Body Mass Index Classification
VariableUnderweight (<18.5 kg/m2) n = 184 n (%)Normal (18.5‐24.9 kg/m2) n = 640 n (%)Overweight (25‐29.9 kg/m2) n = 251 n (%)Obese (30 kg/m2) n = 105 n (%)P Value*
  • NOTE: Continuous variables are represented as mean standard deviations. Discrete variables are represented as number (%). Table adapted with permission from Batsis et al.15

  • Abbreviations: ACE, angiotensin converting enzyme inhibitor; ALC, assisted living center; ARB, angiotensin receptor blocker; ASA, American Society of Anesthesia; COPD, chronic obstructive pulmonary disease; SNF, skilled nursing facility.

  • P values are Kruskal‐Wallis tests for continuous variables and either Fisher Exact or Cochran‐Mantel‐Haenszel values for discrete variables.

  • There were 2 patients with missing data.

  • There was 1 patient with missing data.

  • There were 5 patients with missing data.

Age (years)84.8 8.085.0 7.283.1 7.380.7 7.4<0.001
Female sex171 (92.9)525 (82)177 (70.5)76 (72.4)<0.001
Preadmission residence     
ALC/SNF79 (42.9)250 (39.1)83 (33.1)36 (34.3)0.024
Home105 (57.1)390 (60.9)168 (66.9)69 (65.7) 
Functional status     
Dependent25 (13.6)80 (12.5)24 (9.6)7 (6.7)0.044
Walking independently159 (86.4)560 (87.5)226 (90.4)97 (93.3) 
History of     
Hypertension84 (45.7)374 (58.4)159 (63.3)70 (66.7)<0.001
Diabetes9 (4.9)71 (11.1)30 (12)30 (28.6)<0.001
Cerebrovascular disease40 (21.7)175 (27.3)77 (30.7)33 (31.4)0.028
Myocardial infarction44 (23.9)140 (21.9)61 (24.3)36 (34.3)0.106
Congestive heart failure48 (26.1)150 (23.4)76 (30.3)44 (41.9)0.003
Atrial fibrillation/flutter49 (26.6)118 (18.4)57 (22.7)26 (24.8)0.985
Chronic renal insufficiency11 (6)64 (10)34 (13.5)20 (19)<0.001
Dementia63 (34.2)233 (36.4)74 (29.5)26 (24.8)0.031
Obstructive sleep apnea2 (1.1)5 (0.8)5 (2.0)6 (5.7)0.005
COPD41 (22.3)100 (15.6)32 (12.7)17 (16.2)0.032
Asthma13 (7.1)47 (7.3)18 (7.2)12 (11.4)0.395
COPD or asthma49 (26.6)133 (20.8)45 (17.9)23 (21.9)0.093
Pulmonary embolism or deep vein thrombosis9 (4.9)21 (3.3)21 (8.4)17 (16.2)<0.001
Osteoporosis77 (41.8)253 (39.5)73 (29.1)31 (29.5)<0.001
Collagen vascular diseases10 (5.4)29 (4.5)9 (3.6)12 (11.4)0.34
Cancer61 (33.2)169 (26.4)75 (29.9)32 (30.5)0.88
Lymphoma2 (1.1)3 (0.5)2 (0.8)2 (1.9)0.25
Leukemia2 (1.1)3 (0.5)1 (0.4)1 (1) 
Major surgery within 90 days3 (1.6)10 (1.6)8 (3.2)3 (2.9)0.366
ASA class     
I or II19 (10.4)93 (14.5)46 (18.3)12 (11.4)0.144
III, IV, or V164 (89.6)547 (85.5)205 (81.7)93 (88.6) 
Type of anesthesia     
General134 (72.8)477 (74.5)192 (76.5)84 (80) 
Other (spinal, epidural, local, combination)50 (27.2)163 (25.5)59 (23.5)21 (20)0.16
Admission medications     
Insulin2 (1.1)18 (2.8)11 (4.4)17 (16.2)<0.001
Aspirin50 (27.2)197 (30.8)82 (32.7)37 (35.2)0.126
Beta‐blockers18 (9.8)90 (14.1)50 (19.9)25 (23.8)<0.001
ACE/ARB32 (17.4)95 (14.8)55 (21.9)28 (26.7)0.009
Calcium‐channel blocker26 (14.1)104 (16.3)39 (15.5)21 (20)0.38
Intensive care unit stay63 (34.2)154 (24.1)61 (24.3)30 (28.6)0.16
Length of stay, days10.3 (9.7)9.7 (6.8)10.2 (7.6)11.1 (8.6)0.10
Discharge destination     
Home20 (10.9)65 (10.2)43 (17.1)19 (18.1) 
ALC/nursing home146 (79.8)547 (85.5)199 (79.3)83 (79)<0.001
In‐hospital death17 (9.3)28 (4.4)9 (3.6)3 (2.9) 

There were 77 (41.8%) postoperative inpatient noncardiac complications in the underweight group, 234 (36.6%) in the normal BMI group, 90 (35.9%) in the overweight group, and 42 (40.0%) in the obese group (P = 0.49). Figure 1 demonstrates the main subcategory complication rates by BMI group, and Table 3 outlines the univariate unadjusted complication rates. Other than gastrointestinal complications being more prevalent as BMI increases (P = 0.005), there were no significant differences in crude complication rates across BMI categories (all P > 0.05) for the other complication subcategories. A multiple comparisons analysis did not demonstrate any differences between normal and any of the other BMI categories for ileus. Normal BMI patients were more likely to be discharged to a nursing facility than overweight or obese patients (85.5% vs. 79.3%, P = 0.03; and 85.5% vs. 79.0%, P = 0.03, respectively). The proportion of in‐hospital deaths among underweight patients was significantly higher than in any of the other groups (9.3% vs. 4.4%; P = 0.01), but mean length of stay was not significantly different.

Figure 1
Rate of inpatient noncardiac complications. Rate of noncardiac complications by BMI category. Unadjusted proportions of the number of patients in each category having a given complication are represented in the data table below the figure (as defined in Patients and Methods).
Univariate Unadjusted Inpatient Noncardiac Complication Rates Among 1,180 Olmsted County, Minnesota, Residents Undergoing Urgent Hip Fracture Repair, 1988‐2002
 Overall Cohort n (%)Underweight (<18.5 kg/m2) n = 184 n (%)Normal (18.5‐24.9 kg/m2) n = 640 n (%)Overweight (25‐29.9 kg/m2) n = 251 n (%)Obese (30 kg/m2) n = 105 n (%)P Value
  • NOTE: All values are represented as count (proportion) for categorical variables; counts are the number of cases that fulfilled the criteria for a given inpatient complication. P values represent a Fisher Exact or Cochran‐Mantel‐Haenszel; P < 0.05 is significant.

Gastrointestinal      
Ileus38 (3.2)1 (0.5)21 (3.3)12 (4.8)4 (3.8)0.03
Gastrointestinal bleeding21 (1.8)1 (0.5)11 (1.7)6 (2.4)3 (2.9)0.35
Infectious      
Pneumonia69 (5.8)12 (6.5)39 (6.1)14 (5.6)4 (3.8)0.51
Bacteremia/sepsis8 (0.7)1 (0.5)2 (0.3)5 (2.0)0 (0)0.06
Urinary tract infection84 (7.1)12 (6.5)47 (7.3)15 (6)10 (9.5)0.78
Wound      
Cellulitis      
Neurological      
Cerebral event‐hypoxia, thrombosis or hemorrhage15 (1.3)1 (0.5)6 (0.9)6 (2.4)2 (1.9)0.21
Transient ischemic attack      
Delirium199 (16.9)40 (21.7)106 (16.6)36 (14.3)17 (16.2)0.08
Renal/metabolic      
Renal failure19 (1.6)3 (1.6)9 (1.4)5 (2.0)2 (1.9)0.82
Dehydration      
Electrolyte abnormalities      
Respiratory      
Respiratory failure53 (4.5)10 (5.4)23 (3.6)15 (6.0)5 (4.8)0.61
Respiratory depression23 (1.9)3 (1.6)11 (1.7)8 (3.2)1 (1.0)0.50
Pulmonary hypoxemia157 (13.3)33 (17.9)78 (12.2)34 (13.5)12 (11.4)0.22
Vascular      
Deep vein thrombosis5 (0.4)0 (0)2 (0.3)3 (1.2)0 (0)0.24
Pulmonary embolism16 (1.4)3 (1.6)7 (1.1)5 (2.0)1 (1.0)0.65
Other      
Fractures6 (0.5)1 (0.5)5 (0.8)0 (0)0 (0)0.57
Falls      

Significant univariate predictors of the composite outcome of any noncardiac complication included: age (OR, 1.04 95% confidence interval [CI>], 1.02‐1.06; P < 0.001), age 75 years (OR, 2.25; 95% CI, 1.52‐3.33; P < 0.001), age 85 years (OR, 1.49; 95% CI, 1.17‐1.89; P < 0.001), male sex (OR, 1.41; 95% CI, 1.05‐1.90; P = 0.02), admission from home (OR, 0.77; 95% CI, 0.61‐0.98; P = 0.03), a history of cerebrovascular disease (OR, 1.41; 95% CI, 1.08‐1.83; P = 0.01), myocardial infarction (OR, 1.41; 95% CI, 1.07‐1.86; P = 0.02), angina (OR, 1.32; 95% CI, 1.03‐1.69; P = 0.03), congestive heart failure (OR, 1.45; 95% CI, 1.11‐1.89; P = 0.006), dementia (OR, 1.39; 95% CI, 1.08‐1.78; P = 0.01), peripheral vascular disease (OR, 1.47; 95% CI, 1.06‐2.03; P = 0.02), COPD/asthma (OR, 1.56; 95% CI, 1.18‐2.08; P = 0.002), osteoarthritis (OR, 1.29; 95% CI, 1.01‐1.65; P = 0.04), code status as Do Not Resuscitate (OR, 0.74; 95% CI, 0.58‐0.94; P = 0.015), or ASA class III‐V (OR, 2.24; 95% CI, 1.53‐3.29; P < 0.001). Results were no different after using the Charlson comorbidity index in place of ASA class (data not shown). No significant differences in overall noncardiac complications were observed when examining BMI as a continuous variable, as a categorical variable, as 25 kg/m2 vs. <25 kg/m2, or as 18.5 kg/m2 to 24.9 kg/m2 vs. all others. Examining renal, respiratory, peripheral vascular, or neurologic complications univariately within these aforementioned strata also did not demonstrate any significant differences among BMI categories (data not shown).

Multivariable analyses (Models 1‐4) are shown for any overall noncardiac inpatient medical complication in Table 4. BMI was not a significant predictor in any of our models, specifically in our main model that examined the effect of BMI adjusting for a priori variables (Model 2). However, older age, male sex, and ASA class were highly significant predictors of complications in all four models; however, surgical year was nonsignificant. Notably, after stepwise selection for other demographic and premorbid variables, a history of COPD or asthma was found to be an additional significant factor both in Model 3 (forcing BMI in the model) and Model 4 (without BMI in the model). Exploratory analysis of individual predictors of inpatient noncardiac complications within each BMI category demonstrated that, in underweight patients, admission use of ‐blockers was a significant predictor of having any medical complication (OR, 3.1; 95% CI, 1.1‐8.60; P = 0.03). In normal BMI patients, age 75 years (OR, 2.6; 95% CI, 1.4‐4.9; P = 0.003), ASA class III‐V (OR, 2.3; 95% CI, 1.3‐3.9; P = 0.003), and a history of cerebrovascular disease (OR, 1.5; 95%CI, 1.04‐2.1; P = 0.03) were predictors; and, in obese patients, only age (OR, 1.1; 95% CI, 1.00‐1.12; P = 0.05) was significant. There were no significant predictors of having a medical complication in the overweight group.

Multivariable Analysis for Inpatient Medical Complications Among 1,180 Olmsted County, Minnesota, Residents Undergoing Urgent Hip Fracture Repair, 1988‐2002
 Underweight <18.5 kg/m2 n = 184* n (%)Normal 18.5‐24.9 kg/m2 n = 640* n (%)Overweight 25‐29.9 kg/m2 n = 251* n (%)Obese 30 kg/m2 n = 105* n (%)AgeMale SexSurgical YearASA Score, III‐V vs. I/IICOPD/ Asthma
  • NOTE: Each row represents a separate multivariable logistic regression analysis. All values are listed as hazard ratios (95% confidence intervals).

  • Abbreviations: ASA, American Society of Anesthesia; BMI, body mass index; COPD, chronic obstructive pulmonary disease.

  • The number of observed number of fractures in this category.

  • Model 1: Effect of BMI category (underweight, normal, overweight, and obese) on overall noncardiac inpatient complication rate adjusted, a priori individually, for age, sex, surgical year, and ASA score univariately.

  • P < 0.05.

  • Model 2: Effect of BMI category (underweight, normal, overweight, and obese) on overall noncardiac inpatient complication rate, after adjusting for age, sex, surgical year, and ASA class.

  • Model 3: Model evaluating other potential risk factors, including baseline demographic and baseline clinical variables that were significant (P < 0.05) univariately using stepwise selection. Model includes BMI as a categorical variable (underweight, normal, overweight, and obese), adjusted for age, sex, surgical year, and ASA class.

  • Model 4: Model evaluating other potential risk factors, including baseline demographic and baseline clinical variables that were significant (P < 0.05) univariately using stepwise selection. Model 3 is similar to this, but does not force BMI in.

Model 1a1.25 (0.89‐1.74)Referent0.97 (0.72‐1.31)1.16 (0.76‐1.76)     
Model 1b1.26 (0.90‐1.77)Referent1.05 (0.77‐1.43)1.38 (0.90‐2.13)1.04 (1.02‐1.06)    
Model 1c1.30 (0.93‐1.83)Referent0.93 (0.68‐1.26)1.12 (0.73‐1.71) 1.47 (1.09‐1.98)   
Model 1d1.28 (0.91‐1.79)Referent0.97 (0.71‐1.31)1.13 (0.74‐1.73)  1.03 (1.00‐1.06)  
Model 1e1.23 (0.88‐1.72)Referent1.00 (0.73‐1.36)1.13 (0.74‐1.73)   2.22 (1.52‐3.24) 
Model 21.33 (0.95‐1.88)Referent1.01 (0.74‐1.38)1.28 (0.82‐1.98)1.04 (1.02‐1.06)1.59 (1.17‐2.17)1.02 (0.99‐1.05)1.89 (1.28‐2.79) 
Model 31.30 (0.92‐1.84)Referent1.04 (0.76‐1.42)1.30 (0.84‐2.02)1.05 (1.03‐1.06)1.52 (1.11‐2.07)1.02 (0.99‐1.05)1.77 (1.20‐2.62)1.58 (1.17‐2.12)
Model 4    1.05 (1.03‐1.06)1.49 (1.10‐2.02) 1.84 (1.25‐2.71)1.58 (1.18‐2.12)

Discussion

Most research describing the association of BMI with postoperative outcomes has concentrated on cardiac surgery, general surgical procedures, and intensive care unit utilization.8‐11,20 In the orthopedic literature, an elevated BMI has been associated with a higher number of short‐term complications, but this was limited to elective knee arthroplasty and spine surgery populations.12,13,21 Conversely, no differences were observed in obese patients undergoing hip arthroplasties.14,22 To the best of our knowledge, this study may be the first to examine the impact of BMI on inpatient hospital outcomes following urgent hip fracture repair. Our results suggest the risk of developing a noncardiac medical complication is the same regardless of BMI.

Our overall complication rate was higher (38%) than previous reports by others.19,23‐26 Thus, Lawrence et al.,19 in their retrospective study of 20 facilities, demonstrated an overall complication rate of 17%, even though they also included postoperative cardiac complications. Although their study period overlapped our own (1982‐1993), they additionally included patients aged 60 to 65 years, a population known to have fewer comorbidities and fewer postoperative complications than the elderly hip‐fracture patients studied here. In addition, their population may have been healthier at baseline, in that a higher proportion lived at home (73%) and a lower percentage were ASA class III‐V (71%) than our cohort. These differences in baseline characteristics may explain the higher complication rates observed in our study.

Our findings did not suggest any relationship of BMI with noncardiac postoperative medical complications in any of the 4 methods we used to stratify BMI (continuous, categorical, normal vs. abnormal, and 25 kg/m2). Evidence is contradictory as to what the effect of BMI has on postoperative complications. An elevated BMI (30 kg/m2) has been shown to lead to increased sternal wound infection and saphenous vein harvest infection in a cardiac surgery population,27 but other studies10,28,29 have demonstrated the opposite effect. Among 6336 patients undergoing elective general surgery procedures, the incidence of complications were similar by body mass.30 A matched study design that included urgent and emergent surgeries also did not find any appreciable increased perioperative risk in noncardiac surgery.28 Whether this may be due to the elective nature of the surgeries in these studies, hence leading to selection bias, is unknown.

In geriatric patients, multiple baseline comorbid conditions often are reflected in a higher ASA class, which increases the risk of significant perioperative complications. Our multivariate modeling showed that a high ASA class strongly predicts morbidity and mortality following hip fracture repair, in line with other studies.19,31,32 Although the Charlson comorbidity index could alternatively been used, we elected to adjust for ASA class as it is more commonly used and is simple to use. Interestingly, surgical year did not significantly predict any complication, which can suggest that practice changes play a minimal impact on patient outcomes. However, we caution that because the individual event rates, particularly vascular, were low, we were unable to fully determine whether changes in practice management, such as improved thromboprophylaxis, would impact event rates over time. Finally, other predictors such as older age33 and a concomitant history of either COPD or asthma,34 are well‐accepted predictors of inpatient complications. Our attempt to examine specific predictors of complications in each BMI category revealed differing results, making interpretations difficult. Because of power considerations, this was meant solely as an exploratory analysis, and larger cohorts are needed to further ascertain whether predictors are different in these groups. Such a study may in fact identify perioperative issues that allow practitioners caring for this population to modify these factors.

One of the major limitations in our study was our inability to adjust for individual complications using multivariable models, such as deep vein thrombosis or delirium, within each BMI stratum, because of statistical power issues. Such a study would require large numbers of individual complications or events to allow for appropriate adjustments. The authors acknowledge that such individual complication rates may vary dramatically. We were aware of this potential problem, and therefore a priori ascertained a composite outcome of any noncardiac medical complication. However, our results do provide preliminary information regarding the impact of BMI on noncardiac medical complications. Further studies would be needed, though, to fully determine the effect of BMI on the number of cases with each complication.

Obesity (or BMI) is a known cardiovascular risk factor, and our previous study's aim was to determine cardiovascular events in a comparable manner to the way risk indices, such as the Goldman, Lee, or the AHA preoperative algorithm function. The surgical literature often presents noncardiac complications separately, allowing us to directly compare our own data to other published studies. We used 2 separate approaches, focusing on the inpatient stay (ascertaining noncardiac complications) and 1‐year cardiac outcomes (cardiac complications), as these are mediated by different mechanisms and factors. Furthermore, the intent of both studies was to dispel any concerns that an elevated BMI would in fact lead to an increased number of complications. Whether cardiac complications, though, would impact noncardiac complications, or vice‐versa, is unknown, and would require further investigation.

Although we relied on well‐established definitions for body mass, they have often been challenged, as they may underestimate adiposity in the elderly population due to age‐related reductions in lean mass.35,36 Studies have demonstrated a poor correlation between percent body fat and BMI in the >65 year age group,37 which could impact our results and outcomes by misclassifying patients. Yet, as an anthropometric measurement, BMI is easily obtainable and its variables are routinely documented in patients' medical records, as compared to other anthropometric measurements. Other means of estimating adiposity, such as densitometry or computed tomography (CT) scanning, are impractical, expensive, and not used clinically but routinely in research settings. The lack of standardization in obtaining height and weight, despite nurse‐initiated protocols for bed calibration, may have introduced a degree of measurement bias. Furthermore, the extent of lean mass lost and volume status changes lead to further challenges of using BMI in hospital settings. Whether other anthropometric measurements, including hip circumference, waist circumference, or waist‐hip ratio, should be used in this group of patients requires further examination. However, despite its shortcomings in elderly patients, BMI is still deemed an appropriate surrogate for obesity.

Our main strength was the use of the Rochester Epidemiology Project medical record linkage system to ascertain all patient data. This focuses on patients from a single geographically‐defined community minimizing referral biases often observed in studies originating from a tertiary care referral center. Previous disease‐related epidemiology studies using the Olmsted County population have demonstrated excellent external validity to the U.S. white population.16 We relied on the medical documentation of the treating clinician for many diagnoses in our data abstraction. Although we attempted to use standardized definitions, clinicians may have inadvertently forgotten to document subjective signs or symptoms that would assist in the categorization of these complications. Hence, added inpatient complications may have been overlooked, suggesting that our results may slightly underestimate the true incidence in this population. Additionally, certain complications may overlap categories, such as pneumonia and infections. We agree with Lawrence et al.19 that long periods of time are necessary to accumulate data of this kind in an effort to describe complication rates epidemiologically.

Despite no difference in outcomes among BMI categories, our results have striking implications for the hospitalized patient. Thus, underweight elderly patients, often considered frail with minimal functional reserve, are at no higher risk for developing inpatient medical complications than patients with higher BMIs. This is contrary to our study focusing on cardiac complications, where underweight patients were at higher risk.15 Conversely, obese patients, who have been demonstrated to be at higher risk of medical complications (particularly pulmonary), had no greater risk than patients with normal BMI. To the practicing geriatrician and hospitalist, this information provides important prognostication regarding additional perioperative measures that need to be implemented in these different groups. Based on our results, BMI does not play a particular role in noncardiac medical complications, dispelling any myths of the added burden of excess weight on surgical outcomes in this population. From a hospital perspective, this may be important since additional testing or preventative management in these patients may lead to additional resource use. However, in‐hospital deaths were higher in underweight patients than in patients with a normal BMI. Although we were underpowered to detect any differences in mortality between groups and could therefore not adjust for additional variables, it is unknown whether cardiac or noncardiac complications may be a stronger predictor of death in the underweight patient population. Further studies would be needed to better ascertain this relationship.

Conclusions

In elderly patients undergoing urgent hip fracture repair, BMI does not appear to lead to an excess rate of inpatient noncardiac complications. Our results are the first to demonstrate that BMI has no impact on morbidity in this patient population. Further research on the influence of body composition on inpatient complications in this population is needed to accurately allow for appropriate perioperative prophylaxis. Whether BMI impacts specific complications or in‐patient mortality in this population still requires investigation.

Acknowledgements

The authors thank Donna K. Lawson, LPN, Kathy Wolfert, and Cherie Dolliver, for their assistance in data collection and management.

References
  1. Spillman BC, Lubitz J.The effect of longevity on spending for acute and long‐term care.N Engl J Med.2000;342(19):14091415.
  2. Flegal KM, Graubard BI, Williamson DF, Gail MH.Excess deaths associated with underweight, overweight, and obesity.JAMA.2005;293(15):18611867.
  3. Melton LJ.Adverse outcomes of osteoporotic fractures in the general population.J Bone Miner Res.2003;18(6):11391141.
  4. Burge R, Dawson‐Hughes B, Solomon DH, Wong JB, King A, Tosteson A.Incidence and economic burden of osteoporosis‐related fractures in the United States, 2005–2025.J Bone Miner Res.2007;22(3):465475.
  5. Huddleston JM, Whitford KJ.Medical care of elderly patients with hip fractures.Mayo Clin Proc.2001;76(3):295298.
  6. Phy MP, Vanness DJ, Melton LJ, et al.Effects of a hospitalist model on elderly patients with hip fracture.Arch Intern Med.2005;165(7):796801.
  7. De Laet C, Kanis JA, Oden A, et al.Body mass index as a predictor of fracture risk: a meta‐analysis.Osteoporos Int.2005;16(11):13301338.
  8. Chang SS, Jacobs B, Wells N, Smith JA, Cookson MS.Increased body mass index predicts increased blood loss during radical cystectomy.J Urol.2004;171(3):10771079.
  9. Schwandner O, Farke S, Schiedeck TH, Bruch HP.Laparoscopic colorectal surgery in obese and nonobese patients: do differences in body mass indices lead to different outcomes?Surg Endosc.2004;18(10):14521456.
  10. Shubair MM, Prabhakaran P, Pavlova V, Velianou JL, Sharma AM, Natarajan MK.The relationship of body mass index to outcomes after percutaneous coronary intervention.J Interv Cardiol.2006;19(5):388395.
  11. Wigfield CH, Lindsey JD, Munoz A, Chopra PS, Edwards NM, Love RB.Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI ≥40.Eur J Cardiothorac Surg.2006;29(4):434440.
  12. Miric A, Lim M, Kahn B, Rozenthal T, Bombick D, Sculco TP.Perioperative morbidity following total knee arthroplasty among obese patients.J Knee Surg.2002;15(2):7783.
  13. Patel N, Bagan B, Vadera S, et al.Obesity and spine surgery: relation to perioperative complications.J Neurosurg Spine.2007;6(4):291297.
  14. Perka C, Labs K, Muschik M, Buttgereit F.The influence of obesity on perioperative morbidity and mortality in revision total hip arthroplasty.Arch Orthop Trauma Surg.2000;120(5–6):267271.
  15. Batsis JA, Huddleston JM, Melton LJ, et al.Body mass index and risk of adverse cardiac events in elderly hip fracture patients: a population‐based study.J Am Geriatr Soc.2009;57(3):419426.
  16. Melton L.History of the Rochester Epidemiology Project.Mayo Clin Proc.1996;71(3):266274.
  17. Melton LJ.The threat to medical‐records research.N Engl J Med.1997;337(20):1466170.
  18. Quetelet L.A Treatise on Man and the Development of His Faculties.Brussels:Musquardt;1871.
  19. Lawrence VA, Hilsenbeck SG, Noveck H, Poses RM, Carson JL.Medical complications and outcomes after hip fracture repair.Arch Intern Med.2002;162(18):20532057.
  20. Akinnusi ME, Pineda LA, El Solh AA.Effect of obesity on intensive care morbidity and mortality: a meta‐analysis.Crit Care Med.2008;36(1):151158.
  21. Patel AD, Albrizio M.Relationship of body mass index to early complications in knee replacement surgery.Arch Orthop Trauma Surg.2008;128(1):59.
  22. Andrew JG, Palan J, Kurup HV, Gibson P, Murray DW, Beard DJ.Obesity in total hip replacement.J Bone Joint Surg Br.2008;90(4):424429.
  23. Hardy DC, Descamps PY, Krallis P, et al.Use of an intramedullary hip‐screw compared with a compression hip‐screw with a plate for intertrochanteric femoral fractures. A prospective, randomized study of one hundred patients.J Bone Joint Surg Am.1998;80(5):618630.
  24. Levi N.Blood transfusion requirements in intracapsular femoral neck fractures.Injury.1996;27(10):709711.
  25. Miller K, Atzenhofer K, Gerber G, Reichel M.Risk prediction in operatively treated fractures of the hip.Clin Orthop Relat Res.1993(293):148152.
  26. Parker MJ.Internal fixation or arthroplasty for displaced subcapital fractures in the elderly?Injury.1992;23(8):521524.
  27. Engelman DT, Adams DH, Byrne JG, et al.Impact of body mass index and albumin on morbidity and mortality after cardiac surgery.J Thorac Cardiovasc Surg.1999;118(5):866873.
  28. Klasen J, Junger A, Hartmann B, et al.Increased body mass index and peri‐operative risk in patients undergoing non‐cardiac surgery.Obes Surg.2004;14(2):275281.
  29. Schwann TA, Habib RH, Zacharias A, et al.Effects of body size on operative, intermediate, and long‐term outcomes after coronary artery bypass operation.Ann Thorac Surg.2001;71(2):521530; discussion 530–531.
  30. Dindo D, Muller MK, Weber M, Clavien PA.Obesity in general elective surgery.Lancet.2003;361(9374):20322035.
  31. Batsis JA, Phy MP, Joseph Melton L, et al.Effects of a hospitalist care model on mortality of elderly patients with hip fractures.J Hosp Med.2007;2(4):219225.
  32. Gdalevich M, Cohen D, Yosef D, Tauber C.Morbidity and mortality after hip fracture: the impact of operative delay.Arch Orthop Trauma Surg.2004;124(5):334340.
  33. Shah MR, Aharonoff GB, Wolinsky P, Zuckerman JD, Koval KJ.Outcome after hip fracture in individuals ninety years of age and older.J Orthop Trauma.2001;15(1):3439.
  34. Jiang HX, Majumdar SR, Dick DA, et al.Development and initial validation of a risk score for predicting in‐hospital and 1‐year mortality in patients with hip fractures.J Bone Miner Res.2005;20(3):494500.
  35. Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB.How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?Am J Epidemiol.1996;143(3):228239.
  36. Smalley KJ, Knerr AN, Kendrick ZV, Colliver JA, Owen OE.Reassessment of body mass indices.Am J Clin Nutr.1990;52(3):405408.
  37. Romero‐Corral A, Somers VK, Sierra‐Johnson J, et al.Accuracy of body mass index in diagnosing obesity in the adult general population.Int J Obes (Lond).2008;32(6):959966.
  38. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI.Clarifying confusion: the confusion assessment method. A new method for detection of delirium.Ann Intern Med.1990;113(12):941948.
References
  1. Spillman BC, Lubitz J.The effect of longevity on spending for acute and long‐term care.N Engl J Med.2000;342(19):14091415.
  2. Flegal KM, Graubard BI, Williamson DF, Gail MH.Excess deaths associated with underweight, overweight, and obesity.JAMA.2005;293(15):18611867.
  3. Melton LJ.Adverse outcomes of osteoporotic fractures in the general population.J Bone Miner Res.2003;18(6):11391141.
  4. Burge R, Dawson‐Hughes B, Solomon DH, Wong JB, King A, Tosteson A.Incidence and economic burden of osteoporosis‐related fractures in the United States, 2005–2025.J Bone Miner Res.2007;22(3):465475.
  5. Huddleston JM, Whitford KJ.Medical care of elderly patients with hip fractures.Mayo Clin Proc.2001;76(3):295298.
  6. Phy MP, Vanness DJ, Melton LJ, et al.Effects of a hospitalist model on elderly patients with hip fracture.Arch Intern Med.2005;165(7):796801.
  7. De Laet C, Kanis JA, Oden A, et al.Body mass index as a predictor of fracture risk: a meta‐analysis.Osteoporos Int.2005;16(11):13301338.
  8. Chang SS, Jacobs B, Wells N, Smith JA, Cookson MS.Increased body mass index predicts increased blood loss during radical cystectomy.J Urol.2004;171(3):10771079.
  9. Schwandner O, Farke S, Schiedeck TH, Bruch HP.Laparoscopic colorectal surgery in obese and nonobese patients: do differences in body mass indices lead to different outcomes?Surg Endosc.2004;18(10):14521456.
  10. Shubair MM, Prabhakaran P, Pavlova V, Velianou JL, Sharma AM, Natarajan MK.The relationship of body mass index to outcomes after percutaneous coronary intervention.J Interv Cardiol.2006;19(5):388395.
  11. Wigfield CH, Lindsey JD, Munoz A, Chopra PS, Edwards NM, Love RB.Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI ≥40.Eur J Cardiothorac Surg.2006;29(4):434440.
  12. Miric A, Lim M, Kahn B, Rozenthal T, Bombick D, Sculco TP.Perioperative morbidity following total knee arthroplasty among obese patients.J Knee Surg.2002;15(2):7783.
  13. Patel N, Bagan B, Vadera S, et al.Obesity and spine surgery: relation to perioperative complications.J Neurosurg Spine.2007;6(4):291297.
  14. Perka C, Labs K, Muschik M, Buttgereit F.The influence of obesity on perioperative morbidity and mortality in revision total hip arthroplasty.Arch Orthop Trauma Surg.2000;120(5–6):267271.
  15. Batsis JA, Huddleston JM, Melton LJ, et al.Body mass index and risk of adverse cardiac events in elderly hip fracture patients: a population‐based study.J Am Geriatr Soc.2009;57(3):419426.
  16. Melton L.History of the Rochester Epidemiology Project.Mayo Clin Proc.1996;71(3):266274.
  17. Melton LJ.The threat to medical‐records research.N Engl J Med.1997;337(20):1466170.
  18. Quetelet L.A Treatise on Man and the Development of His Faculties.Brussels:Musquardt;1871.
  19. Lawrence VA, Hilsenbeck SG, Noveck H, Poses RM, Carson JL.Medical complications and outcomes after hip fracture repair.Arch Intern Med.2002;162(18):20532057.
  20. Akinnusi ME, Pineda LA, El Solh AA.Effect of obesity on intensive care morbidity and mortality: a meta‐analysis.Crit Care Med.2008;36(1):151158.
  21. Patel AD, Albrizio M.Relationship of body mass index to early complications in knee replacement surgery.Arch Orthop Trauma Surg.2008;128(1):59.
  22. Andrew JG, Palan J, Kurup HV, Gibson P, Murray DW, Beard DJ.Obesity in total hip replacement.J Bone Joint Surg Br.2008;90(4):424429.
  23. Hardy DC, Descamps PY, Krallis P, et al.Use of an intramedullary hip‐screw compared with a compression hip‐screw with a plate for intertrochanteric femoral fractures. A prospective, randomized study of one hundred patients.J Bone Joint Surg Am.1998;80(5):618630.
  24. Levi N.Blood transfusion requirements in intracapsular femoral neck fractures.Injury.1996;27(10):709711.
  25. Miller K, Atzenhofer K, Gerber G, Reichel M.Risk prediction in operatively treated fractures of the hip.Clin Orthop Relat Res.1993(293):148152.
  26. Parker MJ.Internal fixation or arthroplasty for displaced subcapital fractures in the elderly?Injury.1992;23(8):521524.
  27. Engelman DT, Adams DH, Byrne JG, et al.Impact of body mass index and albumin on morbidity and mortality after cardiac surgery.J Thorac Cardiovasc Surg.1999;118(5):866873.
  28. Klasen J, Junger A, Hartmann B, et al.Increased body mass index and peri‐operative risk in patients undergoing non‐cardiac surgery.Obes Surg.2004;14(2):275281.
  29. Schwann TA, Habib RH, Zacharias A, et al.Effects of body size on operative, intermediate, and long‐term outcomes after coronary artery bypass operation.Ann Thorac Surg.2001;71(2):521530; discussion 530–531.
  30. Dindo D, Muller MK, Weber M, Clavien PA.Obesity in general elective surgery.Lancet.2003;361(9374):20322035.
  31. Batsis JA, Phy MP, Joseph Melton L, et al.Effects of a hospitalist care model on mortality of elderly patients with hip fractures.J Hosp Med.2007;2(4):219225.
  32. Gdalevich M, Cohen D, Yosef D, Tauber C.Morbidity and mortality after hip fracture: the impact of operative delay.Arch Orthop Trauma Surg.2004;124(5):334340.
  33. Shah MR, Aharonoff GB, Wolinsky P, Zuckerman JD, Koval KJ.Outcome after hip fracture in individuals ninety years of age and older.J Orthop Trauma.2001;15(1):3439.
  34. Jiang HX, Majumdar SR, Dick DA, et al.Development and initial validation of a risk score for predicting in‐hospital and 1‐year mortality in patients with hip fractures.J Bone Miner Res.2005;20(3):494500.
  35. Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB.How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?Am J Epidemiol.1996;143(3):228239.
  36. Smalley KJ, Knerr AN, Kendrick ZV, Colliver JA, Owen OE.Reassessment of body mass indices.Am J Clin Nutr.1990;52(3):405408.
  37. Romero‐Corral A, Somers VK, Sierra‐Johnson J, et al.Accuracy of body mass index in diagnosing obesity in the adult general population.Int J Obes (Lond).2008;32(6):959966.
  38. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI.Clarifying confusion: the confusion assessment method. A new method for detection of delirium.Ann Intern Med.1990;113(12):941948.
Issue
Journal of Hospital Medicine - 4(8)
Issue
Journal of Hospital Medicine - 4(8)
Page Number
E1-E9
Page Number
E1-E9
Publications
Publications
Article Type
Display Headline
Body mass index (BMI) and risk of noncardiac postoperative medical complications in elderly hip fracture patients: A population‐based study
Display Headline
Body mass index (BMI) and risk of noncardiac postoperative medical complications in elderly hip fracture patients: A population‐based study
Legacy Keywords
elderly, hip fractures, inpatient, medical complications, obesity, postoperative
Legacy Keywords
elderly, hip fractures, inpatient, medical complications, obesity, postoperative
Sections
Article Source

Copyright © 2009 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
John A. Batsis, Section of General Internal Medicine, Dartmouth‐Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03755
Jeanne M. Huddleston, Division of Hospital Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Article PDF Media

Ischemic Stroke After Hip Operation

Article Type
Changed
Sun, 05/28/2017 - 21:44
Display Headline
Predictors of ischemic stroke after hip operation: A population‐based study

In the United States, hip operations (internal fixation of fracture or total hip arthroplasty [THA]) are the most common noncardiac major surgical procedures performed in patients age 65 years and older (45.2 procedures per 100,000 persons per year).1 This number of procedures is projected to increase substantially in the coming decades.

Little is known about the clinical predictors of postoperative stroke in patients undergoing hip surgical procedures. Further, recent results of the Perioperative Ischemic Evaluation (POISE) trial have shown that measures taken to reduce cardiac complications postoperatively may adversely affect the risk of stroke.2 The POISE study showed decreases in myocardial infarction and coronary revascularization but accompanying increases in stroke and death with use of ‐blockers in patients undergoing noncardiac surgery.

Prevention of adverse events is one of the top priorities of the U.S. health care system today.35 Risk stratification and therapeutic optimization of underlying chronic diseases may be important in decreasing perioperative risk and improving postoperative outcomes.

Our objective was to determine the rate of postoperative ischemic stroke in all residents of Olmsted County, MN, who underwent hip operation between 1988 and 2002 and to identify clinical predictors of postoperative stroke.

Subjects and Methods

Olmsted County is one of the few places in the world where comprehensive population‐based studies of disease etiology and outcomes are feasible. This feasibility is due to the Rochester Epidemiology Project, a medical records linkage system that provides access to the records of all medical care in the community.1 All medical diagnoses made for a resident of Olmsted County are entered on a master sheet in the patient's medical record, which is then entered into a central computer index.

Hip operations were identified using the Surgical Information Recording System data warehouse, where detailed data are stored as International Classification of Diseases, 9th edition (ICD‐9) codes for all surgical procedures performed from January 1, 1988, forward. A total of 2028 THAs and hip fracture repairs (ICD‐9 codes 81.51, 81.52, 81.53, 79.15, and 79.25) performed between 1988 and 2002 in Olmsted County were identified. Of the hip procedures, 142 were excluded (Figure 1). The final analysis cohort contained 1886 hip operations1195 hip fracture repairs and 691 THAs.

Figure 1
Flowchart showing subjects included in cohort of residents of Olmsted County, MN, and methods of identification and types of strokes identified. Fx, fracture.

The population‐based cohort was assembled and the data were abstracted from complete inpatient and outpatient records from admission for surgical treatment up to 1 year after surgery. Only those patients who had given prior authorization for research were included in the study cohort. The Mayo Clinic Institutional Review Board approved the study.

Case Ascertainment

We used several screening procedures to completely enumerate all postoperative strokes in our study population (Figure 1). The Mayo Clinic administrative database was used to identify all cases with relevant cerebrovascular disease (ICD‐9 codes 430.0‐437.9, 368.12, 781.4, and 784.3) within 1 year after hip operation. The Rochester Stroke Registry identified incident cases of ischemic stroke in Olmsted County from 1988 through 1994. The clinic's administrative database was also used to identify brain imaging studies (brain computed tomography, magnetic resonance imaging, or carotid ultrasonography) between the day of the procedure and 1 year postoperatively. A neurologist reviewed each image and the associated medical record identified during the screening process in detail for the constellation of signs and symptoms consistent with the diagnosis of stroke. Death certificates and autopsy reports were also reviewed to identify persons with the diagnosis of stroke. The outcome (stroke) was masked to the nurse abstractor who reviewed charts for predictors of postoperative stroke (eg, atrial fibrillation, coronary artery disease [CAD], history of stroke, medication use). The exposed or unexposed status of the patients to the predictors of stroke was masked to the physician (A.S.P.) who screened electronic medical records for the outcome measure (stroke).

Cerebral infarction or ischemic stroke was defined as the acute onset of a neurologic deficit that persisted for longer than 24 hours and corresponded to an arterial vascular territory of the cerebral hemispheres, brainstem, or cerebellum, with or without computed tomographic or magnetic resonance imaging documentation. Transient ischemic attack was defined as an episode of focal neurologic symptoms with abrupt onset and rapid resolution, lasting less than 24 hours, and due to altered circulation to a limited region of the brain.

Only patients with ischemic strokes clinically documented by a neurologist were included in the analysis.

Primary Outcomes

Outcomes were the cumulative probability of ischemic stroke and predictors of stroke in the first 12 months after surgical treatment of the hip.

Statistical Analysis

Continuous variables are presented as mean (standard deviation [SD]); categorical variables are presented as number and percentage. Two‐sample t tests or Wilcoxon rank sum tests were used to test for differences between THAs and hip fracture repairs in demographic characteristics, past medical history, and baseline clinical data composed of continuous variables; 2 or Fisher exact tests were used for categorical variables. No patient was lost to follow‐up during the 1 year after the initial surgery. However, the data of patients who died or had a second hip procedure within that period were censored.

The rate of ischemic stroke within 1 year after the incident hip procedure was calculated using the Kaplan‐Meier method. Second hip procedures within that period were counted as additional cases. Rates were calculated for the overall group, as well as for the univariate risk factors of operative procedure type, age, sex, past medical history of stroke, hypertension, atrial fibrillation, CAD, chronic obstructive pulmonary disease (COPD), diabetes mellitus, and chronic renal insufficiency. Use of ‐blockers, hydroxymethylglutaryl‐coenzyme A (HMG‐CoA) reductase inhibitors, or aspirin at hospital admission was also considered. Cox proportional hazards regression models were used to evaluate the risk of ischemic stroke for each of these univariate risk factors. Multivariable Cox proportional hazards models were constructed with adjustments for operative procedure type, age, sex, and comorbid conditions such as atrial fibrillation and hypertension. These covariates were added in a stepwise selection to identify factors significantly associated with the outcome. To account for patients who had a second hip procedure within 1 year of their first operation, we calculated all Cox proportional hazards regression results using the robust sandwich estimate of the covariance matrix. The proportional hazards assumption for all Cox models was evaluated with the methods proposed by Therneau and Grambsch;6 no violations of this assumption were identified. The rate of postoperative stroke after adjusting for the competing risk of death was calculated using the approach of Gooley et al.7 All statistical tests were 2‐sided, and a P value was considered significant if it was less than 0.05. Statistical analyses were performed using statistical software (SAS version 9.1.3; SAS Institute, Inc., Cary, NC).

Results

Among the patients with the 1886 hip procedures, 67 ischemic strokes were identified within 1 year after the index surgical procedure10 (1.4%) among the 691 THAs and 57 (4.8%) among the 1195 hip fracture repairs. Baseline characteristics are summarized in Table 1. Compared with the THA group, patients in the hip fracture repair group were more likely to be older and female. Additionally, such comorbid conditions as a history of stroke, diabetes mellitus, congestive heart failure, atrial fibrillation, or dementia were more prevalent in the hip fracture repair group.

Baseline Characteristics of Study Population
CharacteristicsSurgical ProcedureTotal (n = 1,886)P Value*
THA (n = 691)Fracture Repair (n = 1,195)
  • NOTE: Continuous variables are represented as mean (SD); categorical variables are represented as number and percentage.

  • Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; CHF, congestive heart failure; THA, total hip arthroplasty.

  • P values are from Kruskal‐Wallis tests for continuous variables and from either 2 or Fisher exact tests for categorical variables.

  • Fifteen cases had no BMI data.

  • One case had no ASA risk classification data.

Age, years74.9 (6.59)84.2 (7.49)80.8 (8.46)<0.001
Sex, male258 (37.3)234 (19.6)492 (26.1)<0.001
Race, White690 (100)1,187 (99.3)1,877 (99.5)0.17
BMI27.7 (5.36)23.3 (4.93)24.9 (5.52)<0.001
History    
Hypertension424 (61.4)695 (58.2)1,119 (59.3)0.17
Diabetes57 (8.2)141 (11.8)198 (10.5)0.02
Stroke50 (7.2)334 (27.9)384 (20.4)<0.001
CHF100 (14.5)321 (26.9)421 (22.3)<0.001
Atrial fibrillation72 (10.4)241 (20.2)313 (16.6)<0.001
Dementia16 (2.3)407 (34.1)423 (22.4)<0.001
ASA risk classification   <0.001
1 or 2343 (49.6)172 (14.4)515 (27.3) 
3, 4, or 5348 (50.4)1,022 (85.6)1,370 (72.7) 
Medication on admission    
Aspirin168 (24.3)369 (30.9)537 (28.5)0.002
‐Blocker134 (19.4)184 (15.4)318 (16.9)0.03
Insulin12 (1.7)48 (4)60 (3.2)0.007
Length of stay, days7.3 (3.9)10.0 (7.61)9.0 (6.63)<0.001

Univariate analyses assessing the rate and risk of postoperative ischemic stroke are shown in Table 2. The rate of stroke was significantly greater among hip fracture repairs than THAs 30 days postoperatively and 1 year postoperatively (1.5% vs. 0.6% and 5.5% vs. 1.5%, respectively; P < 0.001) (Figure 2). In our study we found an annual incidence rate of ischemic stroke of 4093 per 100,000 person‐years (95% confidence interval [CI], 3172‐5198 per 100,000 person‐years). Accounting for death as a competing risk for stroke had little impact on the rate of stroke overall or within the 2 surgical groups (results not shown). Univariate Cox proportional hazards models showed that neither sex nor history of hypertension, diabetes mellitus, COPD, chronic renal insufficiency, or CAD or use of HMG‐CoA reductase inhibitors or ‐blockers were significant predictors of ischemic stroke. However, other clinical risk factors, such as a history of atrial fibrillation (hazard ratio [HR], 2.16; P = 0.005), hip fracture repair vs. THA (HR, 3.80; P < 0.001), increased age (HR, 2.20; P = 0.017), aspirin use (HR, 1.8; P = 0.014), and history of previous stroke (HR, 4.18; P < 0.001), were significantly associated with an increased risk of stroke (Table 2).

Figure 2
Kaplan‐Meier curves of cumulative probability of ischemic stroke after hip fracture repair vs. total hip arthroplasty (THA). Error bars indicate 95% confidence intervals; P < 0.001; hazard ratio = 3.8.
Univariate Estimates and Predictors of Postoperative Ischemic Stroke After Hip Operation
VariableNumber of PatientsNumber of EventsRate (%)Hazard RatioP Value
30‐Day (95% CI)1‐Year (95% CI)
  • Abbreviations: CAD, coronary artery disease; CI, confidence interval; COPD, chronic obstructive pulmonary disease; HMG‐CoA, hydroxymethyglutaryl coenzyme A; THA, total hip arthroplasty.

Overall1886671.2 (0.7‐1.7)3.9 (3‐4.8)  
Type of operative procedure      
THA691100.6 (0.0‐1.1)1.5 (0.6‐2.4)  
Hip fracture repair1195571.5 (0.8‐2.2)5.5 (4.1‐6.9)3.80 (1.94‐7.44)<0.001
Age at operation, years      
<75528111.0 (0.1‐1.8)2.1 (0.9‐3.3)  
751358561.3 (0.7‐1.9)4.7 (3.5‐5.8)2.20 (1.15‐4.21)0.02
Sex      
Female1394541.3 (0.7‐1.9)4.2 (3.1‐5.3)  
Male492130.8 (0.0‐1.7)2.9 (1.3‐4.4)0.69 (0.38‐1.27)0.24
History of stroke      
No1502340.7 (0.3‐1.2)2.4 (1.6‐3.3)  
Yes384333.0 (1.2‐4.7)9.9 (6.6‐13)4.18 (2.59‐6.74)<0.001
History of hypertension      
No767230.8 (0.2‐1.4)3.4 (2.0‐4.7)  
Yes1119441.5 (0.7‐2.2)4.2 (3.0‐5.5)1.29 (0.78‐2.14)0.32
History of atrial fibrillation      
No1573481.0 (0.5‐1.5)3.3 (2.4‐4.2)  
Yes313191.9 (0.4‐3.5)7.0 (3.9‐9.9)2.16 (1.27‐3.67)0.005
History of CAD      
No1224401.1 (0.5‐1.6)3.5 (2.4‐4.5)  
Yes662271.4 (0.5‐2.3)4.7 (2.9‐6.4)1.34 (0.82‐2.19)0.24
History of COPD      
No1606621.4 (0.8‐2.0)4.2 (3.1‐5.2)  
Yes28050 (0.0‐0.0)2.2 (0.3‐4.1)0.49 (0.20‐1.22)0.13
History of diabetes mellitus      
No1688561.1 (0.6‐1.7)3.6 (2.7‐4.5)  
Yes198111.5 (0‐3.3)6.3 (2.6‐9.9)1.75 (0.92‐3.34)0.09
History of renal insufficiency      
No1718581.0 (0.5‐1.5)3.7 (2.7‐4.6)  
Yes16893.0 (0.4‐5.5)5.8 (2‐9.5)1.77 (0.88‐3.57)0.11
Aspirin use      
No1349390.7 (0.2‐1.1)3.2 (2.2‐4.2)  
Yes537282.5 (0.1‐3.8)5.7 (3.6‐7.7)1.86 (1.13‐3.06)0.01
‐Blocker use      
No1568521.1 (0.6‐1.6)3.6 (2.7‐4.6)  
Yes318151.6 (0.2‐3.0)5.1 (2.6‐7.6)1.42 (0.81‐2.52)0.22
HMG‐CoA reductase inhibitor use      
No1736631.2 (0.7‐1.7)4.0 (3.0‐4.9)  
Yes (statin/other lipid lowering drugs)14841.4 (0‐3.2)2.8 (0.1‐5.4)0.70 (0.26‐1.94)0.50

Because age was associated with the type of surgical procedure (87% of hip fracture repair patients were 75 years or older compared with 45% of THA patients), the effect of hip fracture repair on ischemic stroke was adjusted for age. For similar reasons, sex was also examined as an adjusting factor. Adjustment for age and sex resulted in only a slight attenuation of the HR for hip fracture repair vs. THA, from 3.8 to 3.4. A further analysis also adjusted for history of hypertension and history of atrial fibrillation, both comorbidities commonly associated with ischemic stroke. After adjustment for age, sex, history of hypertension, and history of atrial fibrillation, the risk of ischemic stroke was still significantly greater in the hip fracture repair group than in the THA group (HR, 2.8; 95% CI, 1.4‐5.7; P = 0.005).

To determine the most important predictors of postoperative ischemic stroke, multivariable analysis was conducted with stepwise selection. Potential risk factors included the following: operative procedure type (hip fracture repair vs. THA), age, sex, and history of stroke, hypertension, atrial fibrillation, CAD, COPD, diabetes mellitus, and chronic renal insufficiency, as well as use of ‐blockers, HMG‐CoA reductase inhibitors, and aspirin on hospital admission. Among all these factors, history of stroke (HR, 3.27; P < 0.001) and hip fracture repair vs. THA (HR, 2.74; P = 0.004) were confirmed to be significant predictors of postoperative ischemic stroke; the other factors did not significantly affect the model (Figure 2).

Comment

Our findings contrast those of previous studies that focused on perioperative ischemic stroke rates for specific surgical procedures,2, 8, 9 but do seem concordant with published results for early event rates of cerebrovascular accident or transient ischemic attack (1%) following hip fracture.10 The data from our study suggest that perioperative stroke cumulative probability is relatively high for hip procedures at both 30 days (1.2%) and 1 year (3.9%) after the index surgical procedure compared with general procedures. Subjects with a history of stroke who were undergoing hip operation had a postoperative stroke risk of 3.0% at 30 days and 9.9% at 1 year.

The incidence of stroke was greater in the hip fracture repair group (1.5% at 30 days and 5.5% at 1 year) than in the elective THA group (0.6% at 30 days and 1.5% at 1 year). The increased 1‐year mortality for patients undergoing hip surgery compared with the general population is in part due to cerebrovascular disease,10 and, therefore, the 1‐year stroke incidence is important.

After adjustment for age, sex, and comorbidities (hypertension and atrial fibrillation), the risk of postoperative ischemic stroke was 2.71 times greater in the hip fracture repair group than in the THA group (P = 0.006). These data are important in counseling and caring for patients undergoing different types of hip procedures.

From 1985 through 1989, for the age group (75‐84 years old) that best fits the demographics of our cohort, both men and women had limited variation over time in annual incidence rates of stroke (2149‐1074 strokes per 100,000 population per year) for Olmsted County, MN.11 In our study we found an annual incidence rate of ischemic stroke of 4,093 per 100,000 person‐years (95% CI, 3172‐5198 per 100,000 person‐years). The lower limit of the 95% CI is higher than the rates reported for Olmsted County, suggesting that having hip surgery increases the 1‐year risk of ischemic stroke.

Previous studies have shown that the risk factor most consistently correlated to perioperative ischemic stroke is a history of stroke.9 In our study, history of stroke and type of hip fracture surgery were confirmed to be the strongest predictors of postoperative stroke. History of hypertension, atrial fibrillation, CAD, COPD, diabetes, or chronic renal insufficiency was not correlated to perioperative ischemic stroke.

Nonmodifiable risk factors, such as advanced age, serve as markers of stroke risk and help identify high‐risk populations that may require aggressive intervention. After age adjustment of hip fracture repair, age was no longer significantly associated with postoperative stroke.

Cerebrovascular disease appears to be a marker for CAD, and, therefore, patients with a history of stroke usually have a Revised Cardiac Risk Index that may suggest the use of ‐blockers. According to the recent results of the POISE trial, use of ‐blockers could lead to increased stroke incidence.2 Our results showed no significant correlation between stroke risk and ‐blocker use, but our study period was from 1988 to 2002, when titration of ‐blocker dose to heart rates of 55 to 60 beats per minute was not common practice.

Several studies have confirmed the value of aspirin in decreasing the rate of vascular outcomes after diagnosis of transient ischemic attack or stroke.12 In our study, aspirin use on hospital admission was found in the univariate analysis to be associated with an increased risk of stroke, but this finding was not confirmed after adjustments for age, sex, and comorbid conditions. Aspirin use on admission was not a significant predictor of postoperative stroke, most likely because aspirin use can be considered a marker of increased cardiovascular risk and we adjusted for these comorbid conditions.

The limitations of this study are inherent in its retrospective design. First, we identified all incident cases of stroke after hip operation by reviewing medical records and then abstracting data from those records. We may have missed some mild strokes if they were misclassified as peripheral vestibular neuropathy, migraine, or even seizure. Less likely is that we missed strokes within the first 30 days after the procedure because that is the period in which patients with hip operation are either hospitalized or sent for rehabilitation in skilled nursing facilities. It is known that institutionalization leads to better surveillance and more complete ascertainment of any medical event.

The event rate of postoperative stroke at 30 days after hip operation was low. Therefore, we did not have the statistical power to comment meaningfully on predictors of stroke at 30 days after the hip procedure. Any nonrespondent or volunteer bias was addressed by using data from the Rochester Epidemiology Project, which allowed us to identify all Olmsted County residents who underwent hip operation between 1988 and 2002. The diagnostic suspicion bias was also accounted for in our study design because different physicians provided care and outcome measurement.

Our results apply for the patients who underwent hip operation between 1988 and 2002. The noncardiac surgery guidelines have been revised between 1988 and 2002, and we did not perform a stratified analysis by index year. The next step in our study will be to extend our data collection to 2008 and look at time trends.

Conclusion

In this population‐based historical cohort study, patients undergoing hip operation had a 3.9% cumulative probability of ischemic stroke during the first postoperative year. History of stroke and type of hip procedure (ie, hip fracture repair) were the strongest predictors of this complication. Because history of stroke is such a strong predictor of postoperative stroke, the perioperative management of these patients should probably be tailored, with closely observed blood pressure management and antihypertensive medication adjustment, to avoid compromising cerebral perfusion. Also, to avoid postoperative hypercoagulability that increases the risk of stroke, these patients may need to begin receiving antiplatelets as soon as is surgically acceptable.1315

References
  1. Melton LJ.History of the Rochester Epidemiology Project.Mayo Clin Proc.1996;71(3):266274.
  2. POISE Study Group;Devereaux PJ,Yang H,Yusuf S,Guyatt G,Leslie K,Villar JC, et al.Effects of extended‐release metoprolol succinate in patients undergoing non‐cardiac surgery (POISE trial): a randomised controlled trial.Lancet.2008;371(9627):18391847.
  3. Thom T,Haase N,Rosamond W,Howard VJ,Rumsfeld J,Manolio T, et al;American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.Circulation.2006;113(6):e85e151.
  4. Shojania KG, Duncan BW, McDonald KM, Wachter RM, Markowitz AJ, eds.Making health care safer: a critical analysis of patient safety practices. Evidence Report/Technology Assessment No.43.AHRQ publication no. 01‐E058.Rockville, MD:Agency for Healthcare Research and Quality (AHRQ),U.S. Department of Health and Human Services;2001.668 p.
  5. McDonald CJ,Weiner M,Hui SL.Deaths due to medical errors are exaggerated in Institute of Medicine report.JAMA.2000;284(1):9395.
  6. Therneau TM,Grambsch PM.Modeling survival data: extending the Cox model.New York:Springer;2000.
  7. Gooley TA,Leisenring W,Crowley J,Storer BE.Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.Stat Med.1999;18(6):695706.
  8. Larsen SF,Zaric D,Boysen G.Postoperative cerebrovascular accidents in general surgery.Acta Anaesthesiol Scand.1988;32(8):698701.
  9. Landercasper J,Merz BJ,Cogbill TH,Strutt PJ,Cochrane RH,Olson RA, et al.Perioperative stroke risk in 173 consecutive patients with a past history of stroke.Arch Surg.1990;125(8):986989.
  10. Lawrence VA,Hilsenbeck SG,Noveck H,Poses RM,Carson JL.Medical complications and outcomes after hip fracture repair.Arch Intern Med.2002;162(18):2053–2057.
  11. Brown RD,Whisnant JP,Sicks JD,O'Fallon WM,Wiebers DO.Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989.Stroke.1996;27(3):373380.
  12. CAST (Chinese Acute Stroke Trial) Collaborative Group.Randomised placebo‐controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke.Lancet.1997;349(9066):16411649.
  13. Dixon B,Santamaria J,Campbell D.Coagulation activation and organ dysfunction following cardiac surgery.Chest.2005;128(1):229236.
  14. Páramo JA,Rifón J,Llorens R,Casares J,Paloma MJ,Rocha E.Intra‐ and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery.Haemostasis.1991;21(1):5864.
  15. Selim M.Perioperative stroke.N Engl J Med.2007;356(7):706713.
Article PDF
Issue
Journal of Hospital Medicine - 4(5)
Publications
Page Number
298-303
Legacy Keywords
arthroplasty, hip, hip fracture, ischemia, stroke
Sections
Article PDF
Article PDF

In the United States, hip operations (internal fixation of fracture or total hip arthroplasty [THA]) are the most common noncardiac major surgical procedures performed in patients age 65 years and older (45.2 procedures per 100,000 persons per year).1 This number of procedures is projected to increase substantially in the coming decades.

Little is known about the clinical predictors of postoperative stroke in patients undergoing hip surgical procedures. Further, recent results of the Perioperative Ischemic Evaluation (POISE) trial have shown that measures taken to reduce cardiac complications postoperatively may adversely affect the risk of stroke.2 The POISE study showed decreases in myocardial infarction and coronary revascularization but accompanying increases in stroke and death with use of ‐blockers in patients undergoing noncardiac surgery.

Prevention of adverse events is one of the top priorities of the U.S. health care system today.35 Risk stratification and therapeutic optimization of underlying chronic diseases may be important in decreasing perioperative risk and improving postoperative outcomes.

Our objective was to determine the rate of postoperative ischemic stroke in all residents of Olmsted County, MN, who underwent hip operation between 1988 and 2002 and to identify clinical predictors of postoperative stroke.

Subjects and Methods

Olmsted County is one of the few places in the world where comprehensive population‐based studies of disease etiology and outcomes are feasible. This feasibility is due to the Rochester Epidemiology Project, a medical records linkage system that provides access to the records of all medical care in the community.1 All medical diagnoses made for a resident of Olmsted County are entered on a master sheet in the patient's medical record, which is then entered into a central computer index.

Hip operations were identified using the Surgical Information Recording System data warehouse, where detailed data are stored as International Classification of Diseases, 9th edition (ICD‐9) codes for all surgical procedures performed from January 1, 1988, forward. A total of 2028 THAs and hip fracture repairs (ICD‐9 codes 81.51, 81.52, 81.53, 79.15, and 79.25) performed between 1988 and 2002 in Olmsted County were identified. Of the hip procedures, 142 were excluded (Figure 1). The final analysis cohort contained 1886 hip operations1195 hip fracture repairs and 691 THAs.

Figure 1
Flowchart showing subjects included in cohort of residents of Olmsted County, MN, and methods of identification and types of strokes identified. Fx, fracture.

The population‐based cohort was assembled and the data were abstracted from complete inpatient and outpatient records from admission for surgical treatment up to 1 year after surgery. Only those patients who had given prior authorization for research were included in the study cohort. The Mayo Clinic Institutional Review Board approved the study.

Case Ascertainment

We used several screening procedures to completely enumerate all postoperative strokes in our study population (Figure 1). The Mayo Clinic administrative database was used to identify all cases with relevant cerebrovascular disease (ICD‐9 codes 430.0‐437.9, 368.12, 781.4, and 784.3) within 1 year after hip operation. The Rochester Stroke Registry identified incident cases of ischemic stroke in Olmsted County from 1988 through 1994. The clinic's administrative database was also used to identify brain imaging studies (brain computed tomography, magnetic resonance imaging, or carotid ultrasonography) between the day of the procedure and 1 year postoperatively. A neurologist reviewed each image and the associated medical record identified during the screening process in detail for the constellation of signs and symptoms consistent with the diagnosis of stroke. Death certificates and autopsy reports were also reviewed to identify persons with the diagnosis of stroke. The outcome (stroke) was masked to the nurse abstractor who reviewed charts for predictors of postoperative stroke (eg, atrial fibrillation, coronary artery disease [CAD], history of stroke, medication use). The exposed or unexposed status of the patients to the predictors of stroke was masked to the physician (A.S.P.) who screened electronic medical records for the outcome measure (stroke).

Cerebral infarction or ischemic stroke was defined as the acute onset of a neurologic deficit that persisted for longer than 24 hours and corresponded to an arterial vascular territory of the cerebral hemispheres, brainstem, or cerebellum, with or without computed tomographic or magnetic resonance imaging documentation. Transient ischemic attack was defined as an episode of focal neurologic symptoms with abrupt onset and rapid resolution, lasting less than 24 hours, and due to altered circulation to a limited region of the brain.

Only patients with ischemic strokes clinically documented by a neurologist were included in the analysis.

Primary Outcomes

Outcomes were the cumulative probability of ischemic stroke and predictors of stroke in the first 12 months after surgical treatment of the hip.

Statistical Analysis

Continuous variables are presented as mean (standard deviation [SD]); categorical variables are presented as number and percentage. Two‐sample t tests or Wilcoxon rank sum tests were used to test for differences between THAs and hip fracture repairs in demographic characteristics, past medical history, and baseline clinical data composed of continuous variables; 2 or Fisher exact tests were used for categorical variables. No patient was lost to follow‐up during the 1 year after the initial surgery. However, the data of patients who died or had a second hip procedure within that period were censored.

The rate of ischemic stroke within 1 year after the incident hip procedure was calculated using the Kaplan‐Meier method. Second hip procedures within that period were counted as additional cases. Rates were calculated for the overall group, as well as for the univariate risk factors of operative procedure type, age, sex, past medical history of stroke, hypertension, atrial fibrillation, CAD, chronic obstructive pulmonary disease (COPD), diabetes mellitus, and chronic renal insufficiency. Use of ‐blockers, hydroxymethylglutaryl‐coenzyme A (HMG‐CoA) reductase inhibitors, or aspirin at hospital admission was also considered. Cox proportional hazards regression models were used to evaluate the risk of ischemic stroke for each of these univariate risk factors. Multivariable Cox proportional hazards models were constructed with adjustments for operative procedure type, age, sex, and comorbid conditions such as atrial fibrillation and hypertension. These covariates were added in a stepwise selection to identify factors significantly associated with the outcome. To account for patients who had a second hip procedure within 1 year of their first operation, we calculated all Cox proportional hazards regression results using the robust sandwich estimate of the covariance matrix. The proportional hazards assumption for all Cox models was evaluated with the methods proposed by Therneau and Grambsch;6 no violations of this assumption were identified. The rate of postoperative stroke after adjusting for the competing risk of death was calculated using the approach of Gooley et al.7 All statistical tests were 2‐sided, and a P value was considered significant if it was less than 0.05. Statistical analyses were performed using statistical software (SAS version 9.1.3; SAS Institute, Inc., Cary, NC).

Results

Among the patients with the 1886 hip procedures, 67 ischemic strokes were identified within 1 year after the index surgical procedure10 (1.4%) among the 691 THAs and 57 (4.8%) among the 1195 hip fracture repairs. Baseline characteristics are summarized in Table 1. Compared with the THA group, patients in the hip fracture repair group were more likely to be older and female. Additionally, such comorbid conditions as a history of stroke, diabetes mellitus, congestive heart failure, atrial fibrillation, or dementia were more prevalent in the hip fracture repair group.

Baseline Characteristics of Study Population
CharacteristicsSurgical ProcedureTotal (n = 1,886)P Value*
THA (n = 691)Fracture Repair (n = 1,195)
  • NOTE: Continuous variables are represented as mean (SD); categorical variables are represented as number and percentage.

  • Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; CHF, congestive heart failure; THA, total hip arthroplasty.

  • P values are from Kruskal‐Wallis tests for continuous variables and from either 2 or Fisher exact tests for categorical variables.

  • Fifteen cases had no BMI data.

  • One case had no ASA risk classification data.

Age, years74.9 (6.59)84.2 (7.49)80.8 (8.46)<0.001
Sex, male258 (37.3)234 (19.6)492 (26.1)<0.001
Race, White690 (100)1,187 (99.3)1,877 (99.5)0.17
BMI27.7 (5.36)23.3 (4.93)24.9 (5.52)<0.001
History    
Hypertension424 (61.4)695 (58.2)1,119 (59.3)0.17
Diabetes57 (8.2)141 (11.8)198 (10.5)0.02
Stroke50 (7.2)334 (27.9)384 (20.4)<0.001
CHF100 (14.5)321 (26.9)421 (22.3)<0.001
Atrial fibrillation72 (10.4)241 (20.2)313 (16.6)<0.001
Dementia16 (2.3)407 (34.1)423 (22.4)<0.001
ASA risk classification   <0.001
1 or 2343 (49.6)172 (14.4)515 (27.3) 
3, 4, or 5348 (50.4)1,022 (85.6)1,370 (72.7) 
Medication on admission    
Aspirin168 (24.3)369 (30.9)537 (28.5)0.002
‐Blocker134 (19.4)184 (15.4)318 (16.9)0.03
Insulin12 (1.7)48 (4)60 (3.2)0.007
Length of stay, days7.3 (3.9)10.0 (7.61)9.0 (6.63)<0.001

Univariate analyses assessing the rate and risk of postoperative ischemic stroke are shown in Table 2. The rate of stroke was significantly greater among hip fracture repairs than THAs 30 days postoperatively and 1 year postoperatively (1.5% vs. 0.6% and 5.5% vs. 1.5%, respectively; P < 0.001) (Figure 2). In our study we found an annual incidence rate of ischemic stroke of 4093 per 100,000 person‐years (95% confidence interval [CI], 3172‐5198 per 100,000 person‐years). Accounting for death as a competing risk for stroke had little impact on the rate of stroke overall or within the 2 surgical groups (results not shown). Univariate Cox proportional hazards models showed that neither sex nor history of hypertension, diabetes mellitus, COPD, chronic renal insufficiency, or CAD or use of HMG‐CoA reductase inhibitors or ‐blockers were significant predictors of ischemic stroke. However, other clinical risk factors, such as a history of atrial fibrillation (hazard ratio [HR], 2.16; P = 0.005), hip fracture repair vs. THA (HR, 3.80; P < 0.001), increased age (HR, 2.20; P = 0.017), aspirin use (HR, 1.8; P = 0.014), and history of previous stroke (HR, 4.18; P < 0.001), were significantly associated with an increased risk of stroke (Table 2).

Figure 2
Kaplan‐Meier curves of cumulative probability of ischemic stroke after hip fracture repair vs. total hip arthroplasty (THA). Error bars indicate 95% confidence intervals; P < 0.001; hazard ratio = 3.8.
Univariate Estimates and Predictors of Postoperative Ischemic Stroke After Hip Operation
VariableNumber of PatientsNumber of EventsRate (%)Hazard RatioP Value
30‐Day (95% CI)1‐Year (95% CI)
  • Abbreviations: CAD, coronary artery disease; CI, confidence interval; COPD, chronic obstructive pulmonary disease; HMG‐CoA, hydroxymethyglutaryl coenzyme A; THA, total hip arthroplasty.

Overall1886671.2 (0.7‐1.7)3.9 (3‐4.8)  
Type of operative procedure      
THA691100.6 (0.0‐1.1)1.5 (0.6‐2.4)  
Hip fracture repair1195571.5 (0.8‐2.2)5.5 (4.1‐6.9)3.80 (1.94‐7.44)<0.001
Age at operation, years      
<75528111.0 (0.1‐1.8)2.1 (0.9‐3.3)  
751358561.3 (0.7‐1.9)4.7 (3.5‐5.8)2.20 (1.15‐4.21)0.02
Sex      
Female1394541.3 (0.7‐1.9)4.2 (3.1‐5.3)  
Male492130.8 (0.0‐1.7)2.9 (1.3‐4.4)0.69 (0.38‐1.27)0.24
History of stroke      
No1502340.7 (0.3‐1.2)2.4 (1.6‐3.3)  
Yes384333.0 (1.2‐4.7)9.9 (6.6‐13)4.18 (2.59‐6.74)<0.001
History of hypertension      
No767230.8 (0.2‐1.4)3.4 (2.0‐4.7)  
Yes1119441.5 (0.7‐2.2)4.2 (3.0‐5.5)1.29 (0.78‐2.14)0.32
History of atrial fibrillation      
No1573481.0 (0.5‐1.5)3.3 (2.4‐4.2)  
Yes313191.9 (0.4‐3.5)7.0 (3.9‐9.9)2.16 (1.27‐3.67)0.005
History of CAD      
No1224401.1 (0.5‐1.6)3.5 (2.4‐4.5)  
Yes662271.4 (0.5‐2.3)4.7 (2.9‐6.4)1.34 (0.82‐2.19)0.24
History of COPD      
No1606621.4 (0.8‐2.0)4.2 (3.1‐5.2)  
Yes28050 (0.0‐0.0)2.2 (0.3‐4.1)0.49 (0.20‐1.22)0.13
History of diabetes mellitus      
No1688561.1 (0.6‐1.7)3.6 (2.7‐4.5)  
Yes198111.5 (0‐3.3)6.3 (2.6‐9.9)1.75 (0.92‐3.34)0.09
History of renal insufficiency      
No1718581.0 (0.5‐1.5)3.7 (2.7‐4.6)  
Yes16893.0 (0.4‐5.5)5.8 (2‐9.5)1.77 (0.88‐3.57)0.11
Aspirin use      
No1349390.7 (0.2‐1.1)3.2 (2.2‐4.2)  
Yes537282.5 (0.1‐3.8)5.7 (3.6‐7.7)1.86 (1.13‐3.06)0.01
‐Blocker use      
No1568521.1 (0.6‐1.6)3.6 (2.7‐4.6)  
Yes318151.6 (0.2‐3.0)5.1 (2.6‐7.6)1.42 (0.81‐2.52)0.22
HMG‐CoA reductase inhibitor use      
No1736631.2 (0.7‐1.7)4.0 (3.0‐4.9)  
Yes (statin/other lipid lowering drugs)14841.4 (0‐3.2)2.8 (0.1‐5.4)0.70 (0.26‐1.94)0.50

Because age was associated with the type of surgical procedure (87% of hip fracture repair patients were 75 years or older compared with 45% of THA patients), the effect of hip fracture repair on ischemic stroke was adjusted for age. For similar reasons, sex was also examined as an adjusting factor. Adjustment for age and sex resulted in only a slight attenuation of the HR for hip fracture repair vs. THA, from 3.8 to 3.4. A further analysis also adjusted for history of hypertension and history of atrial fibrillation, both comorbidities commonly associated with ischemic stroke. After adjustment for age, sex, history of hypertension, and history of atrial fibrillation, the risk of ischemic stroke was still significantly greater in the hip fracture repair group than in the THA group (HR, 2.8; 95% CI, 1.4‐5.7; P = 0.005).

To determine the most important predictors of postoperative ischemic stroke, multivariable analysis was conducted with stepwise selection. Potential risk factors included the following: operative procedure type (hip fracture repair vs. THA), age, sex, and history of stroke, hypertension, atrial fibrillation, CAD, COPD, diabetes mellitus, and chronic renal insufficiency, as well as use of ‐blockers, HMG‐CoA reductase inhibitors, and aspirin on hospital admission. Among all these factors, history of stroke (HR, 3.27; P < 0.001) and hip fracture repair vs. THA (HR, 2.74; P = 0.004) were confirmed to be significant predictors of postoperative ischemic stroke; the other factors did not significantly affect the model (Figure 2).

Comment

Our findings contrast those of previous studies that focused on perioperative ischemic stroke rates for specific surgical procedures,2, 8, 9 but do seem concordant with published results for early event rates of cerebrovascular accident or transient ischemic attack (1%) following hip fracture.10 The data from our study suggest that perioperative stroke cumulative probability is relatively high for hip procedures at both 30 days (1.2%) and 1 year (3.9%) after the index surgical procedure compared with general procedures. Subjects with a history of stroke who were undergoing hip operation had a postoperative stroke risk of 3.0% at 30 days and 9.9% at 1 year.

The incidence of stroke was greater in the hip fracture repair group (1.5% at 30 days and 5.5% at 1 year) than in the elective THA group (0.6% at 30 days and 1.5% at 1 year). The increased 1‐year mortality for patients undergoing hip surgery compared with the general population is in part due to cerebrovascular disease,10 and, therefore, the 1‐year stroke incidence is important.

After adjustment for age, sex, and comorbidities (hypertension and atrial fibrillation), the risk of postoperative ischemic stroke was 2.71 times greater in the hip fracture repair group than in the THA group (P = 0.006). These data are important in counseling and caring for patients undergoing different types of hip procedures.

From 1985 through 1989, for the age group (75‐84 years old) that best fits the demographics of our cohort, both men and women had limited variation over time in annual incidence rates of stroke (2149‐1074 strokes per 100,000 population per year) for Olmsted County, MN.11 In our study we found an annual incidence rate of ischemic stroke of 4,093 per 100,000 person‐years (95% CI, 3172‐5198 per 100,000 person‐years). The lower limit of the 95% CI is higher than the rates reported for Olmsted County, suggesting that having hip surgery increases the 1‐year risk of ischemic stroke.

Previous studies have shown that the risk factor most consistently correlated to perioperative ischemic stroke is a history of stroke.9 In our study, history of stroke and type of hip fracture surgery were confirmed to be the strongest predictors of postoperative stroke. History of hypertension, atrial fibrillation, CAD, COPD, diabetes, or chronic renal insufficiency was not correlated to perioperative ischemic stroke.

Nonmodifiable risk factors, such as advanced age, serve as markers of stroke risk and help identify high‐risk populations that may require aggressive intervention. After age adjustment of hip fracture repair, age was no longer significantly associated with postoperative stroke.

Cerebrovascular disease appears to be a marker for CAD, and, therefore, patients with a history of stroke usually have a Revised Cardiac Risk Index that may suggest the use of ‐blockers. According to the recent results of the POISE trial, use of ‐blockers could lead to increased stroke incidence.2 Our results showed no significant correlation between stroke risk and ‐blocker use, but our study period was from 1988 to 2002, when titration of ‐blocker dose to heart rates of 55 to 60 beats per minute was not common practice.

Several studies have confirmed the value of aspirin in decreasing the rate of vascular outcomes after diagnosis of transient ischemic attack or stroke.12 In our study, aspirin use on hospital admission was found in the univariate analysis to be associated with an increased risk of stroke, but this finding was not confirmed after adjustments for age, sex, and comorbid conditions. Aspirin use on admission was not a significant predictor of postoperative stroke, most likely because aspirin use can be considered a marker of increased cardiovascular risk and we adjusted for these comorbid conditions.

The limitations of this study are inherent in its retrospective design. First, we identified all incident cases of stroke after hip operation by reviewing medical records and then abstracting data from those records. We may have missed some mild strokes if they were misclassified as peripheral vestibular neuropathy, migraine, or even seizure. Less likely is that we missed strokes within the first 30 days after the procedure because that is the period in which patients with hip operation are either hospitalized or sent for rehabilitation in skilled nursing facilities. It is known that institutionalization leads to better surveillance and more complete ascertainment of any medical event.

The event rate of postoperative stroke at 30 days after hip operation was low. Therefore, we did not have the statistical power to comment meaningfully on predictors of stroke at 30 days after the hip procedure. Any nonrespondent or volunteer bias was addressed by using data from the Rochester Epidemiology Project, which allowed us to identify all Olmsted County residents who underwent hip operation between 1988 and 2002. The diagnostic suspicion bias was also accounted for in our study design because different physicians provided care and outcome measurement.

Our results apply for the patients who underwent hip operation between 1988 and 2002. The noncardiac surgery guidelines have been revised between 1988 and 2002, and we did not perform a stratified analysis by index year. The next step in our study will be to extend our data collection to 2008 and look at time trends.

Conclusion

In this population‐based historical cohort study, patients undergoing hip operation had a 3.9% cumulative probability of ischemic stroke during the first postoperative year. History of stroke and type of hip procedure (ie, hip fracture repair) were the strongest predictors of this complication. Because history of stroke is such a strong predictor of postoperative stroke, the perioperative management of these patients should probably be tailored, with closely observed blood pressure management and antihypertensive medication adjustment, to avoid compromising cerebral perfusion. Also, to avoid postoperative hypercoagulability that increases the risk of stroke, these patients may need to begin receiving antiplatelets as soon as is surgically acceptable.1315

In the United States, hip operations (internal fixation of fracture or total hip arthroplasty [THA]) are the most common noncardiac major surgical procedures performed in patients age 65 years and older (45.2 procedures per 100,000 persons per year).1 This number of procedures is projected to increase substantially in the coming decades.

Little is known about the clinical predictors of postoperative stroke in patients undergoing hip surgical procedures. Further, recent results of the Perioperative Ischemic Evaluation (POISE) trial have shown that measures taken to reduce cardiac complications postoperatively may adversely affect the risk of stroke.2 The POISE study showed decreases in myocardial infarction and coronary revascularization but accompanying increases in stroke and death with use of ‐blockers in patients undergoing noncardiac surgery.

Prevention of adverse events is one of the top priorities of the U.S. health care system today.35 Risk stratification and therapeutic optimization of underlying chronic diseases may be important in decreasing perioperative risk and improving postoperative outcomes.

Our objective was to determine the rate of postoperative ischemic stroke in all residents of Olmsted County, MN, who underwent hip operation between 1988 and 2002 and to identify clinical predictors of postoperative stroke.

Subjects and Methods

Olmsted County is one of the few places in the world where comprehensive population‐based studies of disease etiology and outcomes are feasible. This feasibility is due to the Rochester Epidemiology Project, a medical records linkage system that provides access to the records of all medical care in the community.1 All medical diagnoses made for a resident of Olmsted County are entered on a master sheet in the patient's medical record, which is then entered into a central computer index.

Hip operations were identified using the Surgical Information Recording System data warehouse, where detailed data are stored as International Classification of Diseases, 9th edition (ICD‐9) codes for all surgical procedures performed from January 1, 1988, forward. A total of 2028 THAs and hip fracture repairs (ICD‐9 codes 81.51, 81.52, 81.53, 79.15, and 79.25) performed between 1988 and 2002 in Olmsted County were identified. Of the hip procedures, 142 were excluded (Figure 1). The final analysis cohort contained 1886 hip operations1195 hip fracture repairs and 691 THAs.

Figure 1
Flowchart showing subjects included in cohort of residents of Olmsted County, MN, and methods of identification and types of strokes identified. Fx, fracture.

The population‐based cohort was assembled and the data were abstracted from complete inpatient and outpatient records from admission for surgical treatment up to 1 year after surgery. Only those patients who had given prior authorization for research were included in the study cohort. The Mayo Clinic Institutional Review Board approved the study.

Case Ascertainment

We used several screening procedures to completely enumerate all postoperative strokes in our study population (Figure 1). The Mayo Clinic administrative database was used to identify all cases with relevant cerebrovascular disease (ICD‐9 codes 430.0‐437.9, 368.12, 781.4, and 784.3) within 1 year after hip operation. The Rochester Stroke Registry identified incident cases of ischemic stroke in Olmsted County from 1988 through 1994. The clinic's administrative database was also used to identify brain imaging studies (brain computed tomography, magnetic resonance imaging, or carotid ultrasonography) between the day of the procedure and 1 year postoperatively. A neurologist reviewed each image and the associated medical record identified during the screening process in detail for the constellation of signs and symptoms consistent with the diagnosis of stroke. Death certificates and autopsy reports were also reviewed to identify persons with the diagnosis of stroke. The outcome (stroke) was masked to the nurse abstractor who reviewed charts for predictors of postoperative stroke (eg, atrial fibrillation, coronary artery disease [CAD], history of stroke, medication use). The exposed or unexposed status of the patients to the predictors of stroke was masked to the physician (A.S.P.) who screened electronic medical records for the outcome measure (stroke).

Cerebral infarction or ischemic stroke was defined as the acute onset of a neurologic deficit that persisted for longer than 24 hours and corresponded to an arterial vascular territory of the cerebral hemispheres, brainstem, or cerebellum, with or without computed tomographic or magnetic resonance imaging documentation. Transient ischemic attack was defined as an episode of focal neurologic symptoms with abrupt onset and rapid resolution, lasting less than 24 hours, and due to altered circulation to a limited region of the brain.

Only patients with ischemic strokes clinically documented by a neurologist were included in the analysis.

Primary Outcomes

Outcomes were the cumulative probability of ischemic stroke and predictors of stroke in the first 12 months after surgical treatment of the hip.

Statistical Analysis

Continuous variables are presented as mean (standard deviation [SD]); categorical variables are presented as number and percentage. Two‐sample t tests or Wilcoxon rank sum tests were used to test for differences between THAs and hip fracture repairs in demographic characteristics, past medical history, and baseline clinical data composed of continuous variables; 2 or Fisher exact tests were used for categorical variables. No patient was lost to follow‐up during the 1 year after the initial surgery. However, the data of patients who died or had a second hip procedure within that period were censored.

The rate of ischemic stroke within 1 year after the incident hip procedure was calculated using the Kaplan‐Meier method. Second hip procedures within that period were counted as additional cases. Rates were calculated for the overall group, as well as for the univariate risk factors of operative procedure type, age, sex, past medical history of stroke, hypertension, atrial fibrillation, CAD, chronic obstructive pulmonary disease (COPD), diabetes mellitus, and chronic renal insufficiency. Use of ‐blockers, hydroxymethylglutaryl‐coenzyme A (HMG‐CoA) reductase inhibitors, or aspirin at hospital admission was also considered. Cox proportional hazards regression models were used to evaluate the risk of ischemic stroke for each of these univariate risk factors. Multivariable Cox proportional hazards models were constructed with adjustments for operative procedure type, age, sex, and comorbid conditions such as atrial fibrillation and hypertension. These covariates were added in a stepwise selection to identify factors significantly associated with the outcome. To account for patients who had a second hip procedure within 1 year of their first operation, we calculated all Cox proportional hazards regression results using the robust sandwich estimate of the covariance matrix. The proportional hazards assumption for all Cox models was evaluated with the methods proposed by Therneau and Grambsch;6 no violations of this assumption were identified. The rate of postoperative stroke after adjusting for the competing risk of death was calculated using the approach of Gooley et al.7 All statistical tests were 2‐sided, and a P value was considered significant if it was less than 0.05. Statistical analyses were performed using statistical software (SAS version 9.1.3; SAS Institute, Inc., Cary, NC).

Results

Among the patients with the 1886 hip procedures, 67 ischemic strokes were identified within 1 year after the index surgical procedure10 (1.4%) among the 691 THAs and 57 (4.8%) among the 1195 hip fracture repairs. Baseline characteristics are summarized in Table 1. Compared with the THA group, patients in the hip fracture repair group were more likely to be older and female. Additionally, such comorbid conditions as a history of stroke, diabetes mellitus, congestive heart failure, atrial fibrillation, or dementia were more prevalent in the hip fracture repair group.

Baseline Characteristics of Study Population
CharacteristicsSurgical ProcedureTotal (n = 1,886)P Value*
THA (n = 691)Fracture Repair (n = 1,195)
  • NOTE: Continuous variables are represented as mean (SD); categorical variables are represented as number and percentage.

  • Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; CHF, congestive heart failure; THA, total hip arthroplasty.

  • P values are from Kruskal‐Wallis tests for continuous variables and from either 2 or Fisher exact tests for categorical variables.

  • Fifteen cases had no BMI data.

  • One case had no ASA risk classification data.

Age, years74.9 (6.59)84.2 (7.49)80.8 (8.46)<0.001
Sex, male258 (37.3)234 (19.6)492 (26.1)<0.001
Race, White690 (100)1,187 (99.3)1,877 (99.5)0.17
BMI27.7 (5.36)23.3 (4.93)24.9 (5.52)<0.001
History    
Hypertension424 (61.4)695 (58.2)1,119 (59.3)0.17
Diabetes57 (8.2)141 (11.8)198 (10.5)0.02
Stroke50 (7.2)334 (27.9)384 (20.4)<0.001
CHF100 (14.5)321 (26.9)421 (22.3)<0.001
Atrial fibrillation72 (10.4)241 (20.2)313 (16.6)<0.001
Dementia16 (2.3)407 (34.1)423 (22.4)<0.001
ASA risk classification   <0.001
1 or 2343 (49.6)172 (14.4)515 (27.3) 
3, 4, or 5348 (50.4)1,022 (85.6)1,370 (72.7) 
Medication on admission    
Aspirin168 (24.3)369 (30.9)537 (28.5)0.002
‐Blocker134 (19.4)184 (15.4)318 (16.9)0.03
Insulin12 (1.7)48 (4)60 (3.2)0.007
Length of stay, days7.3 (3.9)10.0 (7.61)9.0 (6.63)<0.001

Univariate analyses assessing the rate and risk of postoperative ischemic stroke are shown in Table 2. The rate of stroke was significantly greater among hip fracture repairs than THAs 30 days postoperatively and 1 year postoperatively (1.5% vs. 0.6% and 5.5% vs. 1.5%, respectively; P < 0.001) (Figure 2). In our study we found an annual incidence rate of ischemic stroke of 4093 per 100,000 person‐years (95% confidence interval [CI], 3172‐5198 per 100,000 person‐years). Accounting for death as a competing risk for stroke had little impact on the rate of stroke overall or within the 2 surgical groups (results not shown). Univariate Cox proportional hazards models showed that neither sex nor history of hypertension, diabetes mellitus, COPD, chronic renal insufficiency, or CAD or use of HMG‐CoA reductase inhibitors or ‐blockers were significant predictors of ischemic stroke. However, other clinical risk factors, such as a history of atrial fibrillation (hazard ratio [HR], 2.16; P = 0.005), hip fracture repair vs. THA (HR, 3.80; P < 0.001), increased age (HR, 2.20; P = 0.017), aspirin use (HR, 1.8; P = 0.014), and history of previous stroke (HR, 4.18; P < 0.001), were significantly associated with an increased risk of stroke (Table 2).

Figure 2
Kaplan‐Meier curves of cumulative probability of ischemic stroke after hip fracture repair vs. total hip arthroplasty (THA). Error bars indicate 95% confidence intervals; P < 0.001; hazard ratio = 3.8.
Univariate Estimates and Predictors of Postoperative Ischemic Stroke After Hip Operation
VariableNumber of PatientsNumber of EventsRate (%)Hazard RatioP Value
30‐Day (95% CI)1‐Year (95% CI)
  • Abbreviations: CAD, coronary artery disease; CI, confidence interval; COPD, chronic obstructive pulmonary disease; HMG‐CoA, hydroxymethyglutaryl coenzyme A; THA, total hip arthroplasty.

Overall1886671.2 (0.7‐1.7)3.9 (3‐4.8)  
Type of operative procedure      
THA691100.6 (0.0‐1.1)1.5 (0.6‐2.4)  
Hip fracture repair1195571.5 (0.8‐2.2)5.5 (4.1‐6.9)3.80 (1.94‐7.44)<0.001
Age at operation, years      
<75528111.0 (0.1‐1.8)2.1 (0.9‐3.3)  
751358561.3 (0.7‐1.9)4.7 (3.5‐5.8)2.20 (1.15‐4.21)0.02
Sex      
Female1394541.3 (0.7‐1.9)4.2 (3.1‐5.3)  
Male492130.8 (0.0‐1.7)2.9 (1.3‐4.4)0.69 (0.38‐1.27)0.24
History of stroke      
No1502340.7 (0.3‐1.2)2.4 (1.6‐3.3)  
Yes384333.0 (1.2‐4.7)9.9 (6.6‐13)4.18 (2.59‐6.74)<0.001
History of hypertension      
No767230.8 (0.2‐1.4)3.4 (2.0‐4.7)  
Yes1119441.5 (0.7‐2.2)4.2 (3.0‐5.5)1.29 (0.78‐2.14)0.32
History of atrial fibrillation      
No1573481.0 (0.5‐1.5)3.3 (2.4‐4.2)  
Yes313191.9 (0.4‐3.5)7.0 (3.9‐9.9)2.16 (1.27‐3.67)0.005
History of CAD      
No1224401.1 (0.5‐1.6)3.5 (2.4‐4.5)  
Yes662271.4 (0.5‐2.3)4.7 (2.9‐6.4)1.34 (0.82‐2.19)0.24
History of COPD      
No1606621.4 (0.8‐2.0)4.2 (3.1‐5.2)  
Yes28050 (0.0‐0.0)2.2 (0.3‐4.1)0.49 (0.20‐1.22)0.13
History of diabetes mellitus      
No1688561.1 (0.6‐1.7)3.6 (2.7‐4.5)  
Yes198111.5 (0‐3.3)6.3 (2.6‐9.9)1.75 (0.92‐3.34)0.09
History of renal insufficiency      
No1718581.0 (0.5‐1.5)3.7 (2.7‐4.6)  
Yes16893.0 (0.4‐5.5)5.8 (2‐9.5)1.77 (0.88‐3.57)0.11
Aspirin use      
No1349390.7 (0.2‐1.1)3.2 (2.2‐4.2)  
Yes537282.5 (0.1‐3.8)5.7 (3.6‐7.7)1.86 (1.13‐3.06)0.01
‐Blocker use      
No1568521.1 (0.6‐1.6)3.6 (2.7‐4.6)  
Yes318151.6 (0.2‐3.0)5.1 (2.6‐7.6)1.42 (0.81‐2.52)0.22
HMG‐CoA reductase inhibitor use      
No1736631.2 (0.7‐1.7)4.0 (3.0‐4.9)  
Yes (statin/other lipid lowering drugs)14841.4 (0‐3.2)2.8 (0.1‐5.4)0.70 (0.26‐1.94)0.50

Because age was associated with the type of surgical procedure (87% of hip fracture repair patients were 75 years or older compared with 45% of THA patients), the effect of hip fracture repair on ischemic stroke was adjusted for age. For similar reasons, sex was also examined as an adjusting factor. Adjustment for age and sex resulted in only a slight attenuation of the HR for hip fracture repair vs. THA, from 3.8 to 3.4. A further analysis also adjusted for history of hypertension and history of atrial fibrillation, both comorbidities commonly associated with ischemic stroke. After adjustment for age, sex, history of hypertension, and history of atrial fibrillation, the risk of ischemic stroke was still significantly greater in the hip fracture repair group than in the THA group (HR, 2.8; 95% CI, 1.4‐5.7; P = 0.005).

To determine the most important predictors of postoperative ischemic stroke, multivariable analysis was conducted with stepwise selection. Potential risk factors included the following: operative procedure type (hip fracture repair vs. THA), age, sex, and history of stroke, hypertension, atrial fibrillation, CAD, COPD, diabetes mellitus, and chronic renal insufficiency, as well as use of ‐blockers, HMG‐CoA reductase inhibitors, and aspirin on hospital admission. Among all these factors, history of stroke (HR, 3.27; P < 0.001) and hip fracture repair vs. THA (HR, 2.74; P = 0.004) were confirmed to be significant predictors of postoperative ischemic stroke; the other factors did not significantly affect the model (Figure 2).

Comment

Our findings contrast those of previous studies that focused on perioperative ischemic stroke rates for specific surgical procedures,2, 8, 9 but do seem concordant with published results for early event rates of cerebrovascular accident or transient ischemic attack (1%) following hip fracture.10 The data from our study suggest that perioperative stroke cumulative probability is relatively high for hip procedures at both 30 days (1.2%) and 1 year (3.9%) after the index surgical procedure compared with general procedures. Subjects with a history of stroke who were undergoing hip operation had a postoperative stroke risk of 3.0% at 30 days and 9.9% at 1 year.

The incidence of stroke was greater in the hip fracture repair group (1.5% at 30 days and 5.5% at 1 year) than in the elective THA group (0.6% at 30 days and 1.5% at 1 year). The increased 1‐year mortality for patients undergoing hip surgery compared with the general population is in part due to cerebrovascular disease,10 and, therefore, the 1‐year stroke incidence is important.

After adjustment for age, sex, and comorbidities (hypertension and atrial fibrillation), the risk of postoperative ischemic stroke was 2.71 times greater in the hip fracture repair group than in the THA group (P = 0.006). These data are important in counseling and caring for patients undergoing different types of hip procedures.

From 1985 through 1989, for the age group (75‐84 years old) that best fits the demographics of our cohort, both men and women had limited variation over time in annual incidence rates of stroke (2149‐1074 strokes per 100,000 population per year) for Olmsted County, MN.11 In our study we found an annual incidence rate of ischemic stroke of 4,093 per 100,000 person‐years (95% CI, 3172‐5198 per 100,000 person‐years). The lower limit of the 95% CI is higher than the rates reported for Olmsted County, suggesting that having hip surgery increases the 1‐year risk of ischemic stroke.

Previous studies have shown that the risk factor most consistently correlated to perioperative ischemic stroke is a history of stroke.9 In our study, history of stroke and type of hip fracture surgery were confirmed to be the strongest predictors of postoperative stroke. History of hypertension, atrial fibrillation, CAD, COPD, diabetes, or chronic renal insufficiency was not correlated to perioperative ischemic stroke.

Nonmodifiable risk factors, such as advanced age, serve as markers of stroke risk and help identify high‐risk populations that may require aggressive intervention. After age adjustment of hip fracture repair, age was no longer significantly associated with postoperative stroke.

Cerebrovascular disease appears to be a marker for CAD, and, therefore, patients with a history of stroke usually have a Revised Cardiac Risk Index that may suggest the use of ‐blockers. According to the recent results of the POISE trial, use of ‐blockers could lead to increased stroke incidence.2 Our results showed no significant correlation between stroke risk and ‐blocker use, but our study period was from 1988 to 2002, when titration of ‐blocker dose to heart rates of 55 to 60 beats per minute was not common practice.

Several studies have confirmed the value of aspirin in decreasing the rate of vascular outcomes after diagnosis of transient ischemic attack or stroke.12 In our study, aspirin use on hospital admission was found in the univariate analysis to be associated with an increased risk of stroke, but this finding was not confirmed after adjustments for age, sex, and comorbid conditions. Aspirin use on admission was not a significant predictor of postoperative stroke, most likely because aspirin use can be considered a marker of increased cardiovascular risk and we adjusted for these comorbid conditions.

The limitations of this study are inherent in its retrospective design. First, we identified all incident cases of stroke after hip operation by reviewing medical records and then abstracting data from those records. We may have missed some mild strokes if they were misclassified as peripheral vestibular neuropathy, migraine, or even seizure. Less likely is that we missed strokes within the first 30 days after the procedure because that is the period in which patients with hip operation are either hospitalized or sent for rehabilitation in skilled nursing facilities. It is known that institutionalization leads to better surveillance and more complete ascertainment of any medical event.

The event rate of postoperative stroke at 30 days after hip operation was low. Therefore, we did not have the statistical power to comment meaningfully on predictors of stroke at 30 days after the hip procedure. Any nonrespondent or volunteer bias was addressed by using data from the Rochester Epidemiology Project, which allowed us to identify all Olmsted County residents who underwent hip operation between 1988 and 2002. The diagnostic suspicion bias was also accounted for in our study design because different physicians provided care and outcome measurement.

Our results apply for the patients who underwent hip operation between 1988 and 2002. The noncardiac surgery guidelines have been revised between 1988 and 2002, and we did not perform a stratified analysis by index year. The next step in our study will be to extend our data collection to 2008 and look at time trends.

Conclusion

In this population‐based historical cohort study, patients undergoing hip operation had a 3.9% cumulative probability of ischemic stroke during the first postoperative year. History of stroke and type of hip procedure (ie, hip fracture repair) were the strongest predictors of this complication. Because history of stroke is such a strong predictor of postoperative stroke, the perioperative management of these patients should probably be tailored, with closely observed blood pressure management and antihypertensive medication adjustment, to avoid compromising cerebral perfusion. Also, to avoid postoperative hypercoagulability that increases the risk of stroke, these patients may need to begin receiving antiplatelets as soon as is surgically acceptable.1315

References
  1. Melton LJ.History of the Rochester Epidemiology Project.Mayo Clin Proc.1996;71(3):266274.
  2. POISE Study Group;Devereaux PJ,Yang H,Yusuf S,Guyatt G,Leslie K,Villar JC, et al.Effects of extended‐release metoprolol succinate in patients undergoing non‐cardiac surgery (POISE trial): a randomised controlled trial.Lancet.2008;371(9627):18391847.
  3. Thom T,Haase N,Rosamond W,Howard VJ,Rumsfeld J,Manolio T, et al;American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.Circulation.2006;113(6):e85e151.
  4. Shojania KG, Duncan BW, McDonald KM, Wachter RM, Markowitz AJ, eds.Making health care safer: a critical analysis of patient safety practices. Evidence Report/Technology Assessment No.43.AHRQ publication no. 01‐E058.Rockville, MD:Agency for Healthcare Research and Quality (AHRQ),U.S. Department of Health and Human Services;2001.668 p.
  5. McDonald CJ,Weiner M,Hui SL.Deaths due to medical errors are exaggerated in Institute of Medicine report.JAMA.2000;284(1):9395.
  6. Therneau TM,Grambsch PM.Modeling survival data: extending the Cox model.New York:Springer;2000.
  7. Gooley TA,Leisenring W,Crowley J,Storer BE.Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.Stat Med.1999;18(6):695706.
  8. Larsen SF,Zaric D,Boysen G.Postoperative cerebrovascular accidents in general surgery.Acta Anaesthesiol Scand.1988;32(8):698701.
  9. Landercasper J,Merz BJ,Cogbill TH,Strutt PJ,Cochrane RH,Olson RA, et al.Perioperative stroke risk in 173 consecutive patients with a past history of stroke.Arch Surg.1990;125(8):986989.
  10. Lawrence VA,Hilsenbeck SG,Noveck H,Poses RM,Carson JL.Medical complications and outcomes after hip fracture repair.Arch Intern Med.2002;162(18):2053–2057.
  11. Brown RD,Whisnant JP,Sicks JD,O'Fallon WM,Wiebers DO.Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989.Stroke.1996;27(3):373380.
  12. CAST (Chinese Acute Stroke Trial) Collaborative Group.Randomised placebo‐controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke.Lancet.1997;349(9066):16411649.
  13. Dixon B,Santamaria J,Campbell D.Coagulation activation and organ dysfunction following cardiac surgery.Chest.2005;128(1):229236.
  14. Páramo JA,Rifón J,Llorens R,Casares J,Paloma MJ,Rocha E.Intra‐ and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery.Haemostasis.1991;21(1):5864.
  15. Selim M.Perioperative stroke.N Engl J Med.2007;356(7):706713.
References
  1. Melton LJ.History of the Rochester Epidemiology Project.Mayo Clin Proc.1996;71(3):266274.
  2. POISE Study Group;Devereaux PJ,Yang H,Yusuf S,Guyatt G,Leslie K,Villar JC, et al.Effects of extended‐release metoprolol succinate in patients undergoing non‐cardiac surgery (POISE trial): a randomised controlled trial.Lancet.2008;371(9627):18391847.
  3. Thom T,Haase N,Rosamond W,Howard VJ,Rumsfeld J,Manolio T, et al;American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.Circulation.2006;113(6):e85e151.
  4. Shojania KG, Duncan BW, McDonald KM, Wachter RM, Markowitz AJ, eds.Making health care safer: a critical analysis of patient safety practices. Evidence Report/Technology Assessment No.43.AHRQ publication no. 01‐E058.Rockville, MD:Agency for Healthcare Research and Quality (AHRQ),U.S. Department of Health and Human Services;2001.668 p.
  5. McDonald CJ,Weiner M,Hui SL.Deaths due to medical errors are exaggerated in Institute of Medicine report.JAMA.2000;284(1):9395.
  6. Therneau TM,Grambsch PM.Modeling survival data: extending the Cox model.New York:Springer;2000.
  7. Gooley TA,Leisenring W,Crowley J,Storer BE.Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.Stat Med.1999;18(6):695706.
  8. Larsen SF,Zaric D,Boysen G.Postoperative cerebrovascular accidents in general surgery.Acta Anaesthesiol Scand.1988;32(8):698701.
  9. Landercasper J,Merz BJ,Cogbill TH,Strutt PJ,Cochrane RH,Olson RA, et al.Perioperative stroke risk in 173 consecutive patients with a past history of stroke.Arch Surg.1990;125(8):986989.
  10. Lawrence VA,Hilsenbeck SG,Noveck H,Poses RM,Carson JL.Medical complications and outcomes after hip fracture repair.Arch Intern Med.2002;162(18):2053–2057.
  11. Brown RD,Whisnant JP,Sicks JD,O'Fallon WM,Wiebers DO.Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989.Stroke.1996;27(3):373380.
  12. CAST (Chinese Acute Stroke Trial) Collaborative Group.Randomised placebo‐controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke.Lancet.1997;349(9066):16411649.
  13. Dixon B,Santamaria J,Campbell D.Coagulation activation and organ dysfunction following cardiac surgery.Chest.2005;128(1):229236.
  14. Páramo JA,Rifón J,Llorens R,Casares J,Paloma MJ,Rocha E.Intra‐ and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery.Haemostasis.1991;21(1):5864.
  15. Selim M.Perioperative stroke.N Engl J Med.2007;356(7):706713.
Issue
Journal of Hospital Medicine - 4(5)
Issue
Journal of Hospital Medicine - 4(5)
Page Number
298-303
Page Number
298-303
Publications
Publications
Article Type
Display Headline
Predictors of ischemic stroke after hip operation: A population‐based study
Display Headline
Predictors of ischemic stroke after hip operation: A population‐based study
Legacy Keywords
arthroplasty, hip, hip fracture, ischemia, stroke
Legacy Keywords
arthroplasty, hip, hip fracture, ischemia, stroke
Sections
Article Source

Copyright © 2009 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Division of Hospital Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Article PDF Media